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ABSTRACT 
Birch, Garrison L.  M.S., Purdue University, December 2011. Lipidomic Profiling 
in Dictyostelium discoideum.  Major Professor:  Robert E. Minto. 
 
 
The lipid profile of Dictyostelium discoideum, a cellular slime mold found 
evolutionarily between plants and animals, has never been clearly defined.  To 
address this, the fatty acid content of vegetative cells was analyzed by gas 
chromatography-mass spectrometry of fatty acid methyl esters and their 
identities verified with synthesized authentic standards.  The synthetic scheme 
developed to produce the unusual fatty acids found in D. discoideum was 
engineered to afford the labeling of compounds (2H) for use in feeding studies to 
elucidate the fatty acid elongation and desaturation pathways present in D. 
discoideum.  After establishing the fatty acid profile and acyl metabolic pathway, 
an initial understanding the complex lipids present in D. discoideum, chiefly 
sphingolipids, was sought.  Triple quadrupole and quadrupole time-of flight mass 
spectrometers equipped with electrospray ionization sources were used to  
identify these complex lipids. 
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CHAPTER 1. INTRODUCTION 
1.1. Fatty acid elongation and Dictyostelium discoideum 
 It has long been understood that de novo fatty acids (FAs; Figure 1) are 
biosynthesized in animals and plants by Type I and II fatty acid synthases, 
respectively (3).  However, it is becoming increasing apparent that fatty acids 
produced from de novo synthesized FAs via elongation pathways exhibit 
extraordinary bioactive functionality, as elongated FAs have become known to be 
essential bioregulators through their incorporation into specialized lipids, such as 
sphingolipids (SLs; Figure 1) (4, 5).  SLs constitute an emerging class of bioactive 
molecules, influencing such biological processes as signal transduction, 
metabolism and apoptosis (6, 7). 
Fatty acid elongation, the lengthening of acyl-CoA chains by two carbon 
units, produces the long-chain fatty acids (LCFAs, C14-C20) and very long-chain 
fatty acids (VLCFAs, >C20).  These fatty acids are lengthened in a manner 
analogous to that mediated by fatty acid synthase, but are instead catalyzed by 
specialized enzymes known as elongases.  The condensation reaction is 
catalyzed by two families of condensing enzymes; the 3-ketoacyl-CoA synthases 
(KCSs), which are characteristic of plants (8), and the ELO enzymes (for 
elongation), which are found in all eukaryotes that have been examined, 
including mammals, plants, algae and fungi (9).  Both condensing enzyme 
families initiate elongation, then pass their product on to a 3-ketoacyl-CoA 
reductase of the elongation complex.  With both alternative pathways ultimately 
arriving at the same end products, it is unclear why some organisms have both 
pathways, while many (such as animals) possess only one. 
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Figure 1.  Relevant lipid structures; a monounsaturated C18 fatty acid, a 
phospholipid, and the sphingolipids, sphingosine-1-phospate, ceramide, and 
glycoceramide. 
Dictyostelium discoideum, the free living cellular slime mold found 
evolutionarily between plants and animals, is an important model for 
understanding fatty acid elongation because it possesses examples of both 
condensing enzyme families; four ELO genes and one 3-ketoacyl-CoA synthase 
gene.  Furthermore, D. discoideum has been shown to be active in the 
elongation of both saturated and unsaturated fatty acid substrates (10).   
D. discoideum is an important model for understanding various signaling 
and developmental processes in higher eukaryotes, such as cell-to-cell 
communication, intracellular signaling, and cytoskeletal organization that have 
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been found to be conserved across eukaryotes (11, 12).  The sequencing of the 
D. discoideum genome was published in 2005 (13).  Comparison of its predicted 
proteome to other eukaryotes resulted in D. discoideum’s placement in the 
eukaryotic phylogeny (Figure 2) along the animal branch, diverging shortly after 
plants and before fungi (14).  Despite the close proximity of D. discoideum to 
fungi, it is thought to have more in common with animals due to fungi’s 
accelerated rate of divergence relative to plants and animals (14). 
 
 
Figure 2.  The positioning of D. discoideum on the eukaryotic phylogenetic tree 
(13). 
Dictyostelium lives in an amoeboid or unicellular form in its natural habitat 
of decaying soil rich in bacteria, which is its main food source.  However, when 
nutrients become scarce, cells aggregate and progress through a developmental 
program ultimately producing a multicellular fruiting body, composed of two main 
cell types: stalk and spore cells (Figure 3).  Spore cells germinate once nutrition 
has been reestablished (12).  During starvation, cells amass in response to cyclic 
adenosine monophosphate (cAMP) pulses, initially forming loose and tight 
mounds of cells (stages 1 and 2), which develop into a “finger” (stage 4) or 
migrating slug (stage 3).  After a variable time period of phototaxis, a “Mexican 
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hat” emerges (stage 5), which culminates and ultimately forms the fruiting body 
(stage 6) (12).  As such, D. discoideum is often referred to as a "social amoeba" 
because it forms a multicellular structure during famine.  Some of the signaling 
pathways involved in this developmental program have been elucidated (11, 12, 
15), and literature suggests that specific molecular species of sphingolipids may 
play particular roles in this development.  Therefore, the practicality of D. 
discoideum as a model organism to interpret the relevance of VLCFAs is twofold.  
Not only is it applicable in terms of elongation studies, but sphingolipids, which 
often contain such VLCFAs, are believed to play a role in a unique 
developmental pathway that is observed when it is subjected to starvation. 
 
Figure 3.  Composite electron micrograph of the developmental stages of D. 
discoideum upon starvation. © M.J. Grimson & R.L. Blanton. 
Studies underscoring the key participatory nature of sphingolipids in 
development and signaling D. discoideum are becoming increasingly more 
common, as well as indications that this organism and its sphingolipids may 
provide valuable information for other fields of research (16-19).  Sphingosine-1-
phosphate (S1P, Figure 1) exhibits a significant role in the signal transduction 
pathways that regulate cell proliferation and cell death, as well as in growth and 
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multicellular development (17).  Disruption of expression of S1P lyase in 
Dictyostelium that is responsible for degradation of S1P resulted in abnormal 
morphogenesis.  The absence of sphingosine-1-phosphate lyase affected 
multiple stages of development; the aggregation of cells, the ability to form 
migrating slugs, the control of developmental gene expression, terminal spore 
differentiation, and the ability to complete morphogenesis (17).   
Dictyostelium sphingolipid metabolism has been used as a model in 
cancer research (18, 20).  Researchers have identified potential means of 
increasing the efficacy of a commonly used chemotherapy drug, cisplatin, using 
D. discoideum as a model organism.  The performance of this drug is often only 
short-term, due to a resistance that develops over time.  A D. discoideum mutant 
defective in the sphingosine-1-phosphate lyase gene was found with increased 
resistance to the drug, uncovering that elevated levels of sphingosine-1-
phosphate correlated to increased resistance to cisplatin.  Treatment of D. 
discoideum cell lines with varying levels of overexpression of sphingosine-1-
phosphate lyase (to increase S1P degradation) with cisplatin resulted in an 
increase in sensitivity to the drug as monitored by assessing cell viability (18).  
This work suggested that blocking sphingolipid production could increase the 
sensitivity to cisplatin, and presented points of pharmacological intervention that 
could increase the clinical effectiveness of the drug (18).   
The unique characteristics of this organism provide an opportunity to 
probe the distinctive (or redundant) properties of each elongase, specifically the 
role of its products in sphingolipids.  Prior to examination of the modes of 
elongation in D. discoideum and interpreting the roles of elongated fatty acids 
and sphingolipids in its biological processes, it is essential to establish the fatty 
acid biosynthetic pathways by which these species are produced, as well as the 
sphingolipid profile of D. discoideum.  As such, this research focuses upon 
characterizing the fatty acids of D. discoideum, elucidating their metabolism, and 
identifying the D. discoideum sphingolipids.  The objective of this work was to 
construct a lipidomic profile of D. discoideum that can be used in addressing the 
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question of whether the identity of a sphingolipid’s acyl chain targets it for a 
specific biological function.  
There are several long-term practical applications from this research.  As 
many of these sphingolipids are responsible for such life-altering signaling 
processes as apoptosis (11), a proper understanding of these pathways may 
allow for the development of pesticides and/or herbicides that can induce similar 
effects while maintaining a low environmental impact.  Alternatively, this work 
may aid in the development of methods of artificially increasing the production of 
specific sphingolipids, such as ceramides, which are becoming popular 
ingredients in therapeutic products such as lotions and creams for skin disorders, 
chiefly eczema (21, 22). 
1.2. Fatty acid biosynthesis and degradation 
Fatty acids are long hydrocarbon chains terminated by a carboxylic acid.  
They are almost exclusively referenced in shorthand.  For example, the 
monounsaturated fatty acid seen in Figure 1, oleic acid, is abbreviated as 18:19, 
conveying that it contains 18 carbons, has one point of unsaturation, located at 
the 9th carbon (∆9; counting from the carboxyl group).  Similarly, a 16:25,9 FA 
describes a C16 chain with double bonds at the 5 and 9 positions.  While fatty 
acids encompass a large class of lipids, the biological functions of FAs can be 
generalized into four basic categories:  1) the building blocks of glycolipids, 
phospholipids and sphingolipids that comprise biomembranes; 2) a major storage 
form of metabolic fuel in the form of triacylglycerols; 3) as hormones and 
secondary messengers upon specific modification; and 4) as modifying agents in 
membrane-bound proteins. 
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1.2.1. Fatty Acid Biosynthesis 
Plants and animals synthesize a wide array of fatty acids although only a 
very few of these lipids are major and common cellular constituents (9).  De novo 
fatty acid biosynthesis occurs in the cytosol of animals and the plastids of plants, 
where the lipids are constructed from acetyl coenzyme A (CoA) units and 
assembled via acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS).  
The primary end product of this iterative process is palmitate (16:0), and to a 
lesser extent myristate (14:0) and stearate (18:0).  Odd chain length fatty acids 
can be constructed in the same fashion by condensation with propionyl-CoA, or 
through an oxidative pathway known as α-oxidation (3). 
Two physically distinct forms of the acetyl-CoA carboxylase enzyme are 
found in nature.  In plants, it is a three subunit enzyme, while a higher efficiency 
form exists in mammals with the three subunits fused into a single polypeptide 
chain and an additional allosteric regulatory subunit activated by citrate to control 
FA production.  Fatty acid synthase also exists in two forms: it occurs as a 
multifunctional homodimer in eukaryotes (Type I), while the more primitive FA 
synthase (Type II; prokaryotes) can be separated into individual subunits (3, 23). 
Acetyl-CoA carboxylase catalyzes the first committed step of fatty acid 
synthesis, the carboxylation of acetyl-CoA to malonyl-CoA.  The biosynthetic 
intermediates are then transferred from coenzyme A-derivatives to an acyl carrier 
protein (ACP) of FA synthase (by acetyl/malonyl transacylases-Figure 4a), and 
acetyl-ACP binds to 3-ketoacyl-ACP synthase (KS; Figure 4b) (3).  Malonyl-ACP 
is equipped for coupling to an acetyl-KS primer; it is decarboxylated to form an 
enolate, which nucleophilically attacks the carbonyl of an acetyl-KAS, displacing 
the acetyl group from the KS unit, and yielding an acetoacyl-ACP (4 carbon 
chain) (3).  Acetoacyl-ACP then undergoes reduction, dehydration, and a second 
reduction catalyzed by 3-ketoacyl-ACP-reductase, 3-hydroxyacyl-ACP-
dehydrase, and enoyl-ACP reductase (Figure 4c,d,e, respectively), to yield 
butyryl-ACP, at which point the process repeats by condensing another malonyl-
ACP with butyryl-ACP to continue building the fatty acid (3).  After seven rounds 
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of elongation, the palmitoyl-ACP product is hydrolyzed from the enzyme by 
palmitoyl thioesterase (Figure 4f), and the 16:0 free fatty acid is quickly 
sequestered again in the form of palmitoyl-CoA, becoming available for 
incorporation into complex lipids and subjection to desaturation, elongation, and 
hydroxylation enzymatic modifications.  However, depending upon the 
modification, it may take place after the fatty acid has been esterified/N-acylated 
to a complex lipid. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The synthesis of saturated fatty acids in plants and mammals. 
Elongation of fatty acids beyond the palmitate product of FA synthase to 
long and very long chain fatty acids is a common modification, with the products 
acting as signaling metabolites and components for waxes and sphingolipids.  
The process involves four enzymes, an acyl-CoA substrate, malonyl-CoA, and 
NADPH (Figure 5) (3).  Unlike acetyl-CoA carboxylase and fatty acid synthase, 
which are soluble enzymes, the elongases are membrane-bound and sited in the 
endoplasmic reticulum (ER), where elongation takes place (24).  Elongation can 
occur not only with de novo saturated and unsaturated fatty acid substrates, but 
also with those obtained through dietary sources (25).  A significant distinction 
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from fatty acids produced during elongation is that the substrates remain 
esterified to Coenzyme A.  Malonyl-CoA continues to serve as the 2-carbon unit 
donor in a reaction sequence similar to standard FA biosynthesis.  The first step 
in FA elongation, the condensation of a C2 unit from malonyl-CoA with a fatty 
acyl-CoA substrate, is catalyzed by a 3-ketoacyl-CoA synthase (Figure 5a; KCS 
or ELO), with liberation of CO2 and CoA.  Next, a 3-ketoacyl-CoA reductase 
(Figure 5b) reduces the resulting ketone to a hydroxyl group, which is dehydrated 
by a 3-hydroxyacyl-CoA dehydratase (Figure 5c) to produce a trans alkene.  
Finally, a second reduction of the alkene is catalyzed by trans-2,3-enoyl-CoA 
reductase (Figure 5d) to form the acyl-CoA (3).  The elongation of acyl-CoA 
precursors can be extensive.  The waxes of plant leaves have been found to 
contain even numbered FA chains up to 36 carbons in length (8) while the 
majority of sphingolipid acyl chains range from C20 to C30 (4). 
 
Figure 5. The primary fatty acid elongation pathway of eukaryotes. 
A second common form of FA modification is desaturation.  Iron-
dependent enzymes known as desaturases introduce double bonds (usually with 
the cis configuration) at regiospecific positions along a fatty acid chain.  
Unsaturated fatty acid chains serve an important function in the structural 
organization of cellular membranes as a proper ratio of saturated to unsaturated 
FAs helps regulate membrane fluidity (3).  They also have bioactive roles, acting 
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as signaling metabolites both in the free fatty acid state as well as when 
incorporated into more complex lipids (3, 4, 26). 
 FA desaturases can be sorted into two groups: the soluble acyl carrier 
protein desaturases and the membrane-bound desaturases.  The soluble ACP 
desaturases introduce double bonds into ACP-linked fatty acids, and are located 
in the stroma of plant plastids (26).  In terms of the membrane-bound enzymes, 
the acyl-lipid desaturases responsible for desaturation of glycerolipid acyl chains 
are sited within the endoplasmic reticulum in mammals and the chloroplast 
membrane in plants.  The acyl-CoA desaturases, which insert double bonds into 
CoA-derivatized fatty acids, are located within the ER of animals and fungi (26). 
The insertion of an alkene in an acyl-CoA is an electron-transfer reaction 
that is accomplished with three membrane proteins of the ER in eukaryotic cells: 
a desaturase, cytochrome b5 and NADH-cytochrome b5 reductase (3, 26).  Two 
protons are extracted from the FA hydrocarbon chain as the double bond is 
formed (Figure 6) by reducing molecular oxygen to form two molecules of water.  
The arrows of Figure 6 outline the flow of electrons from NADH to the desaturase 
via the FAD-containing reductase and cytochrome b5 (26). 
 
Figure 6.  Desaturation of stearoyl-CoA (3). 
Hydroxylated fatty acids are commonly incorporated into sphingolipids and 
are believed to offer stabilizing effects in the form of hydrogen bonding (5), 
imparting greater structural integrity to membranes (27, 28).  The SL acyl groups 
are normally saturated and, while the hydroxyl group most commonly located at 
the α-position, there are examples of ω-hydroxy (5) and dihydroxy FAs that have 
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been observed in sphingolipids (4, 6).  FA hydroxylation reactions often take 
place succeeding this incorporation, as there are fatty acid hydroxylases (also 
referred to as ceramide hydroxylases) with specificity for complex lipid substrates 
such as ceramides (4, 29).  Hydroxylases share a high degree of homology with 
desaturases (30).  In some cases, a substitution of as few as four amino acids 
can differentiate between desaturation or hydroxylation activity (30, 31). 
1.2.2. Fatty Acid Degradation 
 Degradation of fatty acids is commonly referred to as β-oxidation, and is 
the sequential 2-carbon unit breakdown of fatty acids over four enzymatic 
reactions, producing acetyl-CoA units, which can be utilized as metabolic fuel or 
for the biosynthesis of new fatty acids.   Prior to undergoing β-oxidation, free 
fatty acids are released from complex lipids (such as stored or dietary 
triacylglycerols (TAGs) and phospholipids) via lipase enzymes and esterified to 
Coenzyme A (3).  Once an acyl-CoA species, β-oxidation of saturated chains 
begins with the acyl-CoA dehydrogenase-catalyzed oxidation of the β-carbon of 
the acyl-CoA to generate a trans alkene (enoyl-CoA; Figure 7) (3).  Step 2 
involves the stereospecific hydration of the double bond to create 3-hydroxylacyl-
CoA, followed by a second oxidation with NAD+ to yield a 3-ketoacyl-CoA.  The 
fourth and final step utilizes β-ketothiolase, which breaks the diketone bond 
between carbons 2 and 3 via nucleophilic attack of the carbon 3 carbonyl with -
SCoA, thioesterifying the new two-carbon shorter acyl chain and yielding acetyl-
CoA.  The cycle repeats until the fatty acid has been completely degraded, with 
the final round of degradation yielding two acetyl-CoA species (or acetyl-CoA and 
propionyl-CoA during β-oxidation of odd-numbered chains) (3). 
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Figure 7.  Examples of β-oxidation for saturated and unsaturated fatty acids. 
The oxidation of unsaturated fatty acids proceeds in much the same 
fashion as saturated FAs, but requires additional enzymes to facilitate 
degradation of the alkenes.  As most unsaturated FAs do not have double bonds 
closer to the carbonyl than the ∆5 position, one or more cycles of “normal” β-
oxidation will occur until an alkene is encountered.  The cis double bonds of most 
FAs create an obstacle for the enoyl-CoA hydratase enzyme, which 
stereospecifically hydrates a trans alkene (Figure 7).  An enoyl-CoA isomerase is 
therefore employed to convert the alkene to the trans confirmation, and β-
oxidation continues (3).  Another problematic situation is illustrated in Figure 7, 
where the oxidation product of acyl-CoA dehydrogenase yields a trans bond at 
carbon 2, but if there is a point of unsaturation at carbon 4, enoyl-CoA hydratase 
cannot hydrate the alkene at carbon 2 halting β-oxidation.  Reductases reduce 
the diene and shift the 2-alkene to a 3-alkene.  This enoyl-CoA is then 
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isomerized to generate a trans-2-enoyl-CoA, the desired substrate for β-oxidation 
(3).     
 The degradation of odd chain length fatty acids proceeds in precisely the 
same manner, with the final thiolysis step yielding acetyl-CoA and propionyl-CoA 
(3). Propionyl-CoA is decarboxylated and subjected to a cascade of reactions 
that converts it to pyruvate (and ultimately acetyl-CoA).  In terms of biosynthesis, 
odd chains can be produced via an oxidative pathway known as α-oxidation, 
which shortens the overall chain length by a single carbon unit.  α-Oxidation is 
not employed strictly for biosynthetic means, it is also widely utilized to 
breakdown FAs that cannot undergo β-oxidation, specifically those containing 
modifications at the β-carbon.  An illustration of this pivotal process shown in 
Figure 8.  This breakdown begins with hydroxylation at the α-carbon, followed by 
removal of the thioester, and decarboxylation in the form of formyl-CoA.  The 
resulting aldehyde with one fewer carbon atoms can then be oxidized to the 
carboxylic acid by aldehyde dehydrogenase and esterified to CoA, such that 
standard β-oxidation can recommence (3). 
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Figure 8.  α-Oxidation of a β-substituted fatty acid. 
1.3. Sphingolipids 
Sphingolipids are essential for eukaryotic life (5).  They comprise an 
amazingly diverse class of bioactive lipids and until recently were thought to be 
merely structural components of biological membranes.  However, within the past 
decade and a half, these unique lipids have been implicated in an array of 
cellular processes, including cell structure, regulation and metabolism (4, 32).  
Intrinsic to eukaryotes as well as some prokaryotes and viruses, sphingolipids 
have been shown to be active signal transduction mediators: regulating cell 
growth, differentiation, proliferation, and stress responses, and influencing cell 
motility (5).  They also act in the formation of specialized structures (such as lipid 
rafts), mediate cell-cell interactions, and regulate the activity of intracellular 
proteins (5, 6).  As structural components, they constitute an average of 30% of 
the total lipid found in the plasma membranes of eukaryotes (5). 
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In simplistic terms, sphingolipids are derived from a variety of structurally 
similar long chain bases (LCBs-see Figure 9), also referred to as sphingoid 
bases.  An LCB is the defining structural scaffold or “backbone” upon which the 
various classes of sphingolipids are constructed (7).  They are aliphatic amines, 
typically 18 carbons in length, containing two or three hydroxyl groups near the 
amino terminus, and often equipped with a trans alkene at C-4.   In Figure 9, note 
the (2S,3R)-erythro stereochemistry, consistent among all LCBs.  Standard fatty 
acid nomenclature applies, and the italicized prefixes “d” and “t” denote di- and 
trihydroxlyation respectively, while Z or E designates a cis or trans alkene 
configuration, respectively. 
 
Figure 9. The most commonly observed sphingolipid long chain bases in plants, 
animals, and yeast (4, 33). 
Mammalian tissues are found to contain almost exclusively sphingosine, 
while phytosphingosine is the most prevalent LCB identified in plants and yeast 
(4, 5, 33).  Alternatively, insects are often found to contain shorter long chain 
bases: the fruit fly Drosophila melanogaster, commonly used in genetic research, 
has a C14 sphingoid base as its main component (34).  Trace amounts of 
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hundreds of sphingoid bases have been isolated from various organisms and 
characterized (35).  These backbones are distinguished by chain lengths, points 
of unsaturation and hydroxylation, stereochemistry, and even such chain 
modifications as methylations, cyclic rings and the presence of alkynes (35).  
These highly specialized LCBs are usually produced for incorporation into a 
specific class of sphingolipid.  For example, eicosasphingosine (d20:1) is only 
found in the gangliosides extracted from brain (36) and intestinal tissues (35, 37). 
While it may be commonly perceived that only the complex sphingolipids 
are responsible for the bioactivity observed in organisms, this is far from the 
case.  Sphingoid bases exhibit a vast range of structural diversity, and many of 
the known bases have been shown to display important biological functionality in 
their free states, typically in the form of cell signaling (35).  Potent signaling 
properties include the phosphorylated form of sphingosine (sphingosine-1-
phosphate) and other LCB phosphates that have been implicated in the abscisic 
acid-mediated stomatal closure in Arabidopsis (38).  In the fungus Aspergillus 
nidulans, the free LCB forms of d18:0 and t18:0 induce apoptosis (39).  Many of 
the more unique sphingoid natural products have exhibited toxicity towards 
cancer cells and pathogens, giving rise to their further investigation as potential 
chemotherapy leads (35). 
The first instance along the sphingolipid metabolic pathway where long 
chain bases are modified into more specialized sphingolipids occurs when they 
are N-acylated to form the SL subgroup known as ceramides; an example is 
shown in Figure 1.  An acyl chain can range from C14 to upwards of C40 in some 
tissues (4).  They are usually saturated but have been observed to contain up to 
two points of unsaturation; other modifications to the fatty acid include 
hydroxylation (usually at the α-position) and amination (4, 5).  Ceramides are 
very active signaling agents that require tight regulation, as they have been 
shown to mediate such processes as cell growth, differentiation, secretion and 
apoptosis (22).   
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While ceramides are the crucial intermediate for all complex sphingolipids, 
they rarely accumulate in any quantity in tissues other than skin (22).  Due to 
their potentially lethal signaling capacities, they are quickly utilized as precursors 
for more complex lipids, via linkage at the terminal primary hydroxyl group to 
moieties such as phosphates and carbohydrates (Figure 1). 
1.3.1. Sphingolipid Biosynthesis 
De novo sphingoid base synthesis begins with the condensation of 
palmitoyl-CoA and serine to form 3-keto-sphinganine via serine 
palmitoyltransferase (Figure 10).  Similarly, less common bases are formed using 
varying acyl-CoAs.  For example, C20 bases are synthesized by condensation 
with stearoyl-CoA. This first step is thought to be the rate-determining step of 
ceramide biosynthesis (22).  The resulting ketone is reduced by 3-
ketosphinganine reductase, yielding a hydroxyl group at position 3 and the 
product sphinganine (d18:0, dihydrosphingosine), the saturated form of 
sphingosine.  At this point, the fate of sphinganine diverges: its hydroxylation via 
sphinganine hydroxylase yields phytosphingosine (t18:0), or dihydroceramides 
(or phytoceramides) can be generated by ceramide synthase N-acylation of 
sphinganine (or phytosphingosine) (7, 22).   The enzyme dedicated to the 
acylation of LCB is generically labeled as dihydroceramide synthase, but various 
isoforms of this enzyme exist among plants and animals, each with specificities 
for both the long chain base and the acyl-CoA substrates (22).   
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Figure 10.  The biosynthesis of long chain bases and ceramides (22). 
While it may seem counterintuitive, sphingosine is not formed in its free 
long chain base state.  After sphinganine is coupled with an acyl-CoA to form a 
dihydroceramide, a ceramide desaturase enzyme inserts a trans double bond at 
the 4-position of the sphingoid backbone, to yield sphingosine (and the 
designation changes to ceramide) (22).  This is the only pathway with which this 
LCB can be produced, but sphingosine is a bioactive contributor as the free base 
as well.  An additional enzyme is active in regulating the appropriate 
concentrations of sphingosine and ceramide: a ceramidase cleaves the amide 
linkage to liberate the free LCB as needed, and ceramide synthase sequesters 
sphingosine back into ceramide form.  Once at the ceramide platform, a large 
host of enzymes are available to convert this pivotal precursor into more 
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specialized sphingolipids, such as ceramide-1-phosphates, phosphoinositols and 
glycosphingolipids (22).  The particular enzymes that are present and the 
modifications that take place are specific to each organism. 
Ceramide-1-phosphates (C1P; Figure 11) are produced when ceramide 
kinase phosphorylates a ceramide at the terminal (1-position) hydroxyl group of 
the long chain base.  In animals, a specific pool of ceramides is phosphorylated 
by ceramide kinase (22, 40).  However, there is evidence that other means of 
generating ceramide-1-phosphate must exist, as mice in which the ceramide 
kinase gene has been disrupted still demonstrate normal levels of C1P and the 
metabolite cannot be produced via acylation of sphingosine-1-phosphate (41).  
While C1P appears characteristic of animal tissues, a ceramide kinase has also 
been observed in Arabidopsis and other higher plants, but not in yeast (42, 43).  
The enzyme’s function has not been fully elucidated, but as C1P has been 
implicated in defense mechanisms, it may act to remove excess ceramide and 
make the plant more resilient to environmental stresses (44).  Additionally, it 
appears that an equilibrium between ceramide and ceramide-1-phosphate may 
regulate apoptosis (45). 
Another prominent SL class is the inositolphosphoryl ceramides (IPCs; 
Figure 11), which are essentially the sphingolipid analogue of 
phosphatidylinositol.  IPCs constitute a vital component of the sphingolipids in 
many eukaryotic species but are not, however, found in animals (5, 46).  These 
SLs are biosynthesized via ceramide phosphorylinositol synthase, which 
catalyzes the transfer of an inositol phosphate moiety from phosphatidylinositol to 
a ceramide (4).  They are generally comprised of phytosphingosine backbones, 
have been observed in both plants and fungi, and primarily contain saturated 
fatty acid chains, which may be α-hydroxylated (5). 
While only a few plant species have been examined, their IPCs primarily 
contain phytosphingosine bases with 24:0 acyl chains (4, 47). In the case of 
fungi, in S. cerevisiae, the only sphingolipid class that contains polar head groups 
is derived from phosphoinositol (IPC and mannosyl inositol 
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phosphorylceramides-MIPC) with phytosphingosine backbones (1, 5, 48).  P. 
pastoris contains SL classes in addition to IPCs such as glucosylceramides and 
sphinganine-containing species (49). 
 
Figure 11. The building blocks of ceramide, ceramide-1-phosphate, 
glycosylceramide, and inositolphosphoryl ceramide complex sphingolipids (4). 
Glycosphingolipids (GSLs; Figure 11) consist of a saccharide coupled via 
a β-glycosidic linkage to the terminal hydroxyl group of the LCB.  This linkage is 
achieved through the enzyme-catalyzed transfer of a uridine 5-diphosphate-
coupled sugar directly to the ceramide of interest (7, 22).  Some of the most 
common GSLs are glucosylceramide, which is a major constituent of the outer 
leaflet of plasma membranes, and galactosylceramide, the largest single 
component in myelin sheaths (22).  The addition of a carbohydrate head group is 
typically classified as acidic (gangliosides) or neutral (oligoglycosylceramides), 
further diversifying this class of complex sphingolipid.  Over 500 different 
carbohydrate structures have been identified in GSLs, with the most prominent 
sugars being glucose, galactose, fucose, N-acetylglucosamine (GlcNAc), N-
acetylgalactosamine (GalNAc) and sialic acids (Figure 12) (7).  The number of 
sugar head groups ranges from one to upwards of twenty monosaccharide units 
in some animals (7). 
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Figure 12.  Common GSL carbohydrate head groups. 
Research Objectives 
In order to understand the roles of elongated fatty acids and sphingolipids 
in D. discoideum, the identification of the lipids present in a cell is essential.  The 
endogenous FAs must be identified and their metabolic pathways elucidated in 
order to understand the roles of FAs in the organism.  In the current work, fatty 
acids were first identified using commercial and synthetic standards.  Once a 
fatty acid profile was developed, the focus shifted toward elucidating the 
metabolic pathway by which the FAs are biosynthesized and degraded.  This 
work was pursued with particular interest in identifying the source of 18:25,11 and 
18:111 that constitutes the majority of the FAs in Dictyostelium.  Finally, the 
sphingolipids were analyzed.  SL research has evolved from classical TLC to 
HPLC and mass spectrometry-based analysis.  With the innovations of 
instrumentation design that have taken place in the past decade, tandem mass 
spectrometry (MS/MS) combined with electrospray ionization (ESI) has proven to 
be an exceptionally robust and efficient method of analyzing this vast lipid class 
(32, 50).  These analytical techniques are discussed in detail in Chapter 4. 
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CHAPTER 2. FATTY ACID PROFILING OF DICTYOSTELIUM DISCOIDEUM 
2.1. Introduction 
To begin to uncover the products of the two condensing enzyme families 
and available desaturases, it was necessary to correctly identify the fatty acids 
produced by D. discoideum, specifically the chain length and positioning of 
double bonds within the aliphatic chains.  Preliminary determination of the fatty 
acids of D. discoideum was performed with fatty acid methyl esters (FAMEs) 
prepared from axenic cells grown in shaking culture and analyzed by gas 
chromatography-mass spectrometer (GC-MS).  FAMEs are employed because 
the acidic conditions by which they are prepared will cleave the ester bonds that 
link fatty acids to the backbones of complex lipids and converts them to methyl 
esters.  Ester derivatives are preferred over free fatty acids for their ease of 
analysis; they chromatograph and analyze substantially better on a GC-MS (51, 
52). 
Comparisons of GC retention time and MS fragmentation upon ionization 
of FAMEs prepared from cells with the commercial standards 16:0, 16:19, 18:0, 
18:19, and 18:111 allowed for the identification of a number of FAs.  For the 
remaining unidentified FAs, preliminary identifications were made with fatty acid 
pyrrolidine (FAPys) derivatives, which exhibit diagnostic fragmentation patterns 
upon ionization in an electron impact (EI) source. 
The attractiveness of pyrrolidine derivatives is found in their unique display 
of ion fragments that allow for the placement of double bonds deduced from the 
diagnostic fragment ions observed in MS analysis (51).  This is illustrated in 
Figure 13.  Beginning with the molecular ion (m/z 333) and comparing daughter 
ion pairs until a difference of 12 m/z is denoted, a double bond’s position can be 
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ascertained, based upon the number of methylene groups that are between the 
molecular ion and the point at which a difference of 12 mass units is observed 
(51). 
 
 
 
 
 
 
This mathematical approach to locating the alkenyl groups was verified 
using FAPYs of standards.  Using this methodology, the Blacklock lab 
preliminarily identified the remaining uncharacterized FAs in D. discoideum.  As 
no commercial standards exist for many of the preliminarily identified FAs, 
unambiguous identification required the direct synthesis of several compounds in 
order to establish a profile.  The candidate list of fatty acids included 16:15c, 
16:25c,9c, 17:25c,9c, 18:25c,11c, and 18:27c,11c (10).  In addition to the FAs outlined by 
Blacklock et al. (10), two FAs were discussed in the profile of Dictyostelium by 
Saito et al.: 18:15c and 18:25c,9c (53).  To resolve this discrepancy, these two FAs 
were also slated for synthetic production and a strategy was formulated to 
produce these commercially unavailable compounds. 
2.2. Methods and materials 
All manipulations were performed in glass conical vials unless otherwise 
mentioned.  Fatty acid standards were obtained from Sigma Aldrich.  All solvents 
Figure 13. The mass spectrum of the pyrrolidine derivative of 18:25c,11c. 
24 
 
 
used were of HPLC grade.  The components used to make HL5 media and 
penicillin-G potassium were obtained from Fisher Scientific, and streptomycin 
sulfate and N,O-bis(trimethylsilyl) trifluoroacetamide (BSTFA) were supplied by 
Sigma Aldrich.  AX4 D. discoideum was obtained from the dictyBase Stock 
Center and was maintained on 100 x 20 mm BD Falcon polystyrene tissue 
culture dishes (catalog number 353003).   
2.2.1. Maintenance and growth of Dictyostelium discoideum 
D. discoideum was maintained axenically at 22 °C in liquid HL5 media 
(components in Appendix) and penicillin/streptomycin (pen/strep; 100 μg/mL) on 
tissue culture plates.  Passage of cells (150 μL of media from the expiring plate) 
into 15 mL fresh media was performed every 4-6 days.  As living AX4 cells 
adhere to the plastic surface of the plate and dead cells float in the media, the 
plate bottom was flushed with the residing media to suspend living cells into 
solution prior to inoculation of the new plate.  
For analysis of D. discoideum fatty acids, 50-mL cultures were set in 250-
mL autoclaved flasks containing HL5 and pen/strep, and inoculated with 1.0 mL 
of media from a well-established plate of Dictyostelium (grown to the time of 
passage).  Cells were grown at 22 °C with shaking (180 RPM) to a density of 
~3.0x107 cells/mL measured under a microscope using a hemocytometer. 
2.2.2. Preparation and Analysis of Derivatives 
Fatty acid methyl esters were prepared from cells collected by 
centrifugation of cultures (50-mL culture of ~3.0x107 cells/mL) at 450g to remove 
media, and washed by vortexing with nanopure H2O and centrifugation at 450g 
(repeated 3x).  The resulting cellular pellet was incubated for 1 h at 80 °C with 1 
mL of 2% H2SO4 in MeOH.  FAMEs were isolated upon the addition of 1 mL of 
H2O and extraction with 3x with 2 mL of hexane, followed by evaporation of 
hexane to dryness under a stream of nitrogen.   
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Fatty acid pyrrolidines were prepared by incubating a dry sample of fatty 
acid methyl esters from a 50-mL culture of ~3.0x107 cells/mL with 250 μL of 
pyrrolidine and 25 μL of glacial acetic acid at 100 °C for 1 h.  The product was 
isolated upon addition of 1 mL of H2O and extraction with 3 mL of 1:1 diethyl 
ether/hexane, then washing the organic extracts 2x with 1 mL of H2O.  The 
diethyl ether/hexane solution was evaporated under a stream of nitrogen. 
Trimethylsilyl (TMS) derivatives of hydroxy fatty acids were prepared by 
dissolving a neat FAME sample from 50-mL culture of ~3.0x107 cells/mL in 1 mL 
of acetonitrile (ACN) and 70 μL of BSTFA and incubating at 70 °C for 30 min.  
The silylating agent and ACN were evaporated under a stream of nitrogen. 
FAME, FAPy, and TMS-FAME samples were resuspended in 0.5 mL of 
hexane for GC-MS analysis, but volumes were often adjusted to suit the 
particular sample concentration after initial analysis.  Derivatized samples were 
analyzed on an Agilent 7890A GC/5975C MS with a 30 m HP-5 column using the 
GC oven methods outlined in Figure 14 and injection volumes of 1 μL.  The 
ionization efficiencies among all fatty acids were assumed to be equal. 
 
 
 
 
 
 
 
 
Figure 14.  The GC oven methods for FAME and FAPY analysis. 
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2.3. Results and discussion 
2.3.1. Synthesis of authentic fatty acid standards 
The production of the required specialized fatty acids was quite efficient, 
as the synthesis used a single precursor containing functionality readily modified 
to become the carboxylic acid, and relied upon commercially available alkynes 
and alkyl halides to equip each alkyl chain with the desired length and placement 
of alkenyl groups.  The overall synthetic approach utilized the practicality of 
acetylene chemistry to couple alkyl chains together where the alkynes were 
positioned to afford regiospecifically-placed cis alkene(s) upon reduction.    A 
versatile 4-carbon protected alkyl iodide precursor (3; Figure 15) was 
synthetically produced from the commercially available ethyl 4-bromobutanoate, 
and was employed in the development of all fatty acids with the exception of 
18:27,11.  In order to preserve the carbonyl functionality, the precursor was 
protected with a dioxolane, and coupled to attach a variety of alkyl acetylenes.  
After alkyne reduction, the dioxolane was removed, and the resulting aldehyde 
was oxidized to generate each fatty acid. 
 
Figure 15. Generic fatty acid reaction scheme. 
Preparation of 3 commenced with the diisobutylaluminium hydride (DIBAL-
H) reduction of ethyl 4-bromobutanoate to its corresponding aldehyde 1 (54).  
Despite it being well-established that DIBAL is selective for the reduction of 
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esters to the aldehyde oxidation state, initial experimentation showed a 
considerable amount of this ethyl ester was being over-reduced to the alcohol.  It 
was suspected that, while the reaction runs in dichloromethane (DCM) at -78 °C, 
localized heating readily occurs upon addition of DIBAL and that this increase in 
thermodynamic energy is sufficient to cause over-reduction if the reducing agent 
is introduced too quickly.  The issue was resolved by employing a syringe pump 
with addition at 1 mL/min, allowing for 1 to be quantitatively produced.   Despite 
the fact that the reaction was essentially quantitative by 1H NMR, the overall yield 
for compound 1 was extremely variable, largely due to the low molecular weight 
and boiling point of the compound.  Even upon gentle rotary evaporation, the 
material easily entered the vapor phase. 
The aldehyde 1 was then protected from nucleophilic attack in subsequent 
n-BuLi reactions using ethylene glycol and catalytic amounts of para-
toluenesulfonic acid (p-TsOH) (54).  Upon refluxing the mixture in benzene with a 
Dean-Stark apparatus for 3 h, approximately 90% of the aldehyde had been 
converted to the 1,3-dioxolane.  The remaining low boiling point 1 was removed 
from 2 under high vacuum.  To complete the preparation of 3, the alkyl bromide 2 
was converted to an alkyl iodide via reflux with acetone and sodium iodide, also 
known as the Finkelstein reaction (55).  The crude material was subjected to 
purification on a silica gel column to remove any ester and aldehyde materials 
that may have remained affording a 78% yield.  To preserve the material from 
degradation by spontaneous HI formation, 3 was stabilized by storage over 
K2CO3. 
A 6-carbon version of this protected dioxolane (6; Figure 16, the precursor 
necessary to position alkenes at the 7th and 11th carbons for production of the 
18:27,11 fatty acid) was produced through the same synthetic manipulations using 
ethyl 6-bromohexanoate. 
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Figure 16. The synthesis of dioxolanes 3 and 6. 
The selection of an alkyne for the next step pivoted around the desired 
location(s) of the double bonds in the product FA.  For example, in order to 
produce 18:25,11, the 4-carbon unit 3 needed to be attached to the diacetylene 
1,7-octadiyne, placing the alkynyl groups at positions 5 and 11.  Once the 
positions of the acetylenes were locked in place, a second alkylation with an alkyl 
halide (1-iodohexane) of appropriate length to complete the overall chain was 
carried out. 
 The deprotonation of acetylenes by n-BuLi took place in THF at -78 °C 
with the addition of a co-solvent, hexamethylphosphoramide (HMPA), which 
assists by coordinating Li+ and activating the n-Bu anion.  Deprotonation of a 
single terminal alkyne was achieved by addition of 1.2 equivalent units of the 
base with respect to the alkyne.  After stirring for 30 min at -78 °C, deprotonation 
was complete and the reaction was allowed to warm to room temperature, at 
which time the alkyl halide was added, and the mixture refluxed for 18 h.  Upon 
silica-gel purification, the yields for diacetylene reactions (compounds 7, 8, 9) 
hovered around 50%, because ~50% of the diacetylene material is deprotonated 
once, while ~25% is deprotonated twice, and ~25% remains protonated.   
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Figure 17.  The intermediary diacetylenes 7, 8 and 9. 
Secondary couplings that involved a single site of deprotonation were 
obtained in much greater efficiency, with yields approaching 90%.  The 
monounsaturated compounds were completed first (16:15 and 18:15); their low 
yields relative to the others stemmed from a substandard bottle of n-BuLi.  Table 
1 summarizes the various reagents used to afford a particular end product. 
Table 1. Summary of alkylations and the resulting products. 
   Starting Material Alkylating material Product Yield 
 3 1-dodecyne 16:1 
5     (10) 54% 
 3 1-tetradecyne 18:1 
5    (11) 62% 
 7 1-iodohexane 18:2 
5,11 (12) 80% 
 8 1-iodohexane 16:2 
5,9  (13) 85% 
 8 1-iodooctane 18:2 
5,9  (14) 74% 
 8 1-iodoheptane 17:2 
5,9  (15) 76% 
 9 1-iodohexane 18:2 
7,11 (16) 91% 
 
With the aliphatic backbone of each fatty acid assembled, the acetylenes 
were hydrogenated using Lindlar’s catalyst (5% Pd on CaCO3).  The catalyst, 
poisoned with lead, selectively reduces an alkyne to a cis alkene.  This reaction 
was performed in 100% ethanol, with the addition of quinoline, to further poison 
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the reaction, and exposed to H2 atmosphere provided by a balloon (56).  The 
initial reduction test was allowed to react for 24 h, which yielded a mixture of 
over-reduced alkane and the desired product.  In troubleshooting this issue, a 
reaction was set and monitored hly by gas chromatography.  Analysis confirmed 
reduction of the acetylenes after 1 h and 1H NMR verified formation of the 
desired cis alkene in quantitative yield.  Quinoline was removed from the crude 
material by passage through a silica-gel column prior to deprotection.  Removal 
of the dioxolane protecting group was accomplished in 90% yield by refluxing in 
wet acetone (15% H2O) (57).  Lingering dioxolane material was not separated 
from the aldehyde, as its presence did not hinder the final oxidation step and it 
could be more readily purified away from the carboxylic acid than the aldehyde.  
The conversion of the aldehyde to the carboxylic acid was achieved at room 
temperature via an NaH2PO4-buffered water/DMSO solution containing sodium 
chlorite (NaClO2) as the oxidant (58).  The conditions were conducive to 
consumption of virtually all aldehyde starting material.  Following flash 
chromatography, the final compounds were separated from any remaining 
dioxolane species in an 80-90% yield.  An overall summary of this synthetic 
scheme, including yields, is provided in Figure 18.  In addition, Section 5.2 
contains experimental details for each reaction, using the synthesis of 18:25,9 as 
a template. 
31 
 
 
 
Figure 18.  Synthesis of specialized fatty acids. 
2.3.2. The fatty acid profile of D. discoideum 
Upon completion of the synthesis of the fatty acid standards, the 
endogenous FAs of D. discoideum were identified by comparison of the retention 
time and fragmentation pattern of their derivatized forms (FAMEs and FAPys) 
with the synthesized standards.  A representative total ion chromatogram (TIC) 
from the analysis of FAMEs is shown in Figure 19. 
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Figure 19.  The TIC of the FAMEs of D. discoideum. 
A retention time comparison to synthetic standards is made in Table 2, 
comprised of the FAs determined to be present in D. discoideum.  The two 
standards listed at the bottom denote FAs not found in the profile: 18:15 and 
18:25,9.  
Table 2.  GC-MS retention time comparison of methyl ester and pyrrolidine 
derivatized synthetic standards to the FAs found in AX4 D. discoideum. 
Fatty 
Acid FAMES Pyrrolidines  
  Std RT D.d. RT Std RT D.d. RT  
16:25,9 12.964   12.956 27.540 27.530  
16:15 13.107   13.115 27.892 27.898  
17:25,9 14.205 14.205 30.187 30.191  
18:25,11 15.657     15.662 32.868 32.874  
18:27,11 15.751     15.749 33.430 33.435  
        
18:25,9 15.665 - 32.893 -   
18:15 15.934 - 33.356 -   
  
22:0 
18:0 
18:25,11 
16:19 
16:25,9 
18:19 
18:27,11 
17:19 
17:25,9 
16:0 
CHO 
17:0 
18:111 
16:0 
16:15 
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As the pyrrolidine derivative provides a more rigorous examination of 
structural characteristics by mass spectrometry, a comparison of the 
fragmentation patterns of endogenous and standard FAPys removed any 
ambiguity presented by slight variances in retention time.  Figure 20 underscores 
the ability to distinguish between isomers by contrasting the fragmentation 
observed in 18:25,11 and 18:27,11 pyrrolidines. 
 
    
 
 
 
 Generating the fatty acid profile using two separate techniques provided 
unequivocal characterization, and definitively ruled out the presence of 18:15 and 
18:25,9.  The identities of each FA and their percent compositions are presented 
in Figure 21.  The profile was created using the previous work of Blacklock et al. 
(10) and the comparison of synthetic standards.  The percent compositions were 
derived from cell cultures grown axenically to 3.0x107 cells/mL.  The percent 
composition was calculated by obtaining the areas under each peak by 
integration performed by ChemStation to determine the abundance of each FA.  
The area of each FA was then divided by the sum of the areas of all FAs (see 
Equation 1). 
஺௥௘௔௢௙ி஺
ௌ௨௠௢௙௔௥௘௔௦௢௙௔௟௟ி஺௦ ݔͳͲͲ ൌ Ψܿ݋݉݌݋ݏ݅ݐ݅݋݊                  (1) 
Figure 20.  The investigative power of FAPYs in fragmentation-based analysis: 
contrasting 18:25,11 (left) and 18:27,11 (right). 
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Figure 21.  The percent composition of fatty acids of D. discoideum. 
The vast majority (~70%) of all observed fatty acids is comprised of 
18:25,11 and 18:111.   The overall profile of FAs observed in Dictyostelium 
discoideum is as follows: 16:0, 16:15, 16:19, 16:25,9, 17:0, 17:19, 17:25,9, 18:25,11, 
18:27,11, 18:19, 18:111, 18:0, and 22:0, with trace levels of 20:0 (not shown). 
In addition to the collection of saturated and unsaturated FAs, 
hydroxylated fatty acids were also detected in Dictyostelium.  Gas 
chromatographic analysis of these lipids is difficult due to the presence of the 
hydroxyl group.  To reduce the polarity of these compounds, the hydroxyl groups 
can be silylated to form the corresponding TMS derivative (59).  The mass 
spectrum of a TMS-derivatized hydroxylated C20 FA is shown in Figure 22, 
representing the most abundant hydroxy FA observed in D. discoideum.  The 
molecular ion itself is presented as a relatively weak signal (m/z 414), but two 
additional pieces of information make this hydroxylated species readily 
identifiable; strong signals represent the loss of one methyl group of the TMS 
moiety (m/z 399) and the cleavage between carbons 1 and 2 (m/z 355). 
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There were also four α-hydroxy fatty acids detected in much lower 
abundances than h20:0.  Comparable concentrations of h18:0, h19:0, h21:0 and 
h22:0 were observed, which cumulatively accounted for approximately the same 
amount as h20:0 alone. 
The final component observed in the TIC of Dictyostelium FAMEs was 
difficult to identify.  This unknown peak eluted between the C16 and C17 fatty acids 
at 15.1 min, and its molecular weight did not correspond to any possible FAME.  
It was not until it began to exhibit incorporation in the feeding experiments of 
Section 3.3.2. that it became apparent it was potentially a product of fatty acid 
metabolism.  While saturated and monounsaturated fatty acids have an m/z 74 
base peak ion, corresponding to a McClafferty rearrangement, the unknown 
species exhibited a m/z 75 base peak (Figure 23).  The weak molecular ion of 
this species (m/z 285) was only observable when very high sample 
concentrations were injected, and as a result, the initial characterization of this 
compound began under the impression that the m/z 255 signal was the 
molecular ion. 
Figure 22. The mass spectrum of TMS-derivatized 2-hydroxy 
eicosanoic acid (h20:0) from Dictyostelium. 
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Without knowing the correct molecular ion, no feasible identifications 
emerged from the data in hand, so a different strategy was employed to provide 
new information.  It was unclear whether the strong base peak was the product of 
a McClafferty rearrangement (inset Figure 23).  If it was, outside of a nitrogen 
substitution, there was no plausible explanation for a single mass unit difference  
from the classical m/z 74 McClafferty fragment intrinsic to FAMEs.  The methoxy 
end of a McClafferty fragment derives from the acidic methanol incubation that 
transesterifies the fatty acid.  It was reasonable to suspect that if this m/z 75 base 
peak was a McClafferty rearrangement product, it also would contain this 
methoxy group in some fashion.  To test whether it was incorporating the 
methanol-derived methoxy group, the FAME derivatization was modified by 
substituting deuterated methanol (CD3OD) as the reacting solvent in 2% d2-
sulfuric acid.  If the base peak was derived from the transesterification reaction, 
addition of three deuterium should shift it to m/z 78.  The results however, were 
quite perplexing, as the base peak shifted to m/z 81, while the 255 signal only 
increased to m/z 259 (Figure 24).   
Figure 23.  The mass spectrum of the unknown species of D. 
discoideum. 
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Figure 24.  The mass spectrum of the unknown species with CD3OD reacting 
solvent. 
While the outcome was unexpected, it indicated that this was not a 
McClafferty product, as somehow two methyl groups were found in the base 
peak, and if the 255 ion did not increase by m/z 6 as well, then one of the methyl 
groups must be lost, signifying that it was not in fact the molecular ion.  After 
close examination of the CD3OD experiment, a m/z 292 ion could be seen, which 
correlated to a m/z 285 ion in the standard FAME analysis.  The cations that 
correspond to the observed fragments are shown in Figure 25. 
 
Figure 25. The 16:0 acetal fragments. 
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Upon reflecting on the possible reactions that could be occurring to form 
this as the molecular ion, it was determined that the results were consistent with 
a 16:0 aldehyde.  The actual molecule that is being observed upon GC-MS 
analysis was essentially a “protected” aldehyde, or acetal.  The mechanism in 
Figure 26 contrasts how the acetal seen in Figure 25 is produced upon 
incubation with acidic methanol, with the fatty acid methyl ester that is released 
from a complex lipid. 
 
Figure 26.  The mechanisms of FAME and acetal formation. 
The reactions proceed in much the same manner except that only one 
esterification occurs when FAMEs are generated because the complex lipid acts 
as a good leaving group.  As the aldehyde has no such leaving group, the 
hemiacetal is susceptible to a second nucleophilic attack by methanol, 
generating the acetal.  The presence of aldehydes is a curious discovery in 
biological terms.  Free aldehydes have been described in the waxes which cover 
the organs of plants (60), but it may be more plausible to suspect that the 
aldehyde is formed as the result of cleavage of a vinyl ether from a complex lipid 
(structure in Figure 27). 
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Figure 27.  Example of an ether lipid. 
Ether lipids are a form of complex lipid with a polar head group attached to 
a glycerol backbone with either O-alkyl or O-alk-1-enyl ether attachments (as well 
as fatty acids).  Those possessing the alkene moiety have a cis double bond at 
carbon 1 (adjacent to the ether linkage) and are referred to as vinyl ethers (61).  
Typically, only the sn-1 position is ether linked, commonly with 16:0, 18:0, and 
18:1 chains.  Furthermore, vinyl ethers are known to yield aldehydes during 
acidic transesterifications, and such lipids are found in animals and are minor 
components in several higher plants (61).  This is a plausible complex lipid 
structure that would result in the release of an aldehyde upon incubation in acidic 
methanol, and a mechanistic reasoning to support this statement can be seen in 
Figure 28. 
 
Figure 28.  The mechanism of aldehyde release from a vinyl ether. 
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 In summary, five α-hydroxy fatty acids were detected in the AX4 strain D. 
discoideum.  Comparable concentrations of h18:0, h19:0, h21:0 and h22:0 were 
observed, accounting for approximately 50% of the hydroxy FAs, while h20:0 
encompassed the remaining 50%.  Three aldehydes were also found in their 
dimethoxy acetal forms, likely originating from vinyl ethers.  The 16:0 species 
was present in comparable levels to that of the 16:0 FAME, along with traces of 
18:0 and 18:1.  The remainder of the FA profile was composed of the fatty acids 
16:0, 16:15, 16:19, 17:0, 17:19, 16:25,9, 17:25,9, 18:25,11, 18:27,11, 18:19, 18:111, 
18:0, 20:0 (trace) and 22:0, with 18:25,11 and 18:111 comprising approximately 
70% of the content. 
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CHAPTER 3. FATTY ACID METABOLISM IN DICTYOSTELIUM DISCOIDEUM 
3.1. Introduction 
With a fatty acid profile in place, the focus of research shifted towards 
elucidating the metabolic pathway by which D. discoideum FAs are 
biosynthesized by supplementing cultures with deuterium-labeled fatty acids.  
This work was pursued with particular interest in the generation of 18:25,11 and 
18:111, which make up the majority of the FAs in Dictyostelium.  This profile 
differs from plants, which have high levels of ∆9 and ∆12 unsaturated FAs (62, 
63).  The process of developing a fatty acid metabolic pathway for Dictyostelium 
involved deducing the possible cascade(s) of enzymatic reactions that could 
generate the array of fatty acid products observed in the profile from 16:0 and 
18:0.  A hypothetical metabolic pathway was conceived based upon the FA 
profile and known Dictyostelium enzymes (10, 13, 53, 64, 65), in order to begin to 
limit the number of practical paths and provide a general outline for how these 
products may be formed (Figure 29).  The inclusion of the ∆11 desaturase 
pathway was purely hypothetical; however, the extremely high levels of ∆11 
unsaturated fatty acids in the profile begs the question of whether a portion of 
these pools could be attributed to such an enzyme. 
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Figure 29.  The hypothetical fatty acid metabolic pathway for D. discoideum.   
To test this hypothetical metabolic pathway, several deuterium-labeled 
fatty acids were synthesized.  It has become common to use deuterated lipids as 
stable isotopically labeled precursors for metabolic studies (66).  The deuterium 
label is easier to analyze than spin labels used in NMR experiments or 
fluorescent handles, whose properties may change as they travel through 
biological processes or are incorporated into other lipids (66).  By engineering 
fatty acids substituted with strategically placed deuterium atoms for 
supplementation to D. discoideum in culture, in vivo studies could be performed, 
and the host of enzymatic modifications that yield the FA profile could be 
observed via mass spectrometry.  Three saturated fatty acids were designed for 
synthesis: stearate-d5 (49) and palmitate-d5 (50), with five deuterium substitutions 
at the methyl end of the molecule; and a stearate-d4 (55) containing substitutions 
at the β and γ carbons respective to the carbonyl.  In addition, two unsaturated 
FAs were generated: 18:15-d7 (74) and 18:111-d7 (81), with deuterium 
substitutions at carbons 16-18.  The various locations of deuterium on the 
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aliphatic chains allowed us to investigate specific events that may take place in 
fatty acid metabolism in D. discoideum.  The synthetic scheme for developing d5-
stearate and d5-palmitate paralleled the syntheses of the unlabeled fatty acids 
that were utilized as standards, with modifications to the precursor chain length 
to accommodate alkylation by a d5-labeled alkyl bromide chain. 
3.2. Methods and materials 
In vivo feeding studies were conducted using 50-mL shaking cultures set 
in 250-mL autoclaved flasks containing HL5 and pen/strep, with the inclusion of 
0.5-mM labeled FA substrate and 1% NP40 (tergitol) detergent.  Feeding stocks 
were heated to solubilize the FA and then filter sterilized (25mm/0.2 μm).   
Inoculations were made from a starter culture such that all experiments were 
inoculated at 1.0 x 106 cells/mL and shaken (180 rpm) at 22 °C for the prescribed 
time period (6, 12, 24, 48, 72 h).  Upon completion, cells from the 50-mL cultures 
were isolated by centrifugation at 450g to remove media, and washed by 
vortexing with three 1% NP40 washes and centrifugation at 450g (repeated 3x), 
followed by a 4th wash with nanopure H2O.  FAMEs were prepared from the 
cellular pellet and analyzed as described.  Cultures were set in triplicate and 
analyzed at 6, 12, 24, 48 and 72 h of incubation, for a total of 15 cultures per 
compound.  Experimental protocols for the synthesis of deuterium-labeled fatty 
acids can be found in Section 5.3. 
3.2.1. Calculation of incorporation levels 
 Data obtained by GC-MS was processed in two ways.  The first examined 
the results in terms of the ratio between ion abundances of deuterium labeled 
products relative to non-labeled materials (percent incorporation-Equation 2), 
while the second expresses the results in terms of the percent composition of 
labeled compounds (Equation 4). 
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஺௕௨௡ௗ௔௡௖௘௢௙ሺௗఱ௫஼ிሻி஺
஺௕௨௡ௗ௔௡௖௘௢௙ௗబାሺௗఱ௫஼ிሻி஺௦ ൌ Ψ݀ହ݅݊ܿ݋ݎ݌݋ݎܽݐ݅݋݊                              (2) 
To compensate for the lack of isotopic specificity in the d5 compounds, a 
correction factor (CF) was derived from the subtraction of the M+1 and M+2 ion 
counts for the natural abundance values from the summation of the entire range 
of isotopic products from GC-MS analysis of the fed synthetic fatty acids to define 
the d5 ion abundance had scrambling not occurred.  Using the results from GC-
MS analysis of 18:0-d5 and 16:0-d5 FAMEs, the 18:0-d5 experiment required a 
correction factor of 4.36 to offset the deuterium scrambling while the 16:0-d5 
experiments employed a correction factor of 3.30. 
ሺௗభାௗమାௗయାௗరାௗఱାௗలାௗళାௗఴሻିሾெାଵሿିሾெାଶሿ
ௗఱ ൌ ܥܨ                                               (3) 
The second method in which the GC-MS data was analyzed expresses 
the results in terms of the percent composition of labeled compounds, which was 
calculated by taking the percent incorporation value obtained via Equation 2 and 
multiplying it by the sum of the areas under the curve of both labeled and 
unlabeled species (Equation 4).  The analysis must be done in this manner 
because in many cases the labeled species coelute with the endogenous FAs 
such that the two peaks cannot be individually integrated.  The result of this 
calculation is the percent composition of labeled material with respect to the total 
of each fatty acid product. 
Ψ݀ହ݅݊ܿ݋ݎ݌݋ݎܽݐ݅݋݊ݔሺܽݎ݁ܽݏ݋݂݀ହ ൅ ݀଴ܨܣሻ ൌ Ψܿ݋݉݌݋ݏ݅ݐ݅݋݊݋݂݀ହܨܣ  (4) 
The d4 product percent incorporations were calculated in a manner 
analogous to the d5 experiments, with one exception.  As in this experiment both 
d2 and d4 products were observed, the abundance of both products was included 
in the denominator of the equation to attain the percent incorporation of d4 label.  
Additionally, as the [M+2] natural abundance of 13C isotope originating from 
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endogenous fatty acids contributes to the abundance of any d2 ions, it must be 
subtracted, respective of the number of carbons, as seen in Equation 5.  The 
[M+2] natural abundance varies based upon the number of carbons in the chain.  
For example, a C18 chain has an [M+2] value that is 1.8% the abundance of the 
molecular ion, while a C16 compound has a value of 1.4%.  It was not necessary 
to account for deuterium scrambling in this experiment.   
஺௕௨௡ௗ௔௡௖௘௢௙ௗరி஺
஺௕௨௡ௗ௔௡௖௘௢௙ௗబାሺௗమି௡௔௧௨௥௔௟௔௕௨௡ௗ௔௡௖௘ሻାௗరி஺௦ ൌ Ψ݀ସ݅݊ܿ݋ݎ݌݋ݎܽݐ݅݋݊     (5) 
The calculation for d2 percent incorporation analysis was conducted in a 
similar fashion (Equation 6).   
ሺ஺௕௨௡ௗ௔௡௖௘௢௙ௗమି௡௔௧௨௥௔௟௔௕௨௡ௗ௔௡௖௘ሻி஺
஺௕௨௡ௗ௔௡௖௘௢௙ௗబାሺௗమି௡௔௧௨௥௔௟௔௕௨௡ௗ௔௡௖௘ሻାௗరி஺௦ ൌ Ψ݀ଶ݅݊ܿ݋ݎ݌݋ݎܽݐ݅݋݊   (6) 
3.2.2. Statistical analysis 
A rigorous statistical evaluation of the incorporation results was performed 
(student t-test) in order to determine the statistical significance of incorporation 
trends.  This statistical test takes two sets of data (two incubation periods), 
calculates the average, variance and standard deviation between them to 
determine whether the mean average of two sets of data are statistically 
different.  For this analysis, the t-test helped to distinguish the actual trends in the 
incorporation results by determining which changes in percent incorporation were 
truly significant.   A null hypothesis must be selected to weigh the incorporation 
values against; this analysis assumed there was no difference exists between the 
two sets.  A p-value describes the probability that the null hypothesis is true; this 
value was selected as p < 0.05 (less than a 5% chance that it is true).  This value 
sets the threshold for determining whether two data sets are statistically different 
or not. 
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3.3. Results and discussion 
3.3.1. Synthesis of deuterium-labeled fatty acids 
In the synthesis of 16:0 and 18:0 d5-labeled molecules, a dioxolane-
protected alkyl iodide precursor was alkynylated and alkylated with a deuterated 
precursor producing the target chain length.  First, the C8 dioxolane (40) was 
alkynylated with either 1,7-octadiyne or 1,5-hexadiyne, leading to 41 and 42 
respectively (Figure 30).  The corresponding C14 and C16 diacetylenes were then 
alkylated with ethyl bromide-d5 in the presence of NaI to complete the C16 and 
C18 chains.  To generate the saturated chains for palmitate and stearate, the 
alkynes were fully reduced with palladium on carbon under a hydrogen 
atmosphere followed by deprotection and oxidation, as previously described. 
 
Figure 30. The synthetic pathway for producing stearic acid-d5 (49) and palmitic 
acid-d5 (50). 
The synthetic pathway (Figure 31) that was developed to generate d4-
stearate (55) was distinct from the previous approaches.  While a malonate-
mediated strategy was initially considered, a pathway was chosen that combined 
the acetylide coupling methodology of previous FA syntheses with a 
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methoxymethyl (MOM) ether protected alkyne (51) that had been previously 
synthesized by Michael Shepard of the Minto research group to generate an 18 
carbon alkyl chain. 
 
Figure 31.  The synthetic scheme of [3,3,4,4-d4] stearic acid (55). 
In the synthesis of 55, 51 served to place an alkyne between the β and γ 
carbons, which could be alkylated with a long alkyl halide to create an 18 carbon 
chain.  The premise of this approach was that a β, γ-alkynyl group at this position 
could be catalytically reduced with deuterium gas, inserting the label at the 
desired 3 and 4 positions without scrambling.  The protection and alkylation steps 
were straightforward and 52 was readily obtained in high yield (Figure 31).  
However, it was considerably more challenging to selectively add deuterium 
across the alkyne during reduction to its corresponding alkane. 
As the d5-compounds were synthesized first, this lack of isotopic purity 
(scattering) was observed during GC-MS analysis as well, but was initially 
dismissed as ionization-induced rearrangement upon exposure to the harsh 
environment of an electron impact source.  However, upon realization that this 
Boltzmann-like distribution of masses (Figure 32) would not allow the 
interpretation of the results of the d4 experiment, work commenced to determine 
if this was indeed the product of source-induced deuterium scrambling.  A 
previously synthesized deuterium labeled fatty acid, 18:29c,15c (56; Section 5.4), 
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which had been reduced by Lindlar’s catalyst was analyzed by GC-MS, with the 
surprising result that a single molecular ion was observed.  This indicated that 
the problems lay within the synthesis, not the ionization source. 
 
 
Figure 32.  Mass spectrum of the 18:0-d4 (55) FAME derivative using 10% 
palladium on carbon and D2 for alkyne reduction; [M+] m/z 302. 
It was discovered that the catalyst for the reduction step used to generate 
49 and 50 (palladium on carbon) was not capable of yielding an alkane with the 
degree of isotopic purity necessary to be able to interpret the results of the 
feeding study.  Metal catalysts for hydrogenation reactions such as palladium 
and platinum have the propensity to locally redistribute hydrogen (and deuterium) 
within a molecule by 1,3-hydride shifts (67, 68).  While this is imperceptible in 
alkyne reductions with H2, attempting to label a protonated compound with 
deuterium yields a considerable amount of scrambling, as can be seen in Figure 
32.  The mass spectrum illustrates the various isotopic products that were 
formed.  Although the desired d4 product (m/z 302) is the most abundant, 
isomeric products ranged from d0 (m/z 298) all the way to d8 (m/z 306). 
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An improved strategy for reducing the alkyne 52 used Wilkinson’s catalyst, 
as outlined by Rakoff and Rohwedder (68).  Their work demonstrated that this 
rhodium-based catalyst could selectively introduce deuterium to an alkyne 
resulting in an isotopic purity of up to 96%.  In contrast to Figure 32, the resulting 
mass spectrum in Figure 33 shows considerably less scattering in the final 18:0-
d4 fatty acid. 
 
Figure 33.  Mass spectrum of the 18:0-d4 (55) FAME derivative using Wilkinson’s 
catalyst and D2 for alkyne reduction; [M+] = 302 m/z. 
While these conditions allowed for the synthesis of 53 with an isotopic 
purity of approximately 97% d4-product (2% d3-product, 1% d5-product), the 
reaction did not reach full conversion within 48-72 h (~80% alkane), despite the 3 
h reaction time denoted by Rakoff and Rohwedder (68).  After isolating the 
material and subjecting it to a second reaction, the remaining alkyne was 
consumed in 2 h.  The yield of 53 was reduced to 81% as a result of performing 
two workups and purifications.  However, during the silica-gel purification, an 
inseparable contaminant was discovered by GC-MS that paralleled the Rf of 53.  
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The impurity was carried forward in the expectation that it would become 
separable once the desired material had been converted to the final carboxylic 
acid.  Upon hydrolysis by heating in methanol and 2% HCl (57), conversion to the 
aldehyde using Dess-Martin periodinane (69), and sodium chlorite oxidation (58), 
the final oxidation yielded 55.  After flash chromatography, the impurity from the 
Wilkinson’s catalyst reduction was concentrated to an oily yellow substance, and 
identified by Chemstation software as methyl 6,8-dodecadienyl ether (NIST 08 
Mass Spectral Library), presumably a rearranged side-product resulting from the 
dimethoxymethane protection group falling off during the reduction.  The low 
yield of 55 (43% yield) is not a result of poor NaClO2 oxidation, which has 
consistently generated 80-90% yields, but a reflection of the side reaction during 
the reduction. 
The final pair of labeled species that was developed were the unsaturated 
FAs 18:15-d7 and 18:111-d7.  Outlines of the manipulations that were employed to 
yield these two fatty acids are depicted in Figures 34 and 35.  18:15-d7 was 
stitched together with three 6-carbon units.  First, 5-hexyn-1-ol was protected 
with dimethoxymethane to yield 65.  This protected alkyne was coupled to the 
commercially available halide, bromohexane-4,4,5,5,6,6,6-d7, in the customary 
fashion.  The internal acetylene of this twelve carbon product was reduced by 
Wilkinson’s catalyst and hydrogen gas to yield 67.  The reaction halted at about 
80% conversion and it was necessary to resubject the material to a second 
reaction to complete the reduction.  The saturated intermediate 67 was 
subsequently deprotected and converted to the alkyl bromide 69 through 
exposure to triphenylphosphine and bromine, in preparation for its coupling to a 
second 65 molecule.  The resulting C18 chain 70 was reduced again, this time 
with Lindlar’s catalyst and H2 to afford a cis alkene at carbon 5.  The MOM group 
of 71 was then hydrolyzed and the primary alcohol converted to the carboxylic 
acid under the previously described Dess-Martin periodinane and sodium chlorite 
oxidative conditions, to yield 18:15-d7 (74). 
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Figure 34.  The synthetic approach utilized to afford 18:15-d7. 
To procure 18:111-d7, groundwork began with the MOM protection of 
bromodecanol (Figure 35).  In preparation for coupling the resulting alkyl bromide 
with bromohexane-d7, 75 was alkynylated with a TMS-acetylene, followed by 
cleavage of the TMS group with TBAF to yield 76.  After alkylation of the labeled 
chain, 77 was reduced with Lindlar’s catalyst, leading to a ∆11 Z-alkene.  The 
alkene 78 was deprotected and oxidized to complete the 18:111-d7 fatty acid. 
 
Figure 35.  The synthetic methodology of producing 18:111-d7. 
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3.3.2. In vivo feeding studies 
The five deuterium-labeled fatty acids were supplemented to D. 
discoideum cultures, in which they were incorporated into the endogenous FA 
pools, and became substrates for elongation, oxidation, and desaturation.  The 
labeled metabolic products from Dictyostelium were analyzed by preparing 
FAMEs from cell cultures and calculating the percentage of each labeled FA 
relative to its endogenous counterpart.  By monitoring the incubations at specific 
intervals, the flux of the labeled substrate through FA metabolism was observed. 
3.3.2.1. In vivo studies: stearate-d5 and palmitate-d5 
By feeding 16:0-d5 and 18:0-d5, the ensuing reactions could be monitored 
from both the 16:0 perspective, as well as through the 18:0 channel.  The 
experiments relied on the difference of 5 m/z units between the deuterium-
labeled supplemented FAs and endogenous unlabeled FAs to follow the newly 
biosynthesized products by GC-MS analysis.  An example of the GC-MS results 
of the 18:0-d5 supplementation for 24 h is shown in Figure 36, displaying the total 
ion chromatogram (A) with mass data from the 16:0 peak between 14.36 and 
14.52 min (B).  The mass spectrum shows the endogenous 16:0 FAME (m/z 270) 
and the isotopic distribution associated with the d5 labeled 16:0 product (β-
oxidized from 18:0-d5).  The d5-products elute slightly before the endogenous 
FAs, as observed in the split 18:25,11 peak. 
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Figure 36.  The total ion chromatogram (A) from supplementation with 18:0-d5 
and the mass spectrum of the resulting 16:0 FAME product (B). 
The data obtained by GC-MS was processed in two ways.  The first 
examined the results in terms of the ratio between ion abundances of deuterium 
labeled products relative to non-labeled materials (percent incorporation-
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Equation 2), while the second expresses the results in terms of the percent 
composition of labeled compounds (Equation 4).  The percent incorporation 
method illustrates the order and efficiency in which the processes of elongation, 
desaturation and oxidation occurred with the supplemented FA.  Figures 37 and 
40 summarize the percent incorporation results of stearate-d5 and palmitate-d5 
feeding studies. 
In the figures that describe percent incorporation (Figures 37, 40, 45 and 
47), asterisks that are located below the percent incorporation bars indicate a p-
value of 0.05 or less.  Therefore, the time periods marked with asterisks 
designate those that have incorporation results with greater than a 95% 
probability of being different than those of the previous time period.  For example, 
if an asterisk is present below the 24 h incubation period, it can be said with 95% 
confidence than its percent incorporation was statistically different from the 12 h 
results. 
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Figure 37.  Time course of the percent incorporation of d5 label into FA products 
after supplementation with 18:0-d5 and 1% NP-40.1 
The analysis of the percent incorporation of d5 label from supplementation 
with 18:0-d5 supplied a large abundance of information regarding the fatty acid 
metabolism in D. discoideum.  As Figure 37 demonstrates, the labeled substrate 
was quickly taken up by the cells, as the introduction of label into newly 
synthesized fatty acids was observed after 6 h, with several of those labeled 
products having already achieved greater than 50% incorporation (22:0, 18:19, 
17:0, 17:25,9).  It was apparent that the elongation of 18:0 to VLCFAs in D. 
discoideum was quite active.  Within the initial 6 h incubation interval, the 18:0-d5 
substrate had been elongated to such a degree that labeled material comprised 
over 50% of the total 22:0 composition.  While trace quantities of 20:0 exist in D. 
discoideum, it appears the 20:0 elongation product was almost immediately 
                                            
1 Data is presented as the mean percent incorporation of labeled fatty acids ± standard deviation; 
n=3. Asterisks located below the percent incorporation bars indicate a p-value of 0.05 or less. 
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subjected to a second elongation, as incorporation into 20:0 was below the 
detection limits of the GC-MS.  The ∆9 desaturase enzyme of D. discoideum was 
also active, as it converted 18:0-d5 to 18:19-d5 at a rate that rendered nearly 80% 
of all 18:19 FAs as the d5-product after only 6 h incubation.  It appeared that α-
oxidation of the 18:0 substrate also occurred, as the 17:0 species contained 
approximately 70% of the d5 label at the 6 h interval.   
β-Oxidation, as determined by the formation of 16:0-d5, appeared to take 
place more gradually, as the percent incorporation did not greatly deviate over 72 
h from the 20% incorporation observed at 6 h incubation, to ~30% between 24 
and 72 h.  This may be interpreted as Dictyostelium funneling regulated 
quantities of stearate down the β-oxidation pathway to maintain a 16:0 pool as 
the precursor for other reactions.  Following the initial reactions that take place 
directly from the 18:0-d5 substrate, it was evident that a large portion of the newly 
formed 16:0-d5 was a substrate for a ∆9 desaturase, as demonstrated by the 
increasing levels of 16:19-d5 over 72 h.  Upon further incubation, 16:25,9-d5 (the 
apparent product of ∆5 desaturation of 16:19) began to rise notably at the 12 and 
24 h marks.  Following the initiation of 16:25,9-d5 production, the abundance of its 
elongation product, 18:27,11-d5, could be seen growing in at the 24 and 48 h 
marks.   
While 18:111 has been demonstrated to be the EloA-catalyzed elongation 
product of 16:19 (10), there was no clear labeling pathway that outlines its 
formation in Dictyostelium.  Based on Figure 37, its incorporation of 18:0-d5 into 
18:111-d5 behaved similarly to 16:0 in that it is present at a rather consistent 
~10% incorporation of the total 18:111 fatty acid content throughout the time 
course, despite the fact that incorporation 18:25,11 approached 90%.  It is 
possible that 18:111 is an excellent substrate for a ∆5 desaturase (FadA or FadB), 
and is immediately converted into 18:25,11.   Alternatively, these results may 
suggest that the pool of 18:111 is being directly produced from 18:0 (at least in 
part) through a ∆11 desaturase.  If such a desaturase exists, it could be 
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responsible for the production of one of these fatty acids, while the other may be 
produced via a separate pathway. 
The gradual incorporation of d5 label into the 16:0 aldehyde did not give 
any clear indication of its origins.  A plausible scenario is that D. discoideum 
contains some form of a carboxylic acid reductase that converts the 16:0 fatty 
acid to its reduced aldehyde state (only observed in bacteria (70)), or from 
incorporation into a C16 vinyl ether lipid.  No additional information could be 
derived regarding the formation of 17:19 and 17:25,9.  These FAs are presumed to 
be the products of ∆5 and ∆9 desaturases, but the d5-labeling strategy cannot 
unequivocally confirm the substrate that gives rise to them.  Finally, while 16:15 is 
likely produced from 16:0 via a ∆5 desaturase (53, 64, 71), it was not included in 
the analysis because any incorporation of the d5 label was below the detection 
limits of the GC-MS.  The 16:1 d5 incorporation product was identified as 16:19 by 
analysis of fatty acid pyrrolidines from the supplemented cultures (Figure 38). 
 
Figure 38.  The mass spectrum of 16:19-d5 FAPy. 
The second method in which the GC-MS data was analyzed expressed 
the results in terms of the percent composition of labeled compounds (Figure 39).  
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This representation highlights the overall proportions of each new labeled fatty 
acid that is produced by the enzymatic pathways.  For example, all three of the 
C17 FAs show high incorporation levels of the d5 label (Figure 37).  However, the 
percent composition of the three C17 labeled FA products combined for under 5% 
of the total labeled products observed, suggesting that they are turned over at a 
rapid pace. 
In addition, the percent composition underscores the decreasing levels of 
the labeled fatty acid that was available to D. discoideum over time.  In the 18:0-
d5 experiment, the percent composition of the supplemented FA remained quite 
high during the initial h of incubation, decreasing over time as the organism 
gradually consumes it.  This also supplied evidence that the 1% NP40 washes 
applied prior to the preparation of FAMEs were effective in removing 
supplemented fatty acid not taken up by the cells, as the labeled substrate would 
vanish beyond 72 h of incubation, indicative that it had all been incorporated into 
other FAs by that point. 
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Figure 39.  The percent composition of all d5-labeled fatty acids observed upon 
supplementation with 18:0-d5.2 
The percent composition results showed that 18:19 and 18:25,11 had the 
highest incorporation of 18:0-derived d5 label, raising the question of why 18:111 
is not a majority product as observed in the FA profile.  The amount of products 
will differ based upon the point along the metabolic thoroughfare at which a 
synthesized substrate was supplemented.  From the hypothetical FA metabolism 
scheme (Figure 29), it is not surprising that 18:19 appears artificially high in 
comparison to the fatty acid profile.  Since 18:0-d5 was fed, 18:19 only has to 
pass through one ∆9 desaturation reaction, whereas 18:111 must be β-oxidized, 
∆9 desaturated, and elongated if only a ∆9 desaturase, and not a ∆11-specific 
enzyme is available.  However, by that reasoning, 18:25,11 also has to travel 
through the same pathway as 18:111 (plus an additional desaturation).  The 
                                            
2 Data is presented as the mean percent composition of labeled fatty acids ± standard deviation; 
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overwhelming dominance of 18:25,11 together with low deuterium incorporation 
into 18:111 suggests that these two majority FAs may be produced via separate 
pathways.  
In the palmitate-d5 experiments, the substrate did not appear to be 
incorporated into fatty acids with nearly the efficiency of the stearate-d5 (Figure 
40).  While this may have been due to a higher rate of cellular uptake of 18:0 
versus 16:0, 16:0-d5 may have also been used at a slower pace by the enzymes 
downstream of 16:0.  While unanticipated, the 16:0-d5 data allowed for a more 
interpretable picture of the fatty acid metabolism, because the flow of new 
products were generated at a more gradual rate than seen in the stearate-d5 
feeding experiment. 
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Figure 40.  Time course of the percent incorporation of d5 label into FA products 
after supplementation with 16:0-d5 and 1% NP-40.3 
The 16:0-d5 was readily elongated, as the d5 label was present in 60% of 
the total 18:0 FA content at 6 h, and 22:0-d5 was observed at nearly 30% 
incorporation at 72 h (Figure 40).  Beyond the propensity for elongation, the only 
other product generated in 6 h was that of 16:19.  More deuterium-labeled 
products were detected at the 12 and 24 h intervals, with increased formation of 
16:19-d5, the emergence of 16:25,9  and particularly 18:19, which ascended to over 
30% incorporation at 24 h.  Incorporation into 18:27,11 was not observed in this 
experiment.  In the 18:0-d5 labeling experiments, the d5 label did not emerge in 
18:27,11 until 16:25,9 reached incorporation levels nearing 20%.  However, in the 
16:0-d5 experiments, the incorporation levels of 16:25,9-d5 did not exceed 10% 
                                            
3 Data is presented as the mean percent incorporation of labeled fatty acids ± standard deviation; 
n=3. Asterisks located below the percent incorporation bars indicate a p-value of 0.05 or less. 
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until 72 h.  Therefore, if the 16:0-d5 experiment had been allowed to proceed 
another 24 h, 18:27,11-d5 may have been detected. 
The 16:0-d5 incorporation into 18:111 progressed in a similar manner to the 
18:0-d5 experiments, as it exhibited incorporation in only modest amounts and 
remained consistent within the error bars (p > 0.15) throughout the experiments, 
despite an increase in the 18:25,11-d5 product over 72 h.  The very dissimilar 
behavior of 18:111 and 18:25,11 again suggested they may be made via separate 
pathways and it became clear that the 18:0-d5 and 16:0-d5 FAs would not suffice 
to answer the question of how 18:111 and 18:25,11 were being made. 
Incorporation of the d5 label into the C17 carbon FAs occurred at lower 
percentages than in the 18:0-d5 experiments and no definitive information was 
obtained regarding the 16:0 aldehyde, since the d5 aldehyde incorporation 
product was not produced in large abundance (15% incorporation at 72 h).  In 
comparison to other products, its incorporation behavior does not follow that of 
16:19-d5, which is produced directly from 16:0-d5. 
The percent composition of labeled FAs (Figure 41) illustrates the slow 
rate of 16:0-d5 incorporation into other FAs versus 18:0-d5 (Figure 39).  During 
the 18:0-d5 experiment, nearly all of the supplemented material had been 
metabolized by 72 h; whereas 16:0-d5 still accounted for ~40% of the total d5 
labeled fatty acids. 
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Figure 41. The percent composition of all d5-labeled fatty acids observed upon 
supplementation with 16:0-d5.4 
In summary, the supplementation of 18:0-d5 and 16:0-d5 was successful in 
confirming D. discoideum has active elongation, desaturation, and β-oxidative 
pathways, and also suggested that the C17 fatty acids of Dictyostelium may be 
produced via α-oxidation. However, these labeled FAs could not explicitly explain 
the high abundance and behavior of 18:111 and 18:25,11 or if a ∆11 desaturase 
contributes to either of these FA pools.  To address this, an 18:0-d4 feeding 
substrate was designed. 
3.3.2.2. In vivo studies: stearate-d4 
The premise for developing the stearate-d4 feeding strategy was distinct 
from that of the d5-compounds.  While the d5 FAs were employed to observe the 
                                            
4 Data is presented as the mean percent compositon of labeled fatty acids ± standard deviation; 
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entire metabolic pathway, and incorporation of label into both 18:111 and 18:25,11  
was observed, the d4-compound was engineered to gain insight into how the 
large proportions of 18:111 and 18:25,11 are produced, and to test for the 
existence of a ∆11 desaturase activity in D. discoideum.  Figure 42 outlines the 
two potential pathways by which 18:111 and 18:25,11 could be produced from 18:0 
and the premise upon which the stearate-d4 feeding experiment can clarify the 
issue. 
 
Figure 42.  The potential products of stearate-d4 metabolism. 
Upon supplementation with the labeled stearate, the substrate could 
undergo β-oxidation (Pathway 1) and ultimately arrive at 18:111 and 18:25,11 after 
three or four transformations, respectively.  Alternatively, if there is ∆11 
desaturation activity, 18:0 could be directly converted into the 18:111 and 18:25,11 
products (Pathway 2).  The key to this experiment relied on the ability to observe 
the effects of β-oxidation upon stearate-d4 labeled in the β and γ positions.  
Figure 43 below underscores the process by which two deuterium are lost during 
β-oxidation to form d2 products.  While d2 products would be observed regardless 
of the presence or absence of a ∆11 desaturase, if the experiments yielded any 
18:111-d4 or 18:25,11-d4 products, they would provide evidence that a pathway 
exists for making these FAs that is composed solely of desaturases (no β-
oxidation). 
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Figure 43.  The loss of deuterium during β-oxidation of stearate-d4. 
 The results of this experiment were extremely clear and provided strong 
evidence to support the existence of a ∆11 desaturase in D. discoideum; 18:25,11 
was observed as the d4-product by GC-MS.  GC-MS results from the 18:0-d4 
supplementation at 24 h is shown in Figure 44, displaying the total ion 
chromatogram (A), with mass data from the 18:25,11 peak between 15.55 and 
15.72 min (B).  The mass spectrum shows the endogenous 18:25,11 FAME (m/z 
294) and the d4-labeled product (m/z 298).  Significantly, a d2-labeled 18:25,11 
species (m/z 296) was only observed in an approximate 2% incorporation, 
indicating that 18:25,11 is produced from 18:0 almost exclusively via a ∆11 
desaturase pathway. 
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Figure 44.  The total ion chromatogram (A) from 24-h supplementation with 18:0-
d4 and the mass spectrum of the resulting 18:25,11 FAME product (B). 
In the FAME analysis of cultures from the initial 6 h of incubation, the 
presence of 18:25,11-d4, indicated that the supplemented 18:0-d4 material was 
quickly converted to this product directly without β-oxidation (Figure 45).  Longer 
298 
18:25,11 
18:25,11-d4 
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intervals of incubation produced a large quantity of the 18:25,11-d4 product (50% 
incorporation).  
 
Figure 45.  Time course of the percent incorporation of d4 label into FA products 
after supplementation with 18:0-d4 and 1% NP-40.5 
 The results of this experiment allowed for consistent interpretations with 
the conclusions derived from the palmitate-d5 and stearate-d5 studies.  For 
example, 18:19-d4 was produced rapidly, approaching 60% incorporation within 6 
h of incubation, again demonstrating that 18:0 is a substrate for the ∆9 
desaturase in D. discoideum.  Additionally, 18:0-d4 was readily elongated to 22:0-
d4, achieving 25% incorporation at 6 h and peaking with 55% at 24 h.  β-oxidation 
of 18:0 to 16:0 followed by desaturation to form 16:19 and 16:25,9 was further 
affirmed by the absence of any d4-labeled C16 species.  The trace of 16:0-d4 seen 
in Figure 45 was believed to be a background ion sharing the same m/z value 
(mass spectrum of ion in Figure 46).   
                                            
5 Data is presented as the mean percent incorporation of d4-labeled fatty acids ± standard 
deviation; n=3. Asterisks located below the percent incorporation bars indicate a p-value of 0.05 
or less. 
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Figure 46.  Mass spectrum of a background compound sharing the molecular 
weight of the 16:0-d4 product (m/z 274). 
Further evidence that 17:0 is formed from the α-oxidation of 18:0 was 
provided by the presence of 17:0-d4 (40% incorporation at 24 h).  The 17:2-d4 FA 
observed in the profile could be the α-oxidation product (17:24,10 or 17:26,10) of an 
18:2-d4 FA in D. discoideum, but comparison of the pyrrolidine derivative with 
that of a 17:25,9 synthetic standard was consistent with its identity as 17:25,9 (data 
not shown).  Furthermore, as an 18:26,10 FA would need to be present in order to 
generate an 17:25,9 α-oxidation product, it is most likely formed from α-oxidation 
of 18:0, followed by two desaturation steps.  While the pathway could be 
arranged such that a ∆5 desaturase first acts on 17:0 followed by ∆9 desaturation, 
it was confirmed by FAPys and Lipid Library’s collection of FAPy mass spectra 
that the only desaturation product of 17:0 is 17:19.  It is again possible that this 
17:1 FA could originate from the α-oxidation of 18:19, but the confirmation of the 
alkene’s location at position 9 precludes this.  Palmitoyl-CoA and stearoyl-CoA 
are known to be preferred substrates of the ∆9 desaturase (stearoyl-CoA 
desaturase) (72), although it has also been shown to accept other chain lengths 
(73, 74).  In Dictyostelium, the ∆9 desaturase appears to have the same 
specificity for saturated substrates, as evidenced by the production of 16:19 from 
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16:0, 17:19 from 17:0, and 18:19 from 18:0.  And while it has been shown that the 
∆5 desaturases in D. discoideum are active toward both saturated and 
unsaturated FAs (53, 64), the results presented here suggest that the ∆5 
desaturase(s) has a strong preference for monounsaturated substrates, as 
shown in the conversion of 16:25,9 from 16:19, 17:25,9 from 17:19, and potentially 
18:25,11 from 18:111.  The compiled results of the d2 percent incorporation are 
available in Figure 47.   
 
Figure 47.  Time course of the percent incorporation of d2 label into FA products 
after supplementation with 18:0-d4 and 1% NP-40.6 
Another remark about this experiment lies in the apparent strain that the 
18:0-d4 feeding placed on D. discoideum’s long-term health.  All of the feeding 
experiments had lower growth rates than the control (1% NP40 only).  The 
growth curves in Figure 48 illustrate how the 16:0-d5 and 18:0-d5 experiments 
exhibited very similar growth patterns, at a consistently slower rate than the 
control.  However, the 18:0-d4 experiments portrayed similar initial growth 
                                            
6 Data is presented as the mean percent incorporation of d2-labeled fatty acids ± standard 
deviation; n=3. 
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patterns to the other feeding studies, but began to diverge at the 24/48 h mark, 
after which the rate of growth slowed. 
 
Figure 48.  The cell growth curves of the 16:0-d5, 18:0-d5, 18:0-d4, and control 
(NP-40) cultures during time courses.7 
This decreased growth rate was reflected in the d2 and d4 percent 
incorporation results.  The maximal levels of incorporation did not occur at the 
longest incubation period, as was observed in the d5 experiments.  In fact, they 
occurred at 24 h for the d4 products (the same time when the growth rate began 
to slow), and the d2 products showed a decrease between each time period 
following 6 h.  Since the cells did not continue to incorporate labeled material at 
the same rate during longer incubations, percent incorporation did not climb to 
the same levels as observed in the 18:0-d5 experiments.  A specific culprit of this 
stunted growth could not be determined.  However, it was evident from the d2 
data that D. discoideum’s ability to convert 18:0-d4 to 16:0-d2 was diminished 
compared to the d5 experiments suggested that the positioning of deuterium at 
the β and γ carbons hindered β-oxidation.  The percent incorporation of 16:0-d2 
was roughly 13% at its highest point (6 h), while in the 18:0 d5-experiments 16:0 
                                            
7 Data is presented as the mean growth density in 106 cells/mL ± standard deviation; n=3. 
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d5 consistently maintained incorporation levels between 20% and 30%.  The 
elongation from 18:0-d4 to 22:0-d4 occurred more slowly than in the 18:0-d5 
experiments. 
While the rapid production of 18:25,11-d4 provides concrete evidence of 
∆11 desaturase activity, it is curious that little, if any, d4 label was incorporated 
into 18:111.  It is clear that the pathway from 18:0-d4 to 18:25,11-d4 does not pass 
through β-oxidation, and as such, the only combination of enzymes capable of 
affording such a product is a ∆5 and ∆11 desaturase.  D. discoideum has been 
shown to contain at least two ∆5 desaturases-FadA and FadB (53, 64).  D. 
discoideum was demonstrated by comparison of FAPys fragments of a synthetic 
standard to the endogenous FAs to have undetectable levels of 18:15, making it 
unlikely that 18:25,11 is produced by a ∆5 desaturase followed by ∆11 desaturation.  
A second plausible path to 18:25,11 is that the ∆11 desaturase acts first, and the 
18:111-d4 product is immediately transferred to a ∆5 desaturase with such 
proficiency that it is does not enter the 18:111 FA pool.  Additional support for this 
notion stems from the low levels of 18:111-d2 that are produced at longer 
incubation periods, after having passing through the enzymatic machinery of 
Pathway 1 (Figure 42).  A Dictyostelium ELO elongates 16:19 to 18:111 (10), 
suggesting that 18:111 could be generated through Pathway 1.  Therefore, it is 
postulated that the majority of 18:25,11 is produced via Pathway 2, and 18:111 
through Pathway 1. 
A method by which the pathway to 18:25,11 may be elucidated resided with 
the synthesis and supplementation of two additional fatty acids, 18:15-d7 and 
18:111-d7 with deuterium labeling at the methyl ends.  Upon supplementation, one 
of the two fatty acids was expected to be converted into 18:25,11 with the 
deuterium label present while the other would not, allowing the order of 
installation of ∆5 and ∆11 double bonds to be determined.  Preliminary results 
from supplementation with these two fatty acids suggest that 18:15 is produced 
first and is subsequently acted on by a ∆11 desaturase, as demonstrated by the 
formation of 18:25,11-d7 from 18:15-d7 but not 18:111-d7.  As the 18:15 FA is not 
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observed in D. discoideum’s FA profile, the ∆11 desaturase must act very quickly.  
Taking into consideration the 18:0-d4, 18:15-d7, and 18:111-d7 incorporation 
results, evidence of a ∆11 desaturase, and the detection of α-oxidative pathways, 
a current proposal of the fatty acid metabolic pathways of D. discoideum is 
presented in Figure 49. 
 
Figure 49.  The summarized metabolic processes that yield the observed fatty 
acid profile in D. discoideum. 
The pathway does not include the aldehydes observed in D. discoideum, 
as it is still unclear if they are truly metabolic products, such as cleavage 
products from vinyl ether lipids, or degradation products.  Also, 16:15 was not 
included in the pathway in Figure 49 because any incorporation of deuterium 
label was below the detection limits of the GC-MS.  It is still unclear from these 
experiments why the large quantities of 18:111 observed in the FA profile were 
not reflected in the incorporation results. 
Examination of the sequencing work of Eichinger et al. (13) reinforced the 
hypothesis that a ∆11 desaturase is active in the fatty acid metabolism of 
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Dictyostelium: a tBLASTn search of the genome revealed a potential ∆11 
desaturase.  This is particularly intriguing because such enzymes are primarily 
found in insects to date.  A search for ∆11 fatty acid desaturases in BRENDA, the 
Comprehensive Enzyme Information System, output 12 organisms: 11 insects 
(moths) and 1 diatom (Thalassiosira pseudonana) (70).  The possibility of 
demonstrating the presence of such an atypical fatty acid desaturase in this 
organism is an alluring prospect.  The putative gene has been cloned (B. 
Blacklock, personal communication) and will be functionally characterized by 
heterologous expression in S. cerevisiae.  
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CHAPTER 4. SPHINGOLIPID CHARACTERIZATION IN DICTYOSTELIUM 
DISCOIDEUM 
4.1. Introduction 
As a preface to understanding the roles of elongated fatty acids and 
sphingolipids in D. discoideum, a characterization of those lipids is was 
undertaken.  The first objective was to characterize the long chain bases that 
comprise the backbones of these complex lipids.   Harsh basic conditions for 
isolating the LCBs from cells and tandem MS methods were developed using 
commercial sphingolipid standards and Saccharomyces cerevisiae as a model.  
Complex lipid extraction from cells (total lipid extraction), isolation of SLs from 
other lipids (mild alkaline hydrolysis), and conditions for tandem MS analysis of 
sphingolipids were developed using commercial sphingolipid standards and S. 
cerevisiae.  The D. discoideum LCB profile was generated and used during the 
characterization of the intact sphingolipids using the developed techniques. 
4.2. Methods and materials  
All manipulations were performed in glass conical vials unless otherwise 
mentioned.  All solvents used were of HPLC grade.  1-Fluoro-2,4-dinitrobenzene, 
1,4-dioxane, 33% methylamine in absolute ethanol, and barium hydroxide 
octahydrate were obtained from Sigma Aldrich.  Commercial sphingolipids were 
procured from Avanti Polar Lipids.  S. cerevisiae InvSc1 was obtained from 
Invitrogen.  Total lipid extractions were performed using 0.5-mm soda-lime beads 
and a Mini-Beadbeater, both supplied by Biospec Products, Inc.  HPLC 
separations and tandem mass spectrometry was performed on an Agilent 1200 
series LC system and 6410 triple quadrupole (QQQ) MS equipped with 
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electrospray ionization (ESI).  Chromatographic separations were conducted on 
an Agilent 4.6 x 50 mm, 1.8 μm Zorbax Eclipse XBD-C18 column.  High-resolution 
MS data was obtained on an Agilent 6520 quadrupole time-of-flight (QTOF) mass 
spectrometer equipped with ESI and a 1200 series capillary LC system. 
4.2.1. Culturing of D. discoideum and S. cerevisiae 
For analysis of D. discoideum SLs, 50-mL cultures were set in 250-mL 
autoclaved flasks containing HL5 media and 500 μL pen/strep, and inoculated 
with 1.0 mL of media from a well-established plate of Dictyostelium (grown to the 
time of passage).  Cells were then grown at 22 °C with shaking (180 rpm) for 4 
days (density of ~1.0x107 cells/mL), then the entire culture was transferred to a 2 
L autoclaved flask containing HL5 media (450 mL) and 5 mL pen/strep.  After 
shaking at 22 °C for 4 days (density of ~3.0x107 cells/mL), the culture was 
centrifuged at 450g to remove media, followed by vortexing with nanopure H2O 
and centrifugation at 450g (repeated 3x) and cells lyophilized to dryness (1-1.5 
g). 
  For analysis of S. cerevisiae SLs, 50-mL cultures were set in 250-mL 
autoclaved flasks containing yeast peptone dextrose (YPD; recipe in Appendix) 
media, and inoculated with 5.0 mL of media from a starter culture (5 mL) set from 
freezer stock of InvSc1.  Cells were then grown at 30 °C with shaking (250 rpm) 
overnight, then the entire culture was transferred to a 2 L autoclaved flask 
containing YPD media (450 mL).  After shaking for 3 days (to saturation), the 
culture was centrifuged at 450g to remove media, followed by vortexing with 
nanopure H2O and centrifugation at 450g (repeated 3x) and cells lyophilized to 
dryness (3-4 g). 
4.2.2. Ba(OH)2 hydrolysis 
Acyl chains were hydrolyzed from sphingolipids in the methods described 
by Markham et al. (75) and Valentin et al. (76) with modifications to the reaction 
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time as discussed.  Sphingolipid standards (100 μg) or lyophilized cells (100 mg) 
were combined with 1 mL 1,4-dioxane and 1 mL 10% barium hydroxide 
octahydrate (w/v) in water (Ba(OH)2 solution heated to 60 °C prior to aliquoting) 
and reacted in a sealed conical vial for 24 h at 110 °C.  Long chain bases were 
isolated by introduction of 6 mL of chloroform/dioxane/H2O (6:1:5), vortexing and 
removal of the organic layer (bottom).  The extracts were washed with 0.1 M 
KOH (5 mL) and 0.5 M KCl (5 mL), then evaporated under a stream of nitrogen.  
Samples were dissolved in 0.5 mL 1:1 MeOH/CHCl3 for mass spectrometric 
analysis.  For conversion to the dinitrophenyl (DNP) derivative, the dried LCB 
residue was taken directly to the next step.     
4.2.3. Dinitrophenyl derivatization of LCBs 
 DNP derivatives were formed via the method outlined by Valentin et al. 
(76) and Heinz et al. (77).  LCB standards (50 μg) or those generated from 
Ba(OH)2 hydrolysis were dissolved in 1 mL of MeOH to which 4 mL of 2.0 M 
potassium borate buffer (pH 10.5) was slowly added, along with 5 μL of 1-fluoro-
2,4-dinitrobenzene.  The resulting lime-green mixture was vortexed and 
incubated for 30 min at 60 °C.  Following the reaction, DNP-LCBs were isolated 
by introduction of 7.5 mL of chloroform/methanol/H2O (8:4:3), vortexing, 
separation of the CHCl3 layer, and extraction of the aqueous phase a second 
time with 4 mL CHCl3.  The organic phases were pooled and solvent removed 
under a stream of nitrogen.  Samples were dissolved in 0.5 mL of 1:1 
ACN/MeOH for chromatographic separation and LC-MS analysis. 
4.2.4. Total lipid extraction 
Complex lipids (phospholipids and sphingolipids) were extracted from 
lyophilized cells by the method described by Markham et al. (75)  with slight 
alteration to the incubation procedure.  Lyophilized cells (100-400 mg) were 
combined in a 5-mL bead beater vial (plastic) with glass beads (0.5 mm, 3x the 
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mass of cells) and 5 mL of Solvent A (bottom layer of isopropanol/hexane/H2O; 
55:20:25) and beat for 3 min.  The homogenized mixture was then incubated for 
20 min at 60 °C, followed by centrifugation at 250g and removal of the 
supernatant.  These steps were repeated two more times, with substitution of 
bead beating with vortexing (1 min), and the solvent evaporated under a stream 
of nitrogen from the pooled supernatants.  For LC-MS analysis of phospholipids, 
the total lipid extract (TLE) was redissolved in 0.5 mL of Solvent A.  For 
methylamine hydrolysis, this crude mixture was taken on directly. 
4.2.5. Mild alkaline hydrolysis 
The phospholipids of the total lipid extract were degraded in accordance 
with the protocol described by Markham et al. (78).  The residue obtained from 
the TLE procedure was combined with 1 mL of a solution containing 33% 
methylamine in absolute ethanol/water (7:3 v/v) and heated at 50 °C for 1 h, 
yielding an enriched sphingolipid sample free of phospholipids after evaporation 
of solvent and methylamine under a stream of nitrogen.  The concentrated 
product was resuspended in 0.5 mL of Solvent A, vortexed, centrifuged at 250 g 
for 2 min, and the supernatant was transferred to an LC-MS vial for QQQ and 
QTOF analysis. 
4.2.6. Lithiation of sphingolipids 
 Lithium adducts of biological and commercial sphingolipids were 
generated by addition of lithium hydroxide (dissolved in methanol) to sample vials 
at a final solution concentration of 2.0 μmol/mL (79).  Standards were prepared at 
concentrations of approximately 1 nmol/mL in 1:1 MeOH/CHCl3 or Solvent A, 
while biological products of mild alkaline hydrolysis were lithiated directly.  
Samples were immediately analyzed on the QQQ following exposure to LiOH via 
direct injection (no chromatography) (79). 
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4.2.7. LC-MS analysis of lipids 
 With the exception of the DNP derivatives and the quantification of long 
chain bases, all experiments were performed without the aid of chromatography.  
Samples were directly injected into the source via the system autosampler.  
Listed below are the acquisition methods used on the QTOF and QQQ MS to 
analyze various types of biological samples with descriptions of the solvents, 
polarities, and ionization conditions.  All standards used in optimizations were 
prepared as 100 μg/mL in 1:1 CHCl3/MeOH.  Source parameters were set as 
follows: 
x Gas temp: 350 °C 
x Gas flow: 10 L/min 
x Nebulizer: 45 psi 
x Capillary: +/- 4000 V 
Agilent 6520 Quadrupole Time-of-Flight MS 
Spl LCBs pos.m 
x A full scan MS method designed to obtain the accurate mass of long chain 
bases following Ba(OH)2 hydrolysis. 
x Fragmentor: +140 V 
x Solvent A: 20% H2O + 5 mM NH4OAc. Solvent B: 80% 10:3:1 
MeOH/ACN/IPA + 0.1% formic acid. (76) or Solvent A: 20% H2O + 5 mM 
NH4OAc.  Solvent B: 80% 1:1 CHCl3/MeOH (1) 
Spl neg.m 
x A full scan MS method utilized to obtain exact mass data from a 
methylamine hydrolysate containing SLs. 
x Fragmentor: -180 V 
x Solvent A: 20% H2O + 5 mM NH4OAc. Solvent B: 80% 1:1 CHCl3/MeOH 
(1) 
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Agilent 6410 Triple Quadrupole MS 
DNP derivatives.m 
x MS2 full scan method used to analyze DNP-derivatized long chain bases. 
x Diode array detector: 350 nm 
x Fragmentor: -105 V 
x Solvent A: H2O + 5 mM NH4OAc. Solvent B: 10:3:1 MeOH/ACN/IPA + 
0.1% formic acid. (76) 
x Flow: 0.5 mL/min; 80 → 90% organic over 15 min, then 95% until run ends 
x Run time: 23 min 
x Post time: 7 min 
LCB loop positive.m 
x MS2 full scan method used to analyze long chain bases following Ba(OH)2 
hydrolysis (direct injection). 
x Fragmentor: +140 V 
x Solvent A: 20% H2O + 5 mM NH4OAc. Solvent B: 80% 10:3:1 
MeOH/ACN/IPA + 0.1% formic acid. (76) 
LCB MRM1.m 
x Multiple reaction monitoring method (with chromatography) for the 
quantitation of t18:0 (318→300→282→264 m/z), d18:0 (302→284→266 
m/z) and d18:1 (300→282→264 m/z) in D. discoideum.  d17:0 
(288→270→252 m/z) was employed as the internal standard (10 μg/mL). 
o All fragmentor voltages and collision energies were established by 
Optimizer analysis of standards (Table 3). 
x Solvent A: H2O + 5 mM NH4OAc. Solvent B: 10:3:1 MeOH/ACN/IPA + 
0.1% formic acid. (76) 
x Flow: 0.5 mL/min; 80 → 84% organic over 4 min, then 95% until run ends 
x Run time: 10 min 
x Post time: 5 min 
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Table 3.  Optimizer defined conditions for MRM. 
            
Standard Precursor Ion 
Product 
Ion Dwell Fragmentor 
Collision 
Energy 
phytosphingosine 318.3 300.3 200 144 10 
phytosphingosine 318.3 282.3 200 144 14 
phytosphingosine 318.3 60.1 200 144 18 
phytosphingosine 318.3 55.1 200 144 42 
dihydrosphingosine 302.3 284.3 200 114 10 
dihydrosphingosine 302.3 67.1 200 114 34 
dihydrosphingosine 302.3 60.1 200 114 14 
dihydrosphingosine 302.3 55.1 200 114 38 
sphingosine 300.3 282.3 200 100 6 
sphingosine 300.3 69.1 200 100 26 
sphingosine 300.3 67.1 200 100 30 
sphingosine 300.3 55.1 200 100 34 
C17 sphinganine 288.3 270.3 200 126 9 
C17 sphinganine 288.3 60.1 200 126 13 
C17 sphinganine 288.3 55.1 200 126 37 
 
Optimizer.m 
x Template scanning method designed to be resaved as a new name prior 
to being used in Optimizer.  Only the pump conditions are applicable.  All 
other information is selected and derived by Optimizer. 
x Solvent A: 20% H2O + 5 mM NH4OAc. Solvent B: 80% 10:3:1 
MeOH/ACN/IPA + 0.1% formic acid. (76) or Solvent A: 20% H2O + 5 mM 
NH4OAc.  Solvent B: 80% 1:1 CHCl3/MeOH (1) 
LCB pdt ion loop.m 
x Product ion scanning method designed as a template for the collision-
induced dissociation of long chain bases.  Molecular ions of interest in the 
Ba(OH)2 hydrolysate were used as precursor ions. 
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x Solvent A: 20% H2O + 5 mM NH4OAc. Solvent B: 80% 10:3:1 
MeOH/ACN/IPA + 0.1% formic acid. (76) or Solvent A: 20% H2O + 5 mM 
NH4OAc.  Solvent B: 80% 1:1 CHCl3/MeOH (1) 
Optimal C1P conditions.m 
x The method used during the analysis of C1P and lithiated C1P species in 
D. discoideum. Source and collision cell conditions were optimized from 
the d18:1/18:0 C1P standard. 
x Fragmentor: -180 V; collision energy: 50 eV 
x Solvent A: H2O + 10% 5 mM NH4OAc.  Solvent B: 90% 1:1 CHCl3/MeOH 
(1) 
Optimal IPC conditions.m 
x The method used during the analysis of IPC and lithiated IPC species in 
D. discoideum. Source and collision cell conditions were optimized from 
the IPCs in S. cerevisiae. 
x Fragmentor: -180 V; collision energy: 50 eV 
x Solvent A: H2O + 10% 5 mM NH4OAc.  Solvent B: 90% 1:1 CHCl3/MeOH 
(1) 
Optimal MIPC conditions.m 
x The method used during the analysis of MIPC species in S. cerevisiae 
unknown SLs (1064, 1078, 1092 and 1328 m/z) and their lithiated adducts 
in D. discoideum. 
x Fragmentor: -180 V; collision energy: 75 eV 
x Solvent A: H2O + 10% 5 mM NH4OAc.  Solvent B: 90% 1:1 CHCl3/MeOH 
(1) 
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Cerebroside loop neg.m 
x The standard MS2 method utilized to analyze a methylamine hydrolysate 
of SLs, lithiated SLs or phospholipids.   
x Fragmentor: -180 V  
x Solvent A: H2O + 10% 5 mM NH4OAc.  Solvent B: 90% 1:1 CHCl3/MeOH 
(1) 
Cerebroside loop.m 
x The standard MS2 method utilized to analyze phospholipids (total lipid 
extracts) prior to methylamine hydrolysis. 
x Fragmentor: +200 V  
x Solvent A: H2O + 10% 5 mM NH4OAc.  Solvent B: 90% 1:1 CHCl3/MeOH 
(1) 
4.3. Results and discussion 
4.3.1. Identification of sphingolipid long chain bases in D. discoideum 
The first step to effectively analyzing the composition of sphingolipids in D. 
discoideum involved identifying the long chain bases that comprise the backbone 
of sphingolipids.  This was approached by direct harsh alkaline hydrolysis (1:1 
10% w/v Ba(OH)2/1,4-dioxane; 110 °C) (75, 76) of D. discoideum cells to 
hydrolyze the amide bonds of SLs liberating the acyl chain from the LCB 
backbone (Figure 50). 
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Figure 50.  Hydrolysis of N-acyl lipids with Ba(OH)2. 
 The development of the barium hydroxide hydrolysis procedure for 
Dictyostelium sphingolipids required considerable effort and multiple 
experiments, including varying reaction times to determine optimal acyl chain 
cleavage conditions, as monitored by LC-MS.  Initial test reactions were 
conducted with a single C12 glucoceramide (D-glucosyl-β1-1’-N-dodecanoyl-D-
erythro-sphingosine) in order to determine the optimal hydrolysis time for 
complete acyl chain removal.  However, hydrolysis of the standard resulted in 
partial loss of the sugar head group in addition to varying degrees of N-acyl 
group cleavage.  As such head group cleavage was expected to be the result of 
the presence of some proton donor (acid), the 1,4-dioxane was investigated as a 
possible source.  A mock reaction of lipid and dioxane only revealed head group 
loss upon heating, suggesting that peroxides had formed in the aged bottle of 
dioxane capable of removing some of the sugar head groups from the LCB.  New 
solvent eliminated the majority of head group cleavage, yet complete hydrolysis 
of the acyl chain remained variable, even among replicate experiments. 
While published methods reported a 16 h hydrolysis time for quantitative 
acyl chain cleavage (75), the reaction continued to produce increasing amounts 
of long chain base at incubation times to 72 h.  Additionally, despite the absence 
of any acidic component, varying amounts of sugar head group cleavage were 
still observed, as can be seen in the comparison of two replicate Ba(OH)2 time 
courses (Figure 51).  In these replicate time courses, 100 μg of a C12 
glucoceramide standard was reacted for 0, 0.5, 2, 6, 24 and 48 h to determine 
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the optimal reaction time.  The graphs illustrate two points: that identical 
reactions produce varying amounts of psychosine (deacylated glucoceramide), 
as reaction A generated roughly 15% more than reaction B; and that sphingolipid 
deacylation is complete by 24 h, with head group cleavage (or psychosine 
degradation) beginning to occur beyond 24 h.   Despite observing a maximum 
psychosine production at a hydrolysis time of 24 h, the variation in psychosine 
concentration between the replicates showed that the reaction was not consistent 
enough for use in quantitating LCBs, psychosines and related compounds. 
 
 
 
 
 
 
 
 
 
 
 
 
Putting the reproducibility issue aside, upon obtaining the free amine from 
Ba(OH)2 hydrolysis, the free LCBs could either be analyzed directly by LC-MS or 
be subjected to an additional derivatization.  Introducing a DNP handle (inset, 
Figure 52B) with diagnostic absorption at 350nm (76) allowed for the rapid 
screening of complex biological mixtures for LCBs by UV detection.  This 
methodology was validated using S. cerevisiae by testing our ability to identify 
the LCBs observed in literature (76).  The signals from the diode array detector at 
350 nm are displayed in Figure 52.   
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Figure 51.  The psychosine formation from Ba(OH)2 hydrolysis of a C12 GlcCer 
standard performed in replicate under identical conditions. 
 
85 
 
 
 
 
 
 
Figure 52.  HPLC-UV chromatograms of DNP-derivatized LCB standards and 
biological samples. 
S. cerevisiae chiefly contains t18:0 LCB with small quantities of d18:0 
(identified by standard, not shown) (76) as demonstrated in Figure 52 (A/B).  D. 
13.95 min 
C; D. discoideum 
B; t18:0 standard 
A; S. cerevisiae 
16.70 min 
t18:0 
d18:0 
11.80 min 
d18:0 d18:1 
t18:0 
11.79 min 
11.78 min 
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discoideum was found by analysis of DNP derivatives from Ba(OH)2 hydrolysate 
and comparison of UV absorption and retention time to DNP-derivatized 
standards to contain three LCBs; phytosphingosine (t18:0), sphinganine (d18:0) 
and sphingosine (d18:1) (Figure 52 (C)). Figure 52 (B) corresponds to the DNP-
derivatized standard phytosphingosine, while sphinganine, and sphingosine were 
similarly identified and compared to Dictyostelium (not shown). 
The DNP derivatives were very helpful in determining the presence of a 
number of LCBs in D. discoideum.  A mass spectrometry approach was then 
taken to provide a more concrete identification of the long chain bases, without 
derivatization following the barium hydroxide hydrolysis.  The non-derivatized 
LCB species proved to be very stable and provided consistent and valuable 
fragmentation patterns for identification.  A triple quadrupole mass spectrometer 
is particularly useful for such analyses because of its ability to ionize and 
dissociate a large range of compounds.  It utilizes a soft ionization technique 
(such as ESI) to produce charged molecules whose masses can be detected 
directly (MS scan), or fragmented into smaller components by collision-induced 
dissociation (CID).  The fragmentation pattern or “fingerprint” of a molecule is 
unique to that molecule (or class of molecules) and is crucial to compound 
identification and accurate quantitation of biological samples.  The structural 
fragments of t18:0 are illustrated in Figure 53, with a CID spectrum of the t18:0 
standard.  
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Figure 53.  The structural fragmentation of the phytosphingosine backbone upon 
CID (80). 
The three LCB standards (t18:0, d18:0, d18:1) were analyzed by Agilent’s 
Optimizer software, a program designed for the QQQ to derive the best 
conditions of ionization and fragmentation.  Optimizer uses a series of MS-MS 
experiments to find the conditions that most efficiently produce fragments that 
can be used to identify a compound.  Quantitation of the three LCBs identified in 
D. discoideum was achieved via multiple reaction monitoring (MRM), a tandem 
MS technique that screens for the specified molecular weights of target analytes 
in a mixture then applies the optimal collision energies needed to afford 
fragments.  This method matches the fragments defined by Optimizer analysis of 
standards to those observed in a biological sample to unambiguously confirm the 
presence of a molecule, and quantify it based on a response curve.  In this 
quantification, calibration curves were generated by MRM for LCBs using t18:0, 
d18:0 and d18:1 standards (10 concentrations; 40 μg/mL→ 0.078 μg/mL) and the 
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data was normalized to an unnatural d17:0 sphinganine internal standard (10 
μg/mL) added to the dilution solvent.  D. discoideum Ba(OH)2 hydrolysis 
reactions (25 mg dry cell mass) were run for 24 and 48 h with 10 μg/mL d17:0 
internal standard.  Quantities of long chain bases in the hydrolysates at the two 
reaction times are shown in Table 4, where data is presented as the mean 
concentration (μg/mL) of replicate injections ± standard deviation; n=3.  The 
increase in concentration of each LCB from 24 to 48 h indicates that LCBs were 
still being released from SLs after 24 h, despite the experiments that showed the 
C12 glucoceramide standard gave optimal acyl cleavage at 24 h (Figure 51). 
Table 4.  Three long chain bases quantified by MRM as free LCBs. 
t18:0 (μg/mL) d18:0 (μg/mL) d18:1 (μg/mL) 
24 h hydrolysis 13.5 ± 0.3 0.6 ± 0.0 0.0 ± 0.0 
48 h hydrolysis 18.0 ± 0.4 0.6 ± 0.0 0.0 ± 0.0 
 
The above results were initially believed to describe the complete long 
chain base profile in D. discoideum, but as our methods for analyzing 
sphingolipids improved and our LC-MS techniques evolved largely towards 
employing direct injections (no chromatography) which allowed for heightened 
sensitivity and ease of interpretation, the existing profile was reassessed.  To 
improve the chances of detecting new LCBs, the barium hydroxide hydrolysis 
preparation was performed on a larger quantity of cells (100 mg dry cell mass for 
24 and 48 h).  Using the 6410 QQQ in scanning mode, the ions of the 
hydrolysate were determined, followed by product ion scanning of each ion.  The 
ions [M+H+] = 332, 344, 346, 358, 372 m/z in the sample each revealed a 
fragmentation pattern similar to that of previously identified phytosphingosine 
species indicating that they too may be long chain bases (Figure 54). 
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Figure 54.  Fragmentation patterns of additional D. discoideum long chain bases 
from Ba(OH)2 hydrolysate. 
Figure 54 (A) illustrates the fragmentation pattern of biologically derived 
t18:0, which follows with the fragmentation scheme presented in Figure 53.  
Upon collision-induced dissociation, [M+H+] = 332, 344, 346, 358, 372 ions were 
found to produce nearly identical fragmentation patterns to t18:0, differing only by 
integers of m/z 14 indicating increasing number of methylene groups and/or by 
A; t18:0 
B 
C 
D 
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one unit of unsaturation.  While the fragmentation patterns strongly suggested 
that these ions corresponded to longer chain length trihydroxy LCBs, without the 
availability of other authentic standards, the only available method of verifying 
their identities lay in obtaining the accurate masses of each.  The Ba(OH)2 
hydrolysate was therefore analyzed on an Agilent 6520 QTOF under the same 
conditions used on the QQQ.  The MassHunter qualitative analysis software 
generated formulae consistent with t19:0 (m/z 332), t20:0 (m/z 346), t20:1 (m/z 
344), t21:1 (m/z 358) and t22:1 (m/z 372) long chain bases (Figure 55).  t18:0 
(m/z 318) was excluded from this window, because its significantly higher 
abundance (1x106) made it more difficult to view the lower intensity LCBs (full 
spectrum inset in Figure 55).  The two signals at m/z 334 and m/z 337 represent 
background ions.  As discussed above, given the variability associated with the 
Ba(OH)2 hydrolysis, the exact concentrations of these newly discovered LCBs 
were not pursued.  
 
Figure 55.  The exact masses of long chain bases obtained via a quadrupole 
time-of-flight mass spectrometer. 
Ultimately, it seemed that while the DNP approach was sound in principle, 
it did not allow for the full characterization of long chain bases due to the lack of 
sensitivity, which was a particular drawback of having to perform chromatography 
in order to visualize individual LCBs.  The derivatization also greatly decreased 
sample lifetimes.  By shifting to direct injection, Ba(OH)2 hydrolysis to liberate 
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acyl chains from LCBs, and combining the fragmentation patterns obtained from 
the QQQ with the resolving power of the QTOF, eight long chain bases were 
identified in total.  The majority of the LCB content is derived of t18:0, t19:0, t20:0 
and t20:1, with lower abundances of t21:1 and t22:1, followed lastly by d18:0 and 
d18:1.  A percent composition of LCBs representative of the Ba(OH)2 hydrolysis 
reaction is displayed in Figure 56, derived from [M+H+] ion abundances (QTOF 
data). 
 
Figure 56.  Percent composition of D. discoideum LCBs. 
This phytosphingosine-based LCB profile coincides with those usually 
associated with plants (t18:0 and d18:0) and yeast (t18:0 and other trihydroxy 
LCBs) (4, 33).  The dominance of phytosphingosine in Dictyostelium is 
interesting.  Given the corresponding scarcity of sphingosine, it is reasonable to 
suggest that previous work examining of the signaling properties of sphingosine-
1-phosphates (16-20) may have in fact been observing the effects of 
phytosphingosine-1-phosphates.  Misinterpretations such as this have been 
addressed in the past; Courso et al. (81) challenged the commonly accepted 
viewpoint that S1P is essential for signaling in plants due to the fact that 
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sphingosine is rarely present in detectable amounts.  The signaling metabolite for 
stomatal closure in Arabidopsis was initially characterized as S1P, but it was 
shown that this signaling was not specific to S1P, as phytosphingosine-1-
phosphate promoted stomatal closure as well.  Additionally, the sphingosine 
kinase of Arabidopsis (the enzyme that phosphorylates sphingosine to yield S1P) 
is not specific to sphingosine, but can also phosphorylate other LCBs (38).  While 
publications regarding S1P signaling in Dictyostelium relied on the assumption 
that sphingosine-1-phosphate is the long chain base phosphate, without fully 
characterizing the LCBs of D. discoideum as we have, they may have assumed 
incorrectly.  Phytosphingosine-1-phosphate has also been shown to have 
bioactivity in S. cerevisiae (82) and two genes encoding LCB kinases (LCB4 and 
LCB5) that can use sphingosine, dihydrosphingosine, or phytosphingosine have 
been described (83). 
However, there is no evidence that directly challenges S1P’s activity as 
described.  It is also possible that sphingosine acts as a signaling molecule in D. 
discoideum, as suggested by the very low concentrations in our profile, but it may 
be more plausible that the bioactive form is phosphorylated.  Two homologues of 
the sphingosine kinase gene (termed sgkA and sgkB) have been described in 
Dictyostelium (84) and there appears to be no literature precedent to support 
signaling by free sphingosine nor have sphingosine receptors been described in 
Dictyostelium.  Furthermore, mammals, which predominantly have sphingosine 
LCBs, use sphingosine-1-phosphate as a bioactive agent in processes such as 
inflammation (45).  Therefore, experiments could be performed in D. discoideum 
to determine if phytosphingosine-1-phosphate also has activity as shown in 
Arabidopsis (81), and whether the kinases discussed by Alexander et al. (84) will 
phosphorylate other LCBs (38).  Additionally, in terms of the work on 
sphingosine-1-phosphate effects on cisplatin resistence and Dictyostelium 
development (17, 18), an experiment could be performed to determine whether 
sphingosine-1-phosphate lyase is capable of degrading other LCBPs. 
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4.3.2. Isolation of sphingolipids for characterization 
Once a library of long chain bases was created for D. discoideum, the 
focus shifted toward developing protocols for isolating the intact sphingolipids.  A 
generic scheme for how this was accomplished is portrayed in Figure 57 and is 
similar to that of Markham et al. (75).  A polar extraction solvent (Solvent A) and 
bead beating for three min provided sufficient force to break cell membranes and 
allow for the solubilization of complex lipids.  After centrifugation, the supernatant 
of this total lipid extraction contains the sphingolipids, phospholipids, 
triacylglycerols and other lipids of the organism, with phospholipids comprising 
the vast majority of the extract. 
 
Figure 57.  Approach to obtaining and isolating complex lipids from cells. 
Mass spectrometry of a cellular TLE demonstrates that the phospholipid  
abundance is several orders of magnitude greater than that of the sphingolipids 
(1).  Therefore, in order to analyze SLs by mass spectrometry, further 
preparation is required.  Luckily, the carboxyl ester groups of phospholipids are 
much more susceptible to attack by a nucleophile than their amide counterparts 
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in SLs.  By exposure to low concentrations of base, the fatty acids of 
phospholipids can be preferentially hydrolyzed, while sphingolipids remain intact 
as they will not succumb unless subjected to much stronger alkaline conditions 
such as barium hydroxide.  Conditions for this mild alkaline hydrolysis of ester 
bonds in phospholipids have included incubations in low concentrations of NaOH 
in methanol or ethanol (85), but the optimal conditions employ methylamine as 
the base (86).  The reaction is very effective at 50 °C under conditions of 33% 
methylamine in absolute ethanol/water, at a ratio of 7:3 (v/v) for 1 h (78) yielding 
an enriched sphingolipid sample devoid of phospholipids.  The presence of 
hydrolyzed free fatty acids from this degradation is not of great consequence due 
to their low molecular weight relative to SLs; they can be ignored or excluded 
from the scan range in MS. 
The efficiency of the total lipid extraction was tested by including two 
sphingolipid standards, a C12 glucoceramide and a C18 ceramide (100 μg), in a 
mixture with the extraction solvent and 100 mg lyophilized Dictyostelium cells, to 
simulate any matrix effects that may be present, and monitored by MS analysis 
of consecutive extraction fractions.  The procedure from literature (75, 78) stated 
that the sample should be incubated to 60 °C for 20 min prior to centrifugation in 
the first of three extractions, and while the results from repeating this method 
were acceptable, sphingolipid standards were still being found in extractions from 
the cellular mixture after four rounds of extraction.  The protocol was therefore 
modified to include incubations between each extraction.  Figure 58 indicates the 
abundance of sphingolipid standard present in each of four extractions and 
demonstrates that under these conditions, two extractions removed greater than 
90% of the sphingolipid material from the mixture, and with three extractions, all 
SLs were removed. 
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Figure 58.  Efficiency of optimized total lipid extraction procedure, as illustrated 
with SL standards. 
A mock total lipid extract with the phospholipid, 1-oleoyl-2-stearoyl-sn-
glycero-3-phosphocholine (OSPC), C12 GlcCer and C18 Cer standards was used 
to test the efficacy of the mild alkaline hydrolysis in degrading the OSPC while 
leaving the sphingolipids intact throughout the reaction.  A solution of 33% 
methylamine in absolute ethanol as a 7:3 mixture in H2O provided swift 
decomposition of the OSPC species in one h with no apparent decrease in the 
concentrations of the sphingolipid standards. 
To challenge these protocols further, they were also compared to 
published results.  Cells of S. cerevisiae (InvSc1) were grown in shaking cultures, 
lyophilized, subjected to total lipid extraction and mild alkaline hydrolysis, and 
analyzed by ESI-MS.  The results were compared to the work of Wenk et al. (1) 
and Schneiter et al. (87), who characterized the phospholipid and sphingolipid 
profile of S. cerevisiae using similar mass spectrometry-based techniques to 
those we employed.  After some optimization of solvent conditions (1:1 
MeOH/CHCl3 (1)), comparable profiles were obtained for phospholipids and 
sphingolipids.  The spectra obtained of the total lipid extract (A) and sphingolipid 
(B) are provided in Figure 59.  The prominent phospholipids in the TLE are 
phosphatidylinositol (PI) and phosphatidylethanolamine (PE) (1). 
0
1000
2000
3000
4000
5000
6000
1 2 3 4
Ab
un
da
nc
e 
Extraction number 
C12 GlcCer
C18 Cer
96 
 
 
 
 
 
Figure 59.  The complex lipids of S. cerevisiae following total lipid extraction (A) 
and sphingolipids following methylamine hydrolysis (B). 
The ions of m/z 936, 952 and 968 (Figure 59; B) constitute a t18:0/26:0 
inositol phosphorylceramide (IPC) series of SLs, with zero, one and two 
hydroxylations on the C26 fatty acyl chain (1, 88).  Similarly, the ions 1098, 1114 
and 1130 m/z are indicative of t18:0/26:0 mannosyl inositol phosphorylceramides 
(MIPC) SLs, again with zero, one and two hydroxylations to the C26 chain (1, 88) 
(structures in Figure 60).   
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Figure 60.  Examples of the IPC and MIPC SLs in S. cerevisiae. 
Both classes were readily analyzed by ESI/QQQ (-140 V) and yielded 
noteworthy fragmentation patterns upon collision-induced dissociation at 50 eV 
(IPC) and 75 eV (MIPC).  The IPC class of sphingolipid exhibited exceptionally 
diagnostic fragmentation patterns upon CID, as can be seen in Figure 61.  Upon 
selection of the 952.7 ion for dissociation, losses of the phosphoinositol head 
group can be observed as m/z 259 (phosphate+sugar), and its dehydration 
product at m/z 241.  Additionally, while the particular spectra included here were 
obtained in scan ranges of 200-1200 m/z units, a prominent ion of m/z 78.9 is 
also observed when scanning the lower end of the mass range.  This ion is the 
dehydration product of phosphate, signifying the presence of a phosphate group.  
All fragments were confirmed by literature (1, 89). 
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Figure 61.  The fragments resulting from CID at 50 eV of a prominent 
inositolphosphorylceramide (m/z 952.7) in yeast. 
In a similar fashion, the most prominent MIPC (m/z 1114.8) dissociates to 
masses of m/z 421 and 403, which correspond to the same phosphate+inositol 
species as IPC, with the inclusion of a second mannosyl sugar.  With protocols 
and procedures of analysis in place, the research moved to characterizing the 
sphingolipids in D. discoideum. 
4.3.3. Sphingolipid characterization for D. discoideum 
Using the optimized total lipid extraction procedure, Dictyostelium cell 
membranes were broken and the complex lipids obtained.  Upon analysis of the 
extract by tandem MS, the organism was found to contain high concentrations of 
three phosphatidylcholines (PC), with m/z values of 782 (36:4), 754 (34:4) and 
730 (32:2), and a phosphatidylserine (PS 32:1; m/z 704). 
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Figure 62. MS2 scan of the D. discoideum total lipid extract (phospholipids). 
 Phosphatidylcholines are particularly straightforward to distinguish by 
tandem mass spectrometry.  Upon direct injection into the ESI source and 
collision-induced dissociation, the phosphocholine head group dissociates from 
the remainder of the molecule, producing an intense, diagnostic m/z = 184 
fragment.  The product ion scan in Figure 63 illustrates the ease with which PCs 
can be distinguished from other lipids.  The spectrum portrays CID at 30eV of the 
754 m/z ion seen in Figure 62, and exhibits a strong 184 m/z signal for the head 
group.  While the characterization of all the components of the total lipid extract 
was not the goal, it was advantageous to have an idea of what the phospholipids 
were, specifically so that their disappearance could be confirmed following the 
methylamine reaction. 
 
Figure 63.  The collision-induced dissociation spectrum of 34:4 PC via tandem 
mass spectrometry. 
36:4 PC 
34:4 PC 
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 The direct injection MS scan results of the SL-enriched mild alkaline 
hydrolysis product of the total lipid extract are shown in Figure 64. 
 
Figure 64.  Mass spectrum of the enriched sphingolipid sample of D. discoideum 
following methylamine hydrolysis of phospholipids. 
 While the results vary slightly from sample to sample in terms of 
background ions and contaminants, the consistent signals presumed to be 
sphingolipids are as follows: 698, 700, 868, 882, 896, 1064, 1078, 1092, and 
1328 m/z.  Using QQQ and QTOF tandem mass spectrometers, attempts were 
made to identify these potential SLs. 
The fatty acid profile generated in Section 2.3.2. represents the FAs from 
all complex lipids.  To better understand the fatty acids in D. discoideum 
sphingolipids, fatty acid methyl esters were prepared from the sphingolipid mild 
alkaline hydrolysate.  Analysis of FAMEs prepared directly from the hydrolysate 
revealed a near identical distribution of FAMEs to those seen in whole cells, with 
a duplicate set of 18:2 peaks differing by 1 m/z unit, corresponding to methyl 
amides (Figure 65). 
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Figure 65.  The total ion chromatogram (A) from FAME analysis of a mild alkaline 
hydrolysate and the mass spectrum of an 18:25,11 methyl amide (B). 
These amides are the direct products of the methylamine hydrolysis.  As 
the ester bonds of phospholipids are hydrolyzed by nucleophilic attack of 
hydroxide and free carboxylate forms of the fatty acids are released (which are 
later converted to FAMEs during derivatization), methylamine can also attack the 
FAMEs methyl amides 
18:25,11 methyl amide 
m/z= 293 
A 
B 
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carboxyl group, generating the methyl amide derivative of the fatty acid.  In order 
to obtain an accurate assessment of the sphingolipid fatty acids, the sphingolipid 
sample was dissolved in Solvent A and washed with hexane to remove 
protonated free fatty acids/amides prior to the FAME derivatization.  The GC-MS 
results are shown in Figure 66. 
 
Figure 66.  TIC of FAME analysis of a mild alkaline hydrolysate following hexane 
wash. 
While the results showed a significant drop in the methyl amides, this only 
implies that the hexane wash was effective in removing the majority of that 
species but indicates nothing about the removal of free fatty acids from the 
mixture.  The abundance of FAMEs did not appear to decrease, and enrichment 
in VLCFA content was not observed suggesting that the free fatty acids were not 
removed.  As many sphingolipid acylations are hydroxy FAs, TMS derivatives 
were prepared as well, but h18:0-h22:0 were observed in comparable ratios to 
the total FA profile (Figure 67).  It is probable that the FFAs remained in 
carboxylate form following the methylamine hydrolysis, and were therefore not 
removed by the hexane wash.  However, the FAME results from an attempted 
18:2 methyl amides 
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acidification of the hexane wash experiment contained no detectable fatty acids.  
In short, the experiments were not successful in supplying a sphingolipid-specific 
FA profile.  
 
Figure 67. TIC of TMS-FAME analysis of a mild alkaline hydrolysate following 
hexane wash. 
4.3.3.1. Ceramide-1-phosphates 
 The characterization of the potential sphingolipids in Figure 64 began with 
the collision-induced dissociation and formulae generation from accurate mass 
determination of the 698 and 700 ions, suggesting that they represented 
ceramide-1-phosphates differing by one unit of unsaturation.  The fragmentation 
patterns observed for the [M-H+] 698 and 700 ions are shown in Figure 68.  
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Figure 68.  The CID mass spectrum of probable ceramide-1-phosphates in D. 
discoideum; [M-H+] 698 (A) and 700 (B). 
 The m/z 78.8 peak is a signature signal of a dehydrated phosphate group.  
Additionally, signals of m/z 279 and m/z 281 correspond to losses of 18:1 and 
18:2 fatty acid chains from the 698 and 700 m/z parent ions, respectively.  Exact 
mass data of [M-H+] = 698.5152 and 700.5306 m/z was obtained for these ions 
by ESI-QTOF.  MassHunter qualitative software generated formulae for these 
masses corresponding to C39H73NO7P- and C39H75NO7P-; suggesting similar 
structures, differing by one unit of unsaturation.  The presence of 39 carbons in 
each molecule indicates that either the LCB or the FA must be of an odd chain 
length.  The proposed structures of t21:18 LCB, with 18:25,11 and 18:111 FAs 
shown are shown in Figure 69 are supported by the FA and LCB profiles (the 
double bonds of the LCB and FA have been arbitrarily placed).  Alternatively, 
A 
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these structures could have been portrayed as t22:1/17:2 and t22:1/17:1, as D. 
discoideum has been shown to contain such C17 fatty acids and a t22:1 LCB.  
However, given the losses of fragments consistent with 18:1 and 18:2 acyl chains 
during dissociation, the structures in Figure 69 are the most reasonable.  These 
C1Ps are present in nearly a 1:1 ratio, as 54% of the composition is t21:1/18:2, 
while 46% is t21:1/18:1. 
 
Figure 69. The proposed structures of the ceramide-1-phosphates of 
Dictyostelium. [M-H+] 698 and [M-H+] 700. 
Inconsistencies in fragmentation between the d18:1/16:0 C1P standard 
(Figure 70) and the Dictyostelium C1Ps were observed.  The losses of 18:1 and 
18:2 FA from Dictyostelium C1Ps allowed for the assignment of the acyl chain 
while this fragment was not observed for d18:1/16:0 C1P.  Differences may stem 
from the number and location of double bonds and additional hydroxyl group in 
the biological LCB, making the Dictyostelium species more susceptible to 
dissociation in a collision cell.  Unfortunately, this is difficult to confirm, as neither 
phytosphingosine-derived C1Ps nor any C1P standards with greater than one 
unit of unsaturation in the acyl chain are readily available.  Literature data is not 
available that would aid in the structural assignment of the proposed ceramide-1-
phosphates.  In ESI mass spectrometry, sphingolipids are commonly analyzed in 
the presence of cationic species (usually lithiated), affording adducts that create 
diagnostic fragments useful in structural determination (79, 89, 90).  However, no 
information could be located in literature regarding structural determination of 
ceramide-1-phosphates as lithiated adducts.  Additionally, the in-house testing of 
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a ceramide-1-phosphate standard only resulted in the decomposition of the SL, 
no lithiated species emerged that could be dissociated.   
 
Figure 70.  Collision-induced dissociation of d18:1/16:0 ceramide-1-phosphate 
standard. 
In comparing Dictyostelium to other organisms, no clear ceramide kinase 
homologues have been observed in yeast (42, 43), but a gene encoding for 
ceramide kinase activity has been reported in Arabidopsis (44), and C1Ps have 
been shown to regulate cellular processes in plants (45, 47). 
4.3.3.2. Inositol phosphorylceramides 
The IPC series of sphingolipids in S. cerevisiae proved particularly useful 
as standards during the profiling of D. discoideum since there are no commercial 
standards available for these SLs.  A series of ions in the SL-enriched D. 
discoideum extract with m/z = 868, 882 and 896 (Figure 64) suggested the 
presence of SLs varying by one methylene unit (m/z 14) within an SL species.  
CID of the most abundant ion (m/z 868) revealed a fragmentation pattern (m/z 
868→259→241; Figure 71) reminiscent of that observed for the IPC 
sphingolipids in S. cerevisiae (Figure 61). 
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Figure 71.  The mass fragmentation of most prominent IPC sphingolipid of D. 
discoideum ([M-H+] m/z 868). 
Confident in the assignment of the signals (m/z 259 and 241) to an IPC 
head group, the sample was injected into the ESI source of the QTOF to obtain 
its exact mass (868.5959) and formula (C44H87NO13P-).  This data is consistent 
with t18:0/h20:0 (Figure 72).  The low abundance fragment at m/z 688.7 (arrow; 
Figure 71) likely results from the rearrangement product shown in the inset in the 
figure, as described by Hsu et al. (89).  An alternative structure for this molecule 
is t20:0/h18:0.  However, the presence in D. discoideum of 2-hydroxy 20:0 
combined with the high concentrations of t18:0 LCB supports this classification.  
Upon analysis by ESI-QTOF, which has greater sensitivity than the QQQ, the 
presence of t18:0/h18:0 and t18:0/h19:0 (m/z 840 and 854) was revealed and 
verified by fragmentation.  While this method could not definitively identify the 
specific chain length of the LCB in these SLs, there is potential to determine 
them by generation of lithiated SL species (89).  However, further structural 
information could not be gathered for these IPCs.  The percent composition of 
total Dictyostelium IPCs of the t18:0/h18:0 IPC is approximately 4%, while 
t18:0/h19:0 is twice as abundant.  Including the more abundant IPCs t18:0/h20:0 
(50%), t18:0/h21:0 (19%) and t18:0/h22:0 (18%), these discoveries brought the 
total number of IPC sphingolipids in Dictyostelium to five. 
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Figure 72.  t18:0/h20:0 IPC, the most prominent inositolphosphoryl ceramide of 
D. discoideum. 
IPCs constitute a large proportion of the complement of sphingolipids in 
many eukaryotic species, but are not, however, found in animals (5, 46).  As 
such, it is not surprising to find a large abundance of this SL class in D. 
discoideum.  While in some aspects, it may appear to possess more animal-like 
qualities, in this instance, the prominence of IPCs in its sphingolipid profile 
reinforces its placement in the phylogenetic tree between plants and animals. 
4.3.3.3. Unknown sphingolipids 
The group of sphingolipid molecules in the enriched fraction from 
Dictyostelium with m/z values of 1064, 1078 and 1092 could not be correlated to 
any commercial or biological SL standards but exhibited variation by m/z 14, 
indicating that they likely differ by one methylene group.  The ions m/z 1064, 
1078 and 1092 were present in a 51:27:22 ratio, respectively.  A product ion scan 
of the most abundant ion (m/z 1064) is shown in Figure 73.  The only truly 
diagnostic piece of information that could be derived from the CID data was that 
these molecules contain a phosphate group, as indicated by the signal at m/z 
78.8.   
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Figure 73.  Product ion scan of a sphingolipid of D. discoideum ([M-H+] m/z 
1064). 
 Preliminary work with S. cerevisiae sphingolipids suggested that the 
strong 436 fragment was in a mass range associated with some form of an MIPC 
head group.  However, the collision-induced dissociation patterns of the unknown 
Dictyostelium molecules (Figure 73) did not match with that observed with the 
yeast MIPC (Figure 74). 
 
 
 
 
 
 
 
 The exact masses of the unknown sphingolipids did not provide 
assistance either.  A mass of [M-H+] 1063.8670 was obtained for the most 
abundant ion; however, the MassHunter qualitative software could not generate 
Figure 74.  Product ion scan of an MIPC from yeast ([M-H+] m/z 1064) (1, 2). 
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plausible formulae for any of the three unknown ions.  The software produced 
formulae with such anomalous suggestions as 10.5 units of unsaturation, 
indicating the ion may be part of a dimer.  While a sphingolipid in the m/z 2200 
range was improbable, this result could also point to some form of an adduct, for 
example with cationic species such as lithium, sodium or potassium (79, 89, 90).  
There were no such monovalent metal ion species in the LC solvents that could 
contribute to such adducts, however, sodium adducts were observed by Hsu et 
al. (89) during the characterization of IPCs, despite the lack of added sodium 
ions.  Unfortunately, inclusion of these cationic species into the formula 
generation parameters of the MassHunter software did not provide any new 
developments. 
 The exact mass of the largest fragment of the [M-H+] 1064 ion (m/z 436; 
Figure 73) was also obtained with the rationale that it represented the 
sphingolipid head group and may be more straightforward to identify.  
Unfortunately, the accurate mass, [M-H+] 436.2849, was not easily converted into 
a formula by the MassHunter software or by non-automated trial and error of 
possible structures.  There is no evidence to suggest that this signal is even for 
an intact head group, and may be more likely a rearranged fragment.  Possible 
head group and complete sphingolipid structures that correspond to similar exact 
masses are shown in Figure 75.  The sphingolipid shown is an MIPC with a 
sodium sequestered somewhere on the molecule and a t22:1 LCB.  However, 
given the relative abundances of each LCB as demonstrated in Figure 56, it is 
unlikely that the t22:1 LCB could be the sole contributor to such an abundant 
class of SL.  A second reasonable assignment categorizes the LCB as t20:1, 
which was observed in high abundance (~20% composition) with a 20:0 fatty 
acid.  However, the head group that would dissociate from either of these long 
chain base + fatty acid configurations does not correlate to the m/z 436.2849 
obtained, or to any other fragment observed in Figure 73, and the accurate mass 
of either proposed structure is outside the range that determines a reasonable 
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match (m/z = 1063.6548 vs 1063.8670 observed).  Further examination must be 
conducted to unequivocally characterize this Dictyostelium sphingolipid class.   
 
Figure 75.  The proposed structure for the sphingolipid of D. discoideum, [M-H+] 
m/z 1064. 
An analogous approach was used to attempt to determine the identity of 
the signal at m/z 1328 (product ion in Figure 76).  This species may be a larger 
derivative (possibly containing an additional sugar moiety on the head group) of 
the 1064 series of SLs, however, neither the molecular ion nor the m/z 700 ion 
(Figure 76) was amenable to formula generation via accurate mass acquisition, 
which again suggested some sort of adduct formation.  The strong signal of 281 
m/z correlates to an 18:1 fatty acid.  At sufficiently high collision energy (100 eV) 
the dehydration product of phosphate can be observed as well (m/z 78.9, data 
not shown).  With such limited pieces of structural information, no theoretical 
structures could be generated that correlated to the observed exact mass of [M-
H+] 1328.1102 m/z.   
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Figure 76.  Product ion scan of a sphingolipid of D. discoideum ([M-H+] m/z 
1328). 
Attempts were also made to lithiate the sphingolipids of D. discoideum in 
order to gain additional structural information, particularly for the m/z 1064 series 
and the signal at m/z 1328.  However, very limited information was derived from 
these experiments.  Lithium adduct experiments that have been helpful in SL 
structural determination are typically performed on multistage ion-trap (IT) mass 
spectrometers (79, 89-91).  These instruments have high sensitivity as well as 
the ability to generate a more extensive array of fragments through an MS 
technique that allows fragments to be “re-fragmented” multiple times.  The 
effectiveness of using a triple quadrupole instrument (such as in our studies) in 
lithiated SL experiments was compared to that of an ion-trap by Hsu et al. (89).  
They concluded that while a QQQ could be effective in generating some 
fragments from lithiated species, the degree of sensitivity and extensiveness of 
fragments produced via the multistage experiments of an ion-trap is vital for 
obtaining structural identification of such complex sphingolipids as IPCs, GSLs, 
and ceramides (89).  As such, it is doubtful that our instrument is capable of 
detecting the necessary fragments for structural identification of the SLs in the 
1064 and 1328 series.  To obtain these structures, it is likely that they will need to 
be analyzed on an IT-MS. 
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4.3.4. Closing Remarks 
In summary, the sphingolipid profile of D. discoideum was partially 
elucidated.  While the precise LCB+fatty acid combinations of the ceramide-1-
phosphates and IPCs still need to be confirmed via the generation of lithiated 
adducts and analysis on an ion-trap MS, most of the LCB components can be 
accounted for in our preliminary analysis of the SL profile.  The t18:0 (and 
possibly some t20:0) LCBs are the backbone for the majority of IPCs, and t21:1 
(and t22:1) comprise the bulk of the LCBs of the ceramide-1-phosphate 
population.  This leaves the t20:1 LCB with the second largest abundance 
unaccounted for, and may constitute the backbone for the 1064 series of 
uncharacterized SLs in Dictyostelium.   
Sufficient evidence was uncovered to positively identify the most 
prominent sphingolipid class in the organism as inositol phosphorylceramides.  
Five members of this SL class were observed, each differing by one methylene 
unit.  The most abundant IPC was that of a t18:0/h20:0, followed by t18:0/h21:0 
and t18:0/h22:0, with lower levels of t18:0/h18:0 and t18:0/h19:0.  As discussed, 
the exact combinations of long chain base and acyl chains may vary from the 
designations given.  The arrangement of acyl chains and LCBs in the ceramide-
1-phosphates, the second most abundant class of SL observed in Dictyostelium, 
were less subject to interchangeable combinations, and were classified as 
t21:1/18:2 and t21:1/18:1.   Four potential sphingolipids will require additional 
experimental analysis (m/z 1064, 1078, 1092 and 1328) by generating lithiated 
adducts and analyzing on an ion-trap mass spectrometer.  A final overview of the 
sphingolipid profile of D. discoideum is displayed in Table 5. 
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Table 5.  The sphingolipids of Dictyostelium discoideum. 
      
m/z Detected Sphingolipid Percent Composition 
698.5 t21:1/18:2 C1P 54% 
700.5 t21:1/18:1 C1P 46% 
840.5 t18:0/h18:0 IPC 4% 
854.6 t18:0/h19:0 IPC 8% 
868.6 t18:0/h20:0 IPC 50% 
882.6 t18:0/h21:0 IPC 19% 
896.6 t18:0/h22:0 IPC 18% 
1063.8 51% 
1077.8 27% 
1091.8 22% 
1328.1     
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CHAPTER 5. EXPERIMENTAL DETAILS OF THE SYNTHESIS OF FATTY 
ACIDS 
5.1. General experimental information 
All manipulations were performed in oven-dried glassware under an argon 
atmosphere unless otherwise mentioned.  All solvents were dried and were 
distilled freshly before use.  THF was dried and deoxygenated by distillation 
under Ar from sodium-benzophenone ketyl.  Methylene chloride (DCM) was dried 
over CaH2, and hexamethylphosphoramide (HMPA) was vacuum distilled from 
CaH2.  Other reagents were purchased from Sigma-Aldrich or Fisher 
Scientific/ACROS and used without purification.  Silica gel for chromatography 
was procured from Dynamic Absorbents (32-63 micron, #02826), using the 
indicated solvent.  1H-NMR and 13C-NMR spectra were recorded on a Bruker 
Avance-III NMR spectrometer using CDCl3 as solvent; residual CHCl3 (1H, δ 
7.26; 500 MHz) and CDCl3 (13C, δ 77.0; 125 MHz) were used as internal 
references.  Peak multiplicities were given as follows: s, singlet; d, doublet; t, 
triplet; q, quartet; qn, quintet; m, multiplet; br, broad.  IR spectra were determined 
as neat films (using NaCl plate) or by KBr pellets on a Thermo Nicolet Avatar 330 
FT-IR spectrophotometer.  High-resolution MS spectra (HRMS) were obtained on 
an Agilent 6520 quadrupole time-of-flight mass spectrometer equipped with ESI 
and atmospheric pressure chemical ionization (APCI), and through the Indiana 
University Chemistry Department Mass Spectrometry Facility in Bloomington, IN 
for compounds analyzed by chemical ionization (CI)-MS. 
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5.2. Synthetic standards for characterization of fatty acid profile 
5.2.1. Synthesis of 18:2 5,9 (35) 
 
 
3-Bromobutanal (1).  Ethyl 4-bromobutanoate (9.75 g, 50.00 mmol) was 
dissolved in DCM (90 mL) and cooled to -78 °C under argon, to which 
diisobutylaluminum hydride (50 mL, 1.0 M solution in hexanes, 50.00 mmol) was 
added dropwise at 1 mL/min.  A slow rate of addition is required to reproduce the 
reported yield.  The clear solution stirred at -78 °C for 1 h, then was allowed to 
warm to -60 qC for 1 h.  HCl (20 mL, 10%) was added at 0 °C and a gray 
precipitate swiftly formed.  After 1 h stirring, the product was extracted 3x with 
DCM, and organic extracts were washed with water and brine, then dried with 
MgSO4.  Careful evaporation under reduced pressure resulted in a minimal loss 
of the low mw product 1, which was a light yellow oil (6.51 g, 86.1%).  The 
aldehyde, whose NMR was consistent with literature data (54) was used in the 
preparation of 2 without further purification. 
 
 
2-(3-Bromopropyl)-1,3-dioxolane (2).  In a round-bottom flask, the crude 
residue of 1 (6.51 g, 43.10 mmol) was dissolved in benzene (175 mL), and 
ethylene glycol (17.8 mL, 322.50 mmol) and para-toluenesulfonic acid (0.380 g, 
2.00 mmol) were added under argon.  After attaching a Dean-Stark apparatus 
filled with 3Ǻ molecular sieves to the flask, the heterogeneous mixture was 
stirred and refluxed for 3 h.  NaHCO3 (1.575 g, 18.75 mmol) was introduced and 
the reaction mixture was stirred for 10 min prior to being washed 2x with sat. aq. 
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NaHCO3, and dried with MgSO4.  Concentration of the organic phase with a 
rotary evaporator yielded 2 as a light yellow oil (7.352 g, 87.5%).  The dioxolane, 
whose NMR was consistent with literature data (54) was used in the preparation 
of 3 without further purification. 
 
 
2-(3-Iodopropyl)-1,3-dioxolane (3).  To a stirred solution of the crude product 2 
(5.00 g, 25.60 mmol) in HPLC-grade acetone (25 mL) was added sodium iodide 
(4.80 g, 32.00 mmol).  The solution was heated to reflux under an inert 
atmosphere for 3 h.  The mixture was allowed to cool then DI water (25 mL) was 
added and the reaction mixture was stirred for 10 min.  After passing the acetone 
solution through a sintered glass funnel packed with Celite, the filtrate was 
extracted 3x with DCM and dried with MgSO4.  The crude product was subjected 
to flash silica gel chromatography (hexanes-EtOAc gradient, 0-10% EtOAc) to 
yield the yellow product 3 (4.850 g, 78.2%) which was stabilized by storing over 
K2CO3.  The iodide, whose NMR was consistent with literature data (92), was 
used in the preparation of acetylenic derivatives without further purification. 
 
 
2-(Nona-4,8-diynyl)-1,3-dioxolane (8). 1,6-Hexadiyne (0.645 g, 6.20 mmol, 75% 
in pentane), HMPA (1.08 mL, 9.30 mmol) and dry THF (20 mL) were combined in 
a round-bottom flask that was then cooled to -78 °C in a dry-ice acetone bath.  n-
Butyllithium (2.55 mL, 2.43 M in hexanes, 7.44 mmol) was added dropwise over 
10 min and the reaction mixture was stirred for 30 min at -78 °C.  The cooling 
bath was removed and 3 (1.000 g, 4.13 mmol) was added in THF (5 mL).  The 
light yellow mixture was then refluxed for 18 h, producing a dark yellow solution.  
Sat. NH4Cl (~50 mL) was added to the round-bottom flask and the mixture was 
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stirred for 5 min and then extracted 3x with Et2O, dried with MgSO4 and the 
solvent evaporated with the use of a rotary evaporator.  The yellow residue was 
separated by silica gel column chromatography (hexane-EtOAc gradient, 0-5% 
EtOAc) to afford alkyne 8 as a yellow oil (0.330 g, 41.7% yield).  1H NMR (500 
MHz, CDCl3) δ 4.89 (t, J = 4.8 Hz, 1H), 3.98 (m, 2H), 3.86 (m, 2H), 2.39 (s, 4H), 
2.24 (t, J = 7.0 Hz, 2H), 2.03 (t, J = 2.7 Hz, 1H), 1.78 (m, 2H) 1.64 (m, 2H); 13C 
NMR (125 MHz, CDCl3) δ 104.28, 83.04, 80.86, 78.67, 69.06, 64.90 (2C), 32.89, 
23.38, 19.11, 18.88, 18.63; IR (neat film) νmax 3289, 2953, 2883, 2119, 1457, 
1436, 1410, 1135, 1035, 940 cm-1;  HRMS (CI+) m/z [M+H+] calcd C12H17O2  
191.1067, found 191.1069. 
 
 
2-(Heptadeca-4,8-diynyl)-1,3-dioxolane (14). Alkyne 8 (0.310 g, 1.61 mmol), 
HMPA (0.421 mL, 2.41 mmol) and dry THF (13 mL) were combined in a round-
bottom flask and cooled to -78 °C.  n-Butyllithium (0.797 mL, 2.43 M in hexanes, 
1.93 mmol) was added dropwise over 10 min and the solution was then stirred 
for 30 min at -78 °C.  The cold bath was removed and iodooctane (0.465 g, 1.93 
mmol) was added in 5 mL of THF.  The light yellow mixture was then refluxed for 
18 h, resulting in a dark yellow solution.  The reaction was quenched with sat. 
NH4Cl (~25 mL) and allowed to stir for 5 min.  The mixture was extracted 3x with 
Et2O, dried with MgSO4 and the solvent removed with the aid of a rotary 
evaporator.  The yellow crude product was purified by silica gel column 
chromatography (hexane-EtOAc gradient, 0-5% EtOAc) to afford 14 as a yellow 
oil (0.330 g, 74% yield).  1H NMR (500 MHz, CDCl3) δ 4.88 (t, J = 4.8 Hz, 1H), 
3.98 (m, 2H), 3.86 (m, 2H), 2.34 (s, 4H), 2.22 (t, J = 7.0 Hz, 2H), 2.15 (t, J = 7.0 
Hz, 2H), 1.77 (m, 2H), 1.62 (m, 2H), 1.48 (qn, J = 7.5 Hz, 2H), 1.38 (m, 2H), 1.29 
(s, 10H), 0.90 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 104.30, 81.17, 
80.41, 79.30, 78.68, 64.83 (2C), 32.87, 31.87, 29.20, 29.12, 29.00, 28.84, 23.42, 
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22.64, 19.49, 19.47, 18.70, 18.63, 14.08; IR (neat film) νmax 2927, 2856, 1457, 
1436, 1142, 1037, 941 cm-1; HRMS (CI+) m/z [M+H+] calcd C20H35O2 305.2475, 
found 305.2470. 
 
2-((4Z,8Z)-Heptadeca-4,8-dienyl)-1,3-dioxolane (21). A round-bottom flask was 
charged with Pd on CaCO3 (0.104 g, 0.96 mmol, 3.5% Pb, 5.0% Pd), quinoline 
(0.026 mL, 0.22 mmol), 14 (0.243 g, 0.80 mmol) and absolute ethanol (3.5 mL).  
The mixture was flushed with H2 provided by a balloon for 1 min, then stirred for 
1 h, at which time GC analysis confirmed reduction of the acetylenic groups (56).  
The reaction mixture was passed through a sintered glass funnel packed with 
Celite to remove Pd, washed copiously with Et2O, and concentrated under 
reduced pressure by a rotary evaporator.  The residue was subjected to silica gel 
column chromatography (hexane-EtOAc gradient, 0-5% EtOAc) to remove 
quinoline, obtaining 0.245 g (99%) as a clear oil.  1H NMR (500 MHz, CDCl3) δ 
5.40 (m, 4H), 4.87 (t, J = 4.8 Hz, 1H), 4.00 (m, 2H), 3.87 (m, 2H), 2.10 (t, J = 2.6 
Hz, 4H), 2.04 (dt, J = 7.0 Hz, 4H), 1.68 (m, 2H), 1.51 (m, 2H), 1.30 (m, 12H), 0.91 
(t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 130.46, 129.79, 129.61, 129.07, 
104.58, 64.86 (2C), 33.46, 31.91, 29.75, 29.62, 29.54, 29.33, 27.44, 27.36, 
27.28, 27.08, 24.09, 22.69, 14.13; IR (neat film) νmax 2925, 2854, 1653, 1457, 
1141 cm-1; HRMS (CI+) m/z [M+H+] calcd C20H37O2 309.2788, found 309.2787. 
 
(5Z,9Z)-Octadeca-5,9-dienal (28).  The dioxolane 21 (0.200 g, 0.66 mmol) was 
combined with p-TsOH (0.020 g, 0.100 mmol), acetone (6.5 mL) and H2O (1.0 
mL) in a round-bottom flask equipped with a condenser, and heated to reflux 
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(57).  After reacting for 3 h, acetone was evaporated, pTsOH was quenched with 
sat. NaHCO3, and the aldehyde product was extracted 3x with DCM and dried 
with MgSO4.  The crude mixture of 28 (0.163 g, 94% yield) was used in the next 
step without further preparation. 
 
(5Z,9Z)-Octadeca-5,9-dienoic acid (35).  The aldehyde 28 (0.291 g, 0.96 mmol) 
and DMSO (6.0 mL) were combined in a round-bottom flask to which NaH2PO4 
(0.266 g, 1.92 mmol) was slowly added in H2O (3.0 mL, exothermic).  Once the 
solution had cooled to room temperature, aqueous NaClO2 (0.483 g, 4.80 mmol 
in 3.0 mL H2O) was added dropwise over 5 min.  The resulting yellow solution 
was stirred under an inert atmosphere for 4 h (92).  To isolate the product, the 
reaction mixture was poured into ice-cold HCl (10%), extracted 4x with hexane, 
and dried with MgSO4.  After rotary evaporation of the organic phase, the yellow 
residue was purified by silica gel column chromatography (hexane-EtOAc 
gradient with 0.1% acetic acid, 0-5% EtOAc) to elute the clear oil 35 (0.264 g, 
86% yield).  1H NMR (500 MHz, CDCl3) δ 10.85 (br, 1H) 5.36 (m, 4H), 2.38 (t, J = 
7.5 Hz, 2H), 2.09 (t, J = 2.6 Hz, 4H), 2.05 (dt, J = 7.0 Hz, 4H), 1.74 (qn, J = 7.5 
Hz, 2H), 1.29 (m, 12H), 0.91 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
180.10, 130.63, 130.56, 128.91, 128.60, 33.44, 31.91 (2C), 29.74, 29.54, 29.35 
(2C), 27.41, 27.29, 26.49, 24.58, 22.69, 14.11;  IR (neat film) νmax 3007, 2925, 
2854, 1710, 1457 cm-1; HRMS (ESI-) m/z [M-H+] calcd C18H31O2 279.2330, found 
279.2335. 
 Compounds 31-37 were prepared by an analogous series of alkynylation, 
reduction, deprotonation, and oxidation reactions.  The spectroscopic data for the 
final products 31-37 are as follows: 
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(Z)-Hexadec-5-enoic acid (31).  1H NMR (500 MHz, CDCl3) δ 5.35 (m, 1H), 5.25 
(m, 1H), 2.29 (t, J = 7.5 Hz, 2H), 2.02 (q, J = 7.5 Hz, 2H), 1.94 (q, J = 7.5 Hz, 2H) 
1.63 (qn, J = 7.5 Hz, 2H) (s, 16H), 0.81 (t, J = 7.5 Hz, 3H);  13C NMR (125 MHz, 
CDCl3) δ 179.72, 131.39, 128.13, 33.39, 31.98, 29.73, 29.69, 29.65, 29.57, 
29.37, 29.34, 27.26, 26.44, 24.68, 22.73, 14.18; IR (neat film) νmax 3006, 2923, 
2854, 1710, 1457, 1413, 1241, 935 cm-1; HRMS (ESI-) m/z [M-H+] calcd 
C16H29O2 253.2173, found 253.2175.  
 
(Z)-Octadec-5-enoic acid (32).  1H NMR (500 MHz, CDCl3) δ 5.34 (m, 1H), 5.26 
(m, 1H), 2.30 (t, J = 7.5 Hz, 2H), 2.03 (q, J = 7.5 Hz, 2H), 1.96 (q, J = 7.5 Hz, 
2H), 1.65 (qn, J = 7.5 Hz, 2H), 1.20 (s, 16H), 0.80 (t, J = 7.5 Hz, 3H);  13C NMR 
(125 MHz, CDCl3) δ 179.82, 130.59, 129.17, 33.39, 31.98, 29.73, 29.70, 29.69, 
29.66, 29.57, 29.37, 29.34, 29.33, 27.25, 26.44, 24.61, 22.71, 14.13; IR (neat 
film) νmax 3006, 2923, 2854, 1711, 1457, 1413, 1262, 1105 cm-1; HRMS (ESI-) 
m/z [M-H+] calcd C16H29O2 281.2486, found 281.2489. 
 
(5Z,11Z)-Octadeca-5,11-dienoic acid (33). 1H NMR (500 MHz, CDCl3) δ 10.56 
(br, 1H) 5.37 (m, 4H), 2.38 (t, J = 7.0 Hz, 2H), 2.00 (m, J = 2.6 Hz, 8H), 1.73 (t, J 
= 7.5 Hz, 2H), 1.32 (m, 12H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 179.89, 131.19, 130.13, 129.63, 128.25, 31.84 (2C), 29.76, 29.41, 
29.29, 29.05, 29.28, 27.14, 27.10, 26.43, 24.62, 22.75, 14.13;  IR (neat film) νmax 
3005, 2926, 2855, 1710, 1457 cm-1; HRMS (ESI-) m/z [M-H+] calcd C18H31O2 
279.2330, found 279.2331. 
 
(5Z,9Z)-Hexadeca-5,9-dienoic acid (34). 1H NMR (500 MHz, CDCl3) δ 11.21 (br, 
1H), 5.38 (m, 4H), 2.36 (t, J = 7.5 Hz, 2H), 2.03 (m, 8H), 1.76 (t, J = 7.5 Hz, 2H), 
1.36 (m, 8H), 0.92 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 179.40, 
130.63, 130.56, 128.92, 128.61, 33.31, 31.79, 29.70, 29.56, 28.99, 27.41, 27.28, 
26.49, 24.58, 22.66, 14.10;  IR (neat film) νmax 3007, 2926, 2855, 1710, cm-1; 
HRMS (ESI-) m/z [M-H+] calcd C16H27O2 251.2017, found 252.2020.  
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(5Z,9Z)-Heptadeca-5,9-dienoic acid (36). 1H NMR (500 MHz, CDCl3) δ 5.31 (m, 
4H), 2.29 (t, J = 7.5 Hz, 2H), 2.00 (m, 8H), 1.63 (qn, J = 7.5 Hz, 2H), 1.19 (m, 
10H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 179.65, 130.64, 
130.53, 128.94, 128.64, 33.42, 32.62, 31.89, 29.76, 29.28, 29.23, 27.40, 27.27, 
26.49, 24.58, 22.67, 14.11;  IR (neat film) νmax 2926, 2670, 1709, 1457, 1413, 
1242, 967, 937, 723 cm-1; HRMS (ESI-) m/z [M-H+] calcd C17H29O2 265.2173, 
found 265.2176. 
 
(7Z,11Z)-Octadeca-7,11-dienoic acid (37). 1H NMR (500 MHz, CDCl3) δ 10.90 
(br, 1H) 5.39 (m, 4H), 2.38 (t, J = 7.0 Hz, 2H), 2.05 (m, 8H), 1.68 (t, J = 7.5 Hz, 
2H), 1.37 (m, 12H), 0.90 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
180.16, 130.44, 129.87, 129.52, 129.07, 34.04, 31.79, 29.71, 29.32, 29.00, 
28.71, 27.42, 27.37, 27.28, 27.03, 24.58, 22.66, 14.10;  IR (neat film) νmax 3006, 
2927, 2855, 2668, 1711, 1457, 1412, 1279, 1236, 938, 725 cm-1; HRMS (ESI-) 
m/z [M-H+] calcd C18H31O2 279.2330, found 279.2332.  
5.3. Production of 2H-labeled fatty acids for in vivo studies 
This section provides the experimental protocols employed during the 
generation of deuterium-labeled fatty acids for the in vivo studies of D. 
discoideum, split into four subsections.  The first segment discusses the pathway 
of making d5-labeled FAs using stearic acid-d5 as the template; the latter portions 
describe the pathways by which d4 and d7-labeled FAs were produced. 
 
 
 
 
 
123 
 
 
5.3.1. Synthesis of stearic acid-17,17,18,18,18-d5 (49) 
 
 
8-Bromooctanal (38).  Methyl 8-bromooctanoate (5.000 g, 21.1 mmol) was 
dissolved in DCM (38 mL) and cooled to -78 °C under argon, to which 
diisobutylaluminum hydride (21.1 mL, 1.0 M solution in hexanes, 21.1 mmol) was 
added by syringe pump at 1 mL/min.  A slow rate of addition is required to 
reproduce the reported yield.  The clear solution stirred at -78 °C for 1 h, then 
allowed to warm to -60 qC for 1 h.  HCl (20 mL, 10%) was added at 0 °C and gray 
precipitate swiftly formed.  After 1 h stirring, the product was extracted 3x with 
DCM, and organic extracts were washed with water and brine, then dried with 
MgSO4.  Evaporation under reduced pressure resulted in product 38 as a light 
yellow oil (4.225 g, 97%).  The aldehyde, whose NMR was consistent with 
literature data (54), was used in the preparation of 39 without further purification. 
 
 
2-(7-Bromoheptyl)-1,3-dioxolane (39).  In a round-bottom flask, the crude 
residue of 38 (4.225 g, 20.4 mmol) was dissolved with stirring in benzene (80 
mL), and ethylene glycol (10.6 mL, 153 mmol) and para-toluenesulfonic acid 
(0.155 g, 0.82 mmol) were added under argon.  After attaching a Dean-Stark 
apparatus filled with 3-Ǻ molecular sieves to the flask, the heterogeneous mixture 
was stirred and refluxed for 3 h.  NaHCO3 (1.35 g, 16.2 mmol) was introduced 
and the reaction mixture was stirred for 10 min prior to being washed 2x with sat. 
aq. NaHCO3, and dried with MgSO4.  Concentration of the organic phase with a 
rotary evaporator yielded 39 as a light yellow oil (5.100 g, 100%). The dioxolane, 
whose NMR was consistent with literature data (54), was used in the preparation 
of 40 without further purification. 
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2-(2-Iodoheptyl)-1,3-dioxolane (40).  To a stirred solution of the crude bromide 
39 (5.10 g, 20.3 mmol) in HPLC-grade acetone (21 mL) was added sodium 
iodide (3.81 g, 25.4 mmol).  The solution was heated to reflux under an inert 
atmosphere for 3 h.  The mixture was allowed to cool then deionized (DI) water 
(25 mL) was added and the reaction mixture was stirred for 10 min.  After 
passing the acetone solution through a sintered glass funnel packed with Celite, 
the filtrate was extracted 3x with DCM and dried with MgSO4.  Upon 
concentration under reduced pressure yellow product 40 (5.703 g, 94%) was 
obtained, which was stabilized by storing over K2CO3. The iodide, whose NMR 
was consistent with literature data (92), was used in the preparation of acetylenic 
derivatives without further purification. 
 
 
2-(Pentadeca-8,14-diyn-1-yl)-1,3-dioxolane (41). 1,8-Octadiyne (1.062 g, 10.0 
mmol), HMPA (2.60 mL, 15.0 mmol) and dry THF (50 mL) were combined in a 
round-bottom flask that was then cooled to -78 °C in a dry-ice acetone bath.  n-
Butyllithium (4.84 mL, 2.48 M in hexanes, 12.0 mmol) was added dropwise over 
10 min and the reaction mixture was stirred for 30 min at -78 °C.  The cooling 
bath was removed and 40 (1.997 g, 8.25 mmol) was added in THF (2 mL).  The 
light yellow mixture was then refluxed for 18 h, producing a dark yellow solution.  
Sat. NH4Cl (~75 mL) was added to the round bottom flask and the mixture was 
stirred for 5 min and then extracted 3x with Et2O, dried with MgSO4 and the 
solvent evaporated with the use of a rotary evaporator.  The yellow residue was 
separated by silica gel column chromatography (hexane-EtOAc gradient, 0-5% 
EtOAc) to afford alkyne 41 as a yellow oil (0.967 g 52.1% yield).  1H NMR (500 
MHz, CDCl3) δ 4.88 (t, J = 4.8 Hz, 1H), 3.99 (m, 2H), 3.87 (m, 2H), 2.25 (m, 4H), 
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2.16 (m, 2H), 1.98 (t, J = 2.7 Hz, 1H), 1.70-1.58 (m, 6H) 1.49-1.34 (m, 10H); 13C 
NMR (125 MHz, CDCl3) δ 104.67, 84.30, 80.63, 79.53, 68.35, 64.83 (2C), 33.89, 
29.44, 29.07, 29.05, 28.73, 28.05, 27.53, 24.04, 18.74, 18.30, 18.01; IR (neat 
film) νmax 3291, 2932, 2858, 2117, 1461, 1434, 1410, 1140, 1037, 943 cm-1;  
HRMS (CI) m/z [M+H+] calcd C18H29O2 277.2162, found 277.2149. 
2-(Heptadeca-8,14-diyn-1-yl)-1,3-dioxolane-17,17,18,18,18-d5 (43).  Alkyne 41 
(0.500 g, 1.810 mmol), HMPA (0.482 mL, 2.714 mmol) and dry THF (30 mL) 
were combined in a round-bottom flask and cooled to -78 °C.  n-Butyllithium 
(0.924 mL, 2.354 M in hexanes, 2.173 mmol) was added dropwise over 10 min 
and the solution was then stirred for 30 min at -78 °C.  The cold bath was 
removed and ethyl bromide-d5 (0.168 mL, 2.173 mmol), and NaI (0.029 g, 0.173 
mmol) were added.  The light yellow mixture was then refluxed for 18 h, resulting 
in a dark yellow solution.  The reaction was quenched with sat. NH4Cl (~50 mL) 
and allowed to stir for 5 min.  The mixture was extracted 3x with Et2O, dried with 
MgSO4 and the solvent removed with the aid of a rotary evaporator.  The yellow 
crude product was purified by silica gel column chromatography (hexane-EtOAc 
gradient, 0-5% EtOAc) to afford 43 as a yellow oil (0.485 g, 87% yield).  1H NMR 
(500 MHz, CDCl3) δ 4.87 (t, J = 4.8 Hz, 1H), 3.99 (m, 2H), 3.87 (m, 2H), 2.19 (m, 
6H), 1.67 (m, 2H), 1.60 (m, 4H), 1.42 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 
104.69, 80.46 (2C), 79.80, 79.13, 64.84 (2C), 33.90, 29.44, 29.11 (2C), 29.06, 
28.75, 28.26, 24.06, 18.74, 18.35, 18.31; IR (neat film) νmax 2932, 2858, 2231, 
1457, 1140, 1037 cm-1; HRMS (ESI+) m/z [M+H+] calcd C20H28D5O2 310.2789 , 
found 310.2790. 
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2-Heptadecyl-1,3-dioxolane-17,17,18,18,18-d5 (45). A round-bottom flask was 
charged with 10% Pd on carbon (0.350 g), 43 (0.350 g, 1.129 mmol) and 
absolute ethanol (10 mL).  The mixture was flushed with H2 atmosphere provided 
by a balloon for 1 min, then stirred for 1 h, at which time GC analysis confirmed 
reduction of the acetylenes.  The reaction mixture was passed through a sintered 
glass funnel packed with Celite to remove Pd, washed copiously with Et2O, and 
concentrated under reduced pressure by a rotary evaporator.  Dioxolane 45 was 
obtained 0.350 g (98%) as a white solid, and the residue was deprotected 
without further preparation. 
Stearaldehyde-17,17,18,18,18-d5 (47).  The dioxolane 45 (0.350 g, 1.104 mmol) 
was combined with p-TsOH (0.032 g, 0.166 mmol), acetone (12 mL) and H2O 
(1.8 mL) in a round-bottom flask equipped with a condenser, and heated to reflux 
(57).  After reacting for 3 h, acetone was evaporated, p-TsOH was quenched with 
sat. NaHCO3, and the aldehyde product was extracted 3x with DCM and dried 
with MgSO4.  The crude mixture of 47 (0.270 g, 92% yield) was used in the next 
step without further preparation. 
Stearic acid-17,17,18,18,18-d5 (49).  The aldehyde 47 (0.270 g, 1.012 mmol) 
and DMSO (7.0 mL) were combined in a round-bottom flask to which NaH2PO4 
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(0.281 g, 2.037 mmol) was slowly added in H2O (1.0 mL, exothermic).  Once the 
solution had cooled to room temperature, NaClO2 (0.461 g, 5.094 mmol) was 
added dropwise in H2O (1.0 mL).  The resulting yellow solution was stirred under 
an inert atmosphere for 4 h (58).  To isolate the product, the reaction mixture was 
poured into ice-cold HCl (10%), extracted 4x with hexane, and dried with MgSO4.  
After rotary evaporation of the organic phase, the yellow residue was purified by 
silica gel column chromatography (hexane-EtOAc gradient with 0.1% acetic acid, 
0-5% EtOAc) to elute the crystalline white solid 49 (0.233 g, 79% yield) upon 
evaporation of solvents under reduced pressure.  1H NMR (500 MHz, CDCl3) δ 
11.46 (br, 1H), 2.37 (t, J = 7.5 Hz, 2H), 1.66 (quint, J = 7.5 Hz, 2H), 1.29 (m, 
26H).  13C NMR (125 MHz, CDCl3) δ 180.08, 34.04, 31.64, 29.70, 29.68, 29.65, 
29.60 (3C), 29.50, 29.44, 29.37, 29.34, 29.25, 29.07, 24.68.  IR (KBr pellet) νmax 
2917, 2949, 1700, 1679; HRMS (ESI-) m/z [M-H+] calcd C18H30D5O2 289.3029, 
found 289.2956. 
5.3.2. Synthesis of stearic acid-3,3,4,4-d4 (55) 
 
 
4-(Methoxymethoxy)but-1-yne (51).  3-Butyn-1-ol (7.500 g, 0.107 mol) was 
dissolved in dimethoxymethane (175 mL) to which para-toluenesulfonic acid 
(2.033 g, 0.011 mol) and lithium bromide (1.858 g, 0.021 mol) were added, and 
the resulting white solution was allowed to stir at rt for 18 h under Ar (57).  The 
reaction mixture was washed with sat. aq. NaHCO3, and the organics dried with 
MgSO4.  Concentration of the organic phase with a rotary evaporator yielded 51 
as a clear oil (10.100 g, 82.0%).  1H NMR (500 MHz, CDCl3) δ 4.63 (s, 2H), 3.63 
(t, J = 7.0 Hz, 2H), 3.35 (s, 3H), 2.46 (dt, J = 1.3, 3.5 Hz, 2H), 1.98 (d, J = 3.0 Hz, 
1H); 13C NMR (125 MHz, CDCl3) δ 96.31, 81.23, 69.24, 65.65, 55.19 19.90. 
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1-(methoxymethoxy)octadec-3-yne (52).  Alkyne 51 (1.250 g, 10.950 mmol), 
HMPA (2.86 mL, 16.448 mmol) and dry THF (60 mL) were combined in a round-
bottom flask and cooled to -78 °C.  n-Butyllithium (6.625 mL, 2.485 M in hexanes, 
13.158 mmol) was added dropwise over 10 min and the solution was then stirred 
for 30 min at -78 °C.  The cold bath was removed and bromotetradecane (3.645, 
13.158 mmol), and NaI (0.081 g, 1.096 mmol) were added.  The light yellow 
mixture was then refluxed for 18 h, resulting in a dark yellow solution.  The 
reaction was quenched with sat. NH4Cl (~75 mL) and allowed to stir for 5 min.  
The mixture was extracted 3x with Et2O, dried with MgSO4 and the solvent 
removed with the aid of a rotary evaporator.  The yellow crude product was 
purified by silica gel column chromatography (hexane-EtOAc gradient, 0-5% 
EtOAc) to afford 52 as a light yellow oil (2.750 g, 82% yield).  1H NMR (500 MHz, 
CDCl3) δ 4.64 (s, 2H), 3.61 (t, J = 7.0 Hz, 2H), 3.36 (s, 3H), 2.45 (tt, J = 2.5, 4.5 
Hz, 2H), 2.13 (tt, J = 2.5, 4.5 Hz, 2H), 1.46 (qn, J = 7.5 Hz, 2H), 1.25 (s, 22H), 
0.85 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 96.50, 81.65, 66.65, 55.32, 
32.06, 29.83, 29.81, 29.79, 29.75, 29.69, 29.50, 29.32, 29.14, 29.02, 22.83, 
20.43, 18.89, 14.25. IR (neat film) νmax 2925, 2854, 2215, 1466, 1457, 1151, 
1112, 1074, 1030, 920 cm-1; HRMS (CI+) m/z [M+H+] calcd C20H39O2 311.2945, 
found 311.2939. 
 
1-(Methoxymethoxy)octadecane-3,3,4,4-d4 (53). A round-bottom flask was 
charged with RhCl(PPh3)3 (0.072 g, 0.077 mmol) and dry benzene (5 mL) under 
an inert atmosphere.  The stirring mixture was flushed with D2 provided by a 
balloon for 1 min, producing a red solution upon exposure, to which 52 (0.400 g, 
1.290 mmol) was added in 1 mL benzene and allowed to stir for 18 h (68).  
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Benzene was evaporated from the reaction mixture, and the residue was 
redissolved in hexane and passed through a sintered glass funnel packed with 
Celite, and concentrated under reduced pressure by a rotary evaporator.  The 
material was resubjected to a second reduction of 3 h succeeding the first 
workup, at which time GC analysis confirmed complete reduction of the 
acetylene.  The crude product was purified by silica gel column chromatography 
(hexane-EtOAc gradient, 0-3% EtOAc) to afford 53 as a white solid (0.335 g, 
81% yield*).  1H NMR (500 MHz, CDCl3) δ 4.62 (s, 2H), 3.51 (t, J = 7.0 Hz, 2H), 
3.36 (s, 3H), 1.58 (m, J = 7.0 Hz, 2H), 1.25 (s, 26H), 0.85 (t, J = 7.0 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 96.53, 68.03, 55.21, 32.07, 29.84 (8C), 29.81, 29.76, 
29.65, 29.51, 22.83, 14.26. IR (neat film) νmax 2923, 2854, 1457, 1153, 1113, 
1047 cm-1; HRMS (CI+) m/z [(M-OCH3) H+] calcd C19H35D4O2 287.3246, found 
287.3260. 
 
*A contaminant was produced during this reduction step that was carried on because it was not 
separable by silica gel chromatography.  It may have originated from a partial loss of the 
dimethoxymethyl protecting group. 
 
 
Octadecan-1-ol-3,3,4,4-d4 (54).  The methoxymethane-protected 53 (0.500 g, 
1.577 mmol) was solvated in 2% HCl (12 M) in methanol (20 mL) in a round-
bottom flask equipped with a condenser, and heated to 62 °C for 45 min (57), at 
which time HCl was quenched with sat. NaHCO3.  The primary alcohol product 
was extracted 3x with hexane and dried with MgSO4.  The crude mixture of 54 
(0.420 g, 97% yield) was used in the next step without further preparation. 
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Stearaldehyde-3,3,4,4-d4 (55).  To a mixture of 54 (0.420 g, 1.53 mmol) and 
DCM (10 mL) at 0 °C was added Dess-Martin periodinane (0.908 g, 2.15 mmol).  
The ice bath was removed and the translucent clear solution stirred for 2h, at 
which time cold pentane (25 mL) was added and stirred for 10 min to precipitate 
DMP-derived side products.  After filtration through a sintered glass funnel 
packed with Celite, the eluent was washed with saturated NaHCO3/Na2S2O3 (1:1) 
(69).  The organics were dried with MgSO4 and concentrated under reduced 
pressure by a rotary evaporator.  The crude aldehyde (0.420 g, 99% yield) was 
taken to the next step without further preparation. 
 
 
Stearic acid-3,3,4,4-d4 (56).  The aldehyde 55 (0.420 g, 1.544 mmol) and DMSO 
(9.0 mL) were combined in a round-bottom flask to which NaH2PO4 (0.420 g, 
3.09 mmol) was slowly added in H2O (2.0 mL, exothermic).  Once the solution 
had cooled to room temperature, NaClO2 (0.688 g, 7.72 mmol) was added 
dropwise over 5 min in H2O (2.0 mL).  The resulting yellow solution was stirred 
under an inert atmosphere for 4 h (58).  To isolate the product, the reaction 
mixture was poured into ice-cold HCl (10%), extracted 4x with hexane, and dried 
with MgSO4.  After rotary evaporation of the organic phase, the yellow residue 
was purified by silica gel column chromatography (hexane-EtOAc gradient with 
0.1% acetic acid, 0-5% EtOAc) to elute the crystalline white solid 56 (0.190 g, 
43% yield*).  1H NMR (500 MHz, CDCl3) δ 2.34 (qn, J = 7.5 Hz, 2H), 1.64 (qn, J = 
7.0 Hz, 2H), 1.25 (s, 24H), 0.88 (t, J = 7.0 Hz, 3H);  13C NMR (125 MHz, CDCl3) δ 
180.39, 32.07, 29.84 (8C), 29.81, 29.79, 29.74, 29.51, 22.84 14.26; IR (KBr 
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pellet) νmax 3004, 2926, 2854, 2222, 1710 cm-1; HRMS (ESI-) m/z [M-H+] calcd 
C18H31D4O2 287.2894, found 287.2898. 
 
*The contaminant discussed during the Wilkinson reduction step emerged as an oil following 
purification.  The low yield is the result of this impurity comprising approximately half of the mass 
that was carried through. 
5.3.3. Synthesis of octadec-5-enoic acid-16,16,17,17,18,18,18-d7 (74) 
 
 
6-(Methoxymethoxy)hex-1-yne (65).  Hex-5-yn-1-ol (5.000 g, 51.00 mmol) was 
dissolved in dimethoxymethane (85 mL), to which para-toluenesulfonic acid 
(0.967 g, 5.10 mmol) and lithium bromide (0.885 g, 1.05 mmol) were added, and 
the resulting white solution was allowed to stir at rt for 18 h under Ar (57).  The 
reaction mixture was washed with sat. aq. NaHCO3, and the organics dried with 
MgSO4.  Concentration of the organic phase with a rotary evaporator yielded 65 
as a clear oil (7.230 g, 99%). 
 
 
1-(Methoxymethoxy)dodec-5-yne-16,16,17,17,18,18,18-d7 (66).  Alkyne 65 
(0.689 g, 4.84 mmol), HMPA (1.264 mL, 7.27 mmol) and dry THF (35 mL) were 
combined in a round-bottom flask and cooled to -78 °C.  n-Butyllithium (2.340 
mL, 2.485 M in hexanes, 5.81 mmol) was added dropwise over 10 min and the 
solution was then stirred for 30 min at -78 °C.  The cold bath was removed and 
bromohexane-4,4,5,5,6,6,6-d7 (1.000 g, 5.81 mmol), and NaI (0.073 g, 0.48 
mmol) were added.  The light yellow mixture was then refluxed for 18 h, resulting 
in a dark yellow solution.  The reaction was quenched with sat. NH4Cl (~75 mL) 
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and allowed to stir for 5 min.  The mixture was extracted 3x with Et2O, dried with 
MgSO4 and the solvent removed with the aid of a rotary evaporator.  The yellow 
crude product was purified by silica gel column chromatography (hexane-EtOAc 
gradient, 0-3% EtOAc) to afford 66 as a light clear oil (0.908 g, 80% yield).  1H 
NMR (500 MHz, CDCl3) δ 4.48 (s, 2H), 3.41 (t, J = 7.0 Hz, 2H), 3.22 (s, 3H), 2.06 
(dt, J = 2.5, 4.5 Hz, 2H), 1.99 (dt, J = 2.5, 4.5 Hz, 2H), 1.55 (m, J = 6.0 Hz, 2H), 
1.41 (m, 2H), 1.33 (qn, J = 6.5 Hz, 2H), 1.21 (m, 2H);  IR (neat film) νmax 2917, 
2851, 2214, 1150, 1116, 1043 cm-1; HRMS (CI+) m/z [M+H+] calcd C14H20D7O2 
234.2445, found 234.2445. 
 
 
1-(Methoxymethoxy)dodecane-16,16,17,17,18,18,18-d7 (67). A round-bottom 
flask was charged with RhCl(PPh3)3 (0.214 g, 0.23 mmol) and dry benzene (18 
mL) under an inert atmosphere.  The stirring mixture was exposed to D2 
atmosphere provided by a balloon, producing a red solution, to which 66 (0.900 
g, 3.86 mmol) was added in 2 mL of benzene and allowed to stir for 18 h at rt 
(68).  Benzene was evaporated from the reaction mixture, and the residue was 
redissolved in hexane and passed through a sintered glass funnel packed with 
Celite, and concentrated under reduced pressure by a rotary evaporator.  The 
material was resubjected to a second reduction of 3 h succeeding the first 
workup, at which time GC analysis confirmed complete reduction of the 
acetylene.  The crude product was purified by silica gel column chromatography 
(hexane-EtOAc gradient, 0-3% EtOAc) to afford 67 as a clear oil (0.820 g, 92% 
yield). 
 
 
 
Dodecan-1-ol-16,16,17,17,18,18,18-d7 (68).  The methoxymethane-protected 67 
(0.820 g, 3.46 mmol) was solvated with 2% HCl (12 M) in methanol (50 mL) in a 
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round-bottom flask equipped with a condenser, and heated to 62 °C for 45 min 
(57), at which time HCl was quenched with sat. NaHCO3, and the primary alcohol 
product was extracted 3x with hexane and dried with MgSO4.  The crude mixture 
of 68 (0.671 g, 100% yield) was used in the next step without further preparation. 
1H NMR (500 MHz, CDCl3) δ 3.59 (t, J = 7.0 Hz, 2H), 1.48 (m, 8H), 1.25 (m, 8H); 
IR (neat film) νmax 2920, 2851, 1651, 1559, 660 cm-1; HRMS (CI+) m/z 
[(M+CH3CN) H+] calcd C14H23D7NO2 235.2761, found 235.2759. 
 
 
 
Bromododecan-1-ol-16,16,17,17,18,18,18-d7 (69).  PPh3 (1.878 g, 7.16 mmol) 
and dry DCM (18 mL) were combined in a round-bottom flask at 0 °C.  Bromine 
(0.173 mL, 6.82 mmol) was added dropwise to the stirring mixture.  The resulting 
cloudy, light-yellow solution stirred at 0 °C for 30 min, at which time the ice bath 
was removed and 68 (0.660 g, 3.41 mmol) was added in DCM (2 mL).  The clear 
solution stirred for 2 h at rt.  The DCM was evaporated and the residue was 
redissolved in hexane, passed through a sintered glass funnel packed with 
Celite, and then concentrated under reduced pressure by a rotary evaporator.  
The product was isolated by silica gel column chromatography (hexane-EtOAc 
gradient, 0-1% EtOAc) to afford 69 as a clear, light oil (0.815 g, 93% yield).  1H 
NMR (500 MHz, CDCl3) δ 3.43 (t, J = 7.0 Hz, 2H), 1.90 (qn, J = 7.5 Hz, 2H), 1.45 
(m, 2H), 1.28 (s, 10H); 13C NMR (125 MHz, CDCl3) δ 34.08, 32.86, 29.64, 29.58, 
29.56, 29.45, 29.11, 28.79, 28.20. 
 
 
 
1-(Methoxymethoxy)octadec-5-yne-16,16,17,17,18,18,18-d7 (70).  Alkyne 65 
(0.370 g, 2.60 mmol), HMPA (0.679 mL, 3.12 mmol) and dry THF (20 mL) were 
combined in a round-bottom flask and cooled to -78 °C.  n-Butyllithium (1.256 
mL, 2.485 M in hexanes, 3.12 mmol) was added dropwise over 10 min and the 
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solution was then stirred for 30 min at -78 °C.  The cold bath was removed and 
69 (0.800, 3.12 mmol), and NaI (0.047 g, 0.31 mmol) were added.  The light 
yellow mixture was then refluxed for 18 h, resulting in a dark yellow solution.  The 
reaction was quenched with sat. NH4Cl (~75 mL) and allowed to stir for 5 min.  
The mixture was extracted 3x with Et2O, dried with MgSO4 and the solvent 
removed with the aid of a rotary evaporator.  The yellow crude product was 
purified by silica gel column chromatography (hexane-EtOAc gradient, 0-4% 
EtOAc) to afford 70 as a clear oil (0.670 g, 67% yield).  1H NMR (500 MHz, 
CDCl3) δ 4.55 (s, 2H), 3.47 (t, J = 7.0 Hz, 2H), 3.29 (s, 3H), 2.13 (dt, J = 2.5, 4.5 
Hz, 2H), 2.06 (dt, J = 2.5, 4.5 Hz, 2H), 1.63 (qn, J = 7.5 Hz, 2H), 1.50 (qn, J = 7.5 
Hz, 2H), 1.38 (qn, J = 7.5 Hz, 2H), 1.18 (s, 14H); 13C NMR (125 MHz, CDCl3) δ 
96.39, 80.67, 79.66, 67.32, 55.12, 29.70, 29.65, 29.62, 29.57, 29.18, 29.16, 
29.13, 28.90, 28.88, 25.83, 18.76, 18.56; IR (neat film) νmax 2925, 2854, 1648, 
1556, 1451, 1149, 1113, 1044, 932 cm-1; HRMS (CI+) m/z [M+H+] calcd 
C20H32D7O2 318.3384, found 318.3383. 
 
(Z)-1-(Methoxymethoxy)octadec-5-ene-16,16,17,17,18,18,18-d7 (71). A round-
bottom flask was charged with Pd on CaCO3 (0.279 g, 2.57 mmol, 3.5% Pb, 
5.0% Pd), quinoline (0.073 mL, 0.62 mmol), 70 (0.660 g, 2.06 mmol) and 
absolute ethanol (12 mL).  The mixture was exposed to H2 atmosphere provided 
by a balloon for 1 h, at which time GC analysis confirmed reduction of the 
acetylenes (56).  The reaction mixture was passed through a sintered glass 
funnel packed with Celite to remove Pd, washed copiously with Et2O, and 
concentrated under reduced pressure by a rotary evaporator.  The residue was 
subjected to silica gel column chromatography (hexane-EtOAc gradient, 0-5% 
EtOAc) to remove quinoline, obtaining 0.570 g (85%) as a clear oil.  1H NMR 
(500 MHz, CDCl3) δ 5.30 (m, 2H), 4.55 (s, 2H), 3.46 (t, J = 7.0 Hz, 2H), 3.29 (s, 
3H), 1.95 (m, 4H), 1.50 (qn, J = 7.5 Hz, 2H), 1.35 (qn, J = 7.5 Hz, 2H), 1.18 (s, 
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16H); 13C NMR (125 MHz, CDCl3) δ 130.40, 129.42, 96.37, 67.77, 55.18, 32.60, 
32.37, 29.76, 29.72, 29.66, 29.62, 29.54, 29.35, 29.20, 29.12, 27.24, 26.94, 
26.37, 26.20; IR (neat film) νmax 2924, 2854, 1647, 1553, 1458, 1147, 1112, 
1045, 922 cm-1; HRMS (CI+) m/z [M+H+] calcd C20H34D7O2 320.3540, found 
320.3536. 
 
(Z)-Octadec-5-en-1-ol-16,16,17,17,18,18,18-d7 (72).  The methoxymethyl-
derivative 71 (0.570 g, 1.77 mmol) was dissolved in 2% HCl (12 M) in methanol 
(40 mL) in a round-bottom flask equipped with a condenser, and heated to 62 °C 
for 45 min (57), at which time HCl was quenched with sat. aqueous NaHCO3, and 
the primary alcohol product was extracted 3x with hexane and dried with MgSO4.  
The crude mixture of 72 (0.465 g, 95% yield) was used in the next step without 
further preparation. 
 
(Z)-Octadec-5-enal-16,16,17,17,18,18,18-d7 (73).  To a mixture of 72 (0.465 g, 
1.700 mmol) and DCM (20 mL) at 0 °C was added Dess-Martin periodinane 
(1.006 g, 2.38 mmol).  The ice bath was removed and the translucent clear 
solution stirred for 2 h, at which time cold pentane (50 mL) was added and stirred 
for 10 min to precipitate DMP species.  After filtration through a sintered glass 
funnel packed with Celite, the eluent was washed with saturated 
NaHCO3/Na2S2O3 (1:1) (69).  The organics were dried with MgSO4 and 
concentrated under reduced pressure by a rotary evaporator.  The crude 
aldehyde (0.460 g, 97% yield) was taken to the next step without further 
preparation. 
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 (Z)-Octadec-5-enoic acid-16,16,17,17,18,18,18-d7 (74).  The aldehyde 73 
(0.460 g, 1.70 mmol) and DMSO (12 mL) were combined in a round-bottom flask 
to which NaH2PO4 (0.486 g, 3.50 mmol) was slowly added in H2O (2.0 mL, 
exothermic).  Once the solution had cooled to room temperature, NaClO2 (0.798 
g, 8.50 mmol) was added dropwise over 5 min in H2O (2.0 mL).  The resulting 
yellow solution was stirred under an inert atmosphere for 4 h (58).  To isolate the 
product, the reaction mixture was poured into ice-cold HCl (10%), extracted 4x 
with hexane, and dried with MgSO4.  After rotary evaporation of the organic 
phase, the yellow residue was purified by silica gel column chromatography 
(hexane-EtOAc gradient with 0.1% acetic acid, 0-5% EtOAc) to elute a yellow oil 
containing the Z isomer of 74 (0.175 g, 37% yield*).  1H NMR (500 MHz, CDCl3) 
δ 5.40 (m, 1H), 5.30 (m, 1H), 2.35 (t, J = 7.5 Hz, 2H), 2.09 (q, J = 7.0 Hz, 2H), 
2.00 (q, J = 7.0 Hz, 2H), 1.69 (qn, J = 7.5 Hz, 2H) 1.24 (s, 16H);  13C NMR (125 
MHz, CDCl3) δ 179.23, 131.40, 128.11, 33.27, 29.71, 29.69, 29.66, 29.63, 29.62, 
29.57, 29.33, 29.13, 27.25, 26.43, 24.62; IR (neat film) νmax 3004, 2925, 2854, 
2675, 2215, 1711, 1458, 1413, 1288, 1236, 938 cm-1; HRMS (ESI-) m/z [M-H+] 
calcd C18H26D7O2 288.2925, found 288.2921. 
 
*An approximate 1:2 mixture of cis and trans products was observed following Lindlar catalyst 
reduction step.  Separation of 74 from (E)-octadec-5-enoic acid-16,16,17,17,18,18,18-d7 was 
required on a 5% AgNO3 silica chromatotron plate.   
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5.3.4. Synthesis of octadec-11-enoic acid-16,16,17,17,18,18,18-d7 (81) 
 
 
1-Bromo-10-(methoxymethoxy)decane (75).  10-Bromodecan-1-ol (5.000 g, 
21.00 mmol) was dissolved in dimethoxymethane (35 mL), to which para-
toluenesulfonic acid (0.365 g, 2.00 mmol) and lithium bromide (0.398 g, 5.00 
mmol) were added, and the resulting white solution was allowed to stir at rt for 18 
h under argon (57).  The reaction mixture was washed with sat. aq. NaHCO3, and 
the organics dried with MgSO4.  Concentration of the organic phase with a rotary 
evaporator yielded 75 as a clear oil (5.500 g, 93%). 
 
12-(Methoxymethoxy)dodec-1-yne (76).  TMS-acetylene (1.571 g, 16.00 
mmol), HMPA (2.784 mL, 16.00 mmol) and dry THF (40 mL) were combined in a 
round-bottom flask and cooled to -78 °C.  n-Butyllithium (7.725 mL, 2.485 M in 
hexanes, 19.20 mmol) was added dropwise over 10 min and the solution was 
then stirred for 30 min at -78 °C.  The cold bath was removed and 75 (3.000, 
10.67 mmol), and NaI (0.160 g, 1.07 mmol) were added.  The light yellow mixture 
was then refluxed for 18 h, resulting in a dark yellow solution.  The reaction was 
quenched with sat. NH4Cl (~75 mL) and allowed to stir for 5 min.  The mixture 
was extracted 3x with Et2O, dried with MgSO4 and the solvent removed with the 
aid of a rotary evaporator.  The yellow crude product was purified by silica gel 
column chromatography (hexane-EtOAc gradient, 0-5% EtOAc) to afford the 
TMS derivative of 76 as a light yellow oil (0.920 g, 38% yield*).  The TMS product 
(0.920 g, 3.09 mmol) was transferred to a round-bottom flask in THF (20 mL) and 
deprotected by stirring with TBAF (6.170 mL, 1.0 M in THF, 6.17 mmol) for 2 h at 
room temperature.  The reaction was quenched with sat. NH4Cl (~50 mL) and 
allowed to stir for 5 min.  The mixture was extracted 3x with Et2O, dried with 
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MgSO4 and the solvent removed with the aid of a rotary evaporator, to yield 76 
(0.625 g, 90%) as a clear oil.  1H NMR (500 MHz, CDCl3) 4.61 (s, 2H), 3.51 (t, J 
= 7.0 Hz, 2H), 3.35 (s, 3H), 2.38 (t, J = 6.5 Hz, 2H) 2.17 (dt, J = 6.5 Hz, 4H), 1.94 
(t, J = 3.0 Hz, 1H), 1.53 (m, 4H), 1.26 (s, 8H); 13C NMR (125 MHz, CDCl3) δ 
96.39, 84.80, 68.04, 67.88, 55.09, 53.87, 29.74, 29.52, 29.41, 29.08, 28.74, 
26.20, 20.81, 18.39. 
 
*Low yield was due to a flask that imploded under vacuum, resulting in significant product loss. 
 
 
1-(Methoxymethoxy)octadec-11-yne-16,16,17,17,18,18,18-d7 (77).  Alkyne 76 
(0.548 g, 2.42 mmol), HMPA (0.632 mL, 3.63 mmol) and dry THF (20 mL) were 
combined in a round-bottom flask and cooled to -78 qC.  n-Butyllithium (1.169 
mL, 2.485 M in hexanes, 2.90 mmol) was added dropwise over 10 min and the 
solution was then stirred for 30 min at -78 qC.  The cold bath was removed and 
bromohexane-4,4,5,5,6,6,6-d7 (0.500 g, 2.90 mmol), and NaI (0.036 g, 0.24 
mmol) were added.  The light yellow mixture was then refluxed for 18 h, resulting 
in a dark yellow solution.  The reaction was quenched with sat. NH4Cl (~55 mL) 
and allowed to stir for 5 min.  The mixture was extracted 3x with Et2O, dried with 
MgSO4 and the solvent removed with the aid of a rotary evaporator.  The yellow 
crude product was purified by silica gel column chromatography (hexane-EtOAc 
gradient, 0-5% EtOAc) to afford 77 as a light yellow oil (0.585 g, 76% yield).   
(Z)-1-(Methoxymethoxy)octadec-11-ene-16,16,17,17,18,18,18-d7 (78). A round 
bottom flask was charged with Pd on CaCO3 (0.237 g, 1.812 mmol, 3.5% Pb, 
5.0% Pd), quinoline (0.062 mL, 0.52 mmol), 77 (0.570 g, 1.79 mmol) and 
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absolute ethanol (10 mL).  The mixture was exposed to H2 atmosphere provided 
by a balloon for 1 h, at which time GC analysis confirmed reduction of the 
acetylenes (56).  The reaction mixture was passed through a sintered glass 
funnel packed with Celite to remove Pd, washed copiously with Et2O, and 
concentrated under reduced pressure by a rotary evaporator.  The residue was 
subjected to silica gel column chromatography (hexane-EtOAc gradient, 0-2% 
EtOAc) to remove quinoline, obtaining 0.575 g (99%) as a clear oil.  1H NMR 
(500 MHz, CDCl3) δ 5.32 (m, 2H), 4.57 (s, 2H), 3.47 (t, J = 7.0 Hz, 2H), 3.29 (s, 
3H), 1.94 (q, J = 6.5 Hz, 4H), 1.50 (qn, J = 7.5 Hz, 2H), 1.23 (s, 18H); 13C NMR 
(125 MHz, CDCl3) δ 129.95, 129.89, 96.38, 67.91, 55.11, 29.78, 29.76, 29.71, 
29.61, 29.58, 29.54, 29.46, 29.31, 28.77, 27.25, 27.21, 26.22; IR (neat film) νmax 
2924, 2854, 1653, 1559, 1540, 1457, 1150, 1112, 1046, 919 cm-1; HRMS (CI+) 
m/z [M+H+] calcd C20H34D7O2 320.3540, found 320.3541. 
 
(Z)-Octadec-11-en-1-ol-16,16,17,17,18,18,18-d7 (79).  The protected alcohol 78 
(0.570 g, 1.79 mmol) was dissolved in 2% HCl (12 M) in methanol (40 mL) in a 
round-bottom flask equipped with a condenser, and heated to 62 °C for 45 min 
(57), at which time HCl was quenched with sat. NaHCO3, and the primary alcohol 
product was extracted 3x with hexane and dried with MgSO4.  The crude mixture 
of 79 (0.460 g, 94% yield) was used in the next step without further preparation. 
(Z)-Octadec-11-enal-16,16,17,17,18,18,18-d7 (80).  To a mixture of 79 (0.455 g, 
1.64 mmol) and DCM (20 mL) at 0 °C was added Dess-Martin periodinane (0.975 
g, 2.30 mmol).  The ice bath was removed and the translucent clear solution 
stirred for 2 h, at which time cold pentane (50 mL) was added and stirred for 10 
min to precipitate DMP-derived side products.  After filtration through a sintered 
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glass funnel packed with Celite, the eluent was washed with saturated 
NaHCO3/Na2S2O3 (1:1) (69).  The organics were dried with MgSO4 and 
concentrated under reduced pressure by a rotary evaporator.  The crude 
aldehyde (0.438 g, 97% yield) was taken to the next step without further 
preparation. 
(Z)-Octadec-11-enoic acid-16,16,17,17,18,18,18-d7 (81).  The aldehyde 80 
(0.438 g, 1.62 mmol) and DMSO (12 mL) were combined in a round-bottom flask 
to which NaH2PO4 (0.388 g, 3.23 mmol) was slowly added in H2O (2.0 mL, 
exothermic).  Once the solution had cooled to room temperature, NaClO2 (0.731 
g, 8.08 mmol) was added dropwise over 5 min in H2O (2.0 mL).  The resulting 
yellow solution was stirred under an inert atmosphere for 4 h (58).  To isolate the 
product, the reaction mixture was poured into ice-cold HCl (10%), extracted 4x 
with hexane, and dried with MgSO4.  After rotary evaporation of the organic 
phase, the yellow residue was purified by silica gel column chromatography 
(hexane-EtOAc gradient with 0.1% acetic acid, 0-5% EtOAc) to elute the yellow 
oil 81 (0.405 g, 87% yield).  1H NMR (500 MHz, CDCl3) δ 5.28 (m, 2H), 2.28 (t, J 
= 7.0 Hz, 2H), 1.94 (q, J = 7.0 Hz, 4H), 1.58 (qn, J = 7.0 Hz, 2H) 1.24 (s, 16H);  
13C NMR (125 MHz, CDCl3) δ 178.30, 128.93, 128.82, 32.91, 28.73, 28.68, 
28.45, 28.38, 28.24, 28.21, 28.04, 27.73, 26.21, 26.17, 23.66; IR (neat film) νmax 
3005, 2924, 2854, 2675, 2215, 1713, 1458, 1442, 1288, 1237, 937, 722 cm-1; 
HRMS (ESI-) m/z [M-H+] calcd C18H26D7O2 288.2925, found 288.2928. 
5.4. Synthesis of 2H-labeled fatty acid stereoisomers 
This discussion pertains to the generation of two specialized fatty acid 
isomers with deuterium substitutions at the 17 and 18 position carbons: 18:29c,15c 
and 18:29c,15t.  The production of these compounds built upon the synthetic 
scheme created to produce the FA standards that were used to develop the FA 
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profile of D. discoideum.  These compounds were produced through a 
collaboration effort with Dr. Robert Minto in the Department of Chemistry and 
Chemical Biology at IUPUI.  His group transformed a ∆12 desaturase found in 
Phanerochaete chrysosporium into S. cerevisiae for the purpose of determining 
the catalytic potential of the enzyme.  These two compounds were used to 
elucidate the enzyme’s specificity for the cis or trans substrate (at carbon 15).  
While this synthetic strategy did not directly impact the research discussed in this 
manuscript, it does however provide the opportunity to discuss a unique and 
effective method of making cis/trans fatty acids, and it was this approach that 
inspired the synthetic scheme for making the deuterium labeled FAs used during 
in vivo studies of D. discoideum.   
This synthesis began as previously discussed, with the preparation of a 
dioxolane-protected alkyl halide designed to be the electrophile for n-butyllithium 
assisted coupling to a diacetylene.  This diacetylene 41 was then taken in two 
paths to afford the two isomers: the first, more straightforward pathway was that 
of producing 18:29c,15c.  This was first illustrated in the step to make Compound 
43, whereas a second n-BuLi reaction used ethyl bromide-d5 as the alkyl halide, 
inserting five deuterium to assemble the 18-carbon chain.  Upon purification, 43 
was equipped for metal-catalyzed hydrogenation with Lindlar’s Catalyst, followed 
by deprotection and oxidation under the conditions discussed in Sections 5.2. 
and 5.3., to afford the dicis carboxylic acid 18:29,15.  Its stereochemical 
counterpart, 18:29c,15t, was not so easily obtained.   
142 
 
 
 
Figure 77. The abbreviated synthesis of 18:29c,15c and 18:29c,15t. 
 The strategy to generate a trans double bond at the 15 position was 
achieved via the hydroboration of 41.  Pereira and Srebnik42 showed that a 
terminal alkyne such as this could be hydroborated with pinacolborane in the 
presence of a catalytic amount of zirconocene chloride hydride (HZrCp2Cl), also 
known as Schwartz’ Reagent (93).  This chemistry allowed for the formation of 
the boronic ester 59, as the desired (E)-alkene.  The rationale in using such a 
reaction to attain the necessary stereochemistry was that the resulting 
organoborane would be a prime candidate for a Suzuki-style reaction with 
bromoethane-d5 to complete the alkyl chain. 
 While the traditional palladium-catalyzed Suzuki Coupling was first 
published as a cross coupling between organoboronic acid and aryl halides, the 
number of catalysts and reaction partners has since increased tremendously.  
Once such iteration of the reaction was defined by Gregory Fu et al. (94), which 
detailed the coupling of alkyl bromides to boronic acids at room temperature.  
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They developed the trialkylphosphine catalyst [HP(t-Bu)2Me]BF4], which 
successfully activates Pd(0) for oxidative addition with alkyl halides.  Upon 
refluxing the boronic ester in sodium periodate and ammonium acetate to 
generate the boronic acid necessary for this coupling (95), the anticipated 
product 61 was obtained in greater than 90% yield.  The remaining internal 
acetylene was reduced with Lindlar’s Catalyst, and the dioxolane was 
deprotected, then oxidized as discussed previously to afford the 18:29c,15t d5-
labeled fatty acid (64). 
 
Synthesis and spectral data 
 
8-Bromooctanal (38).  Methyl 8-bromooctanoate (5.000 g, 21.1 mmol) was 
dissolved in DCM (38 mL) and cooled to -78 °C under argon, to which 
diisobutylaluminum hydride (21.1 mL, 1.0 M solution in hexanes, 21.1 mmol) was 
added by syringe pump at 1 mL/min.  A slow rate of addition is required to 
reproduce the reported yield.  The clear solution stirred at -78 °C for 1 h, then 
allowed to warm to -60 °C for 1 h.  HCl (20 mL, 10%) was added at 0 °C and gray 
precipitate swiftly formed.  After 1 h stirring, the product was extracted 3x with 
DCM, and organic extracts were washed with water and brine, then dried with 
MgSO4.  Evaporation under reduced pressure resulted in product 38 as a light 
yellow oil (4.225 g, 97%).  The aldehyde, whose NMR was consistent with 
literature data (54), was used in the preparation of 39 without further purification. 
 
 
2-(7-Bromoheptyl)-1,3-dioxolane (39).  In a round-bottom flask, the crude 
residue of 38 (4.225 g, 20.4 mmol) was resuspended with stirring in benzene (80 
mL), and ethylene glycol (10.6 mL, 153.0 mmol) and para-toluenesulfonic acid 
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(0.155 g, 0.82 mmol) were added under argon.  After attaching a Dean-Stark 
apparatus filled with 3Ǻ molecular sieves to the flask, the heterogeneous mixture 
was refluxed for 3 h.  NaHCO3 (1.35 g, 16.2 mmol) was introduced and the 
reaction mixture was stirred for 10 min prior to being washed 2x with sat. aq. 
NaHCO3, and dried with MgSO4.  Concentration of the organic phase with a 
rotary evaporator yielded 39 as a light yellow oil (5.100 g, 100%). The dioxolane, 
whose NMR was consistent with literature data (54), was used in the preparation 
of 40 without further purification. 
 
 
2-(2-Iodoethyl)-1,3-dioxolane (40).  To a stirred solution of the crude bromide 
39 (5.10 g, 20.3 mmol) in HPLC-grade acetone (21 mL) was added sodium 
iodide (3.81 g, 25.4 mmol).  The solution was heated to reflux under an inert 
atmosphere for 3 h.  The mixture was allowed to cool then deionized water (25 
mL) was added and the reaction mixture was stirred for 10 min.  After passing 
the acetone solution through a sintered glass funnel packed with Celite, the 
filtrate was extracted 3x with DCM and dried with MgSO4.  Upon concentration 
under reduced pressure yellow product 40 (5.703 g, 94%) was obtained, which 
was stabilized by storing over K2CO3. The iodide, whose NMR was consistent 
with literature data (92), was used in the preparation of acetylenic derivatives 
without further purification. 
 
 
2-(Pentadeca-8,14-diyn-1-yl)-1,3-dioxolane (41). 1,8-Octadiyne (1.062 g, 10.0 
mmol), HMPA (2.60 mL, 15.0 mmol) and dry THF (50 mL) were combined in a 
round-bottom flask that was then cooled to -78 °C in a dry-ice acetone bath.  n-
Butyllithium (4.84 mL, 2.48 M in hexanes, 12.0 mmol) was added dropwise over 
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10 min and the reaction mixture was stirred for 30 min at -78 °C.  The cooling 
bath was removed and 40 (1.997 g, 8.25 mmol) was added in THF (2 mL).  The 
light yellow mixture was then refluxed for 18 h, producing a dark yellow solution.  
Sat. NH4Cl (~75 mL) was added to the round bottom flask and the mixture was 
stirred for 5 min and then extracted 3x with Et2O, dried with MgSO4 and the 
solvent evaporated with the use of a rotary evaporator.  The yellow residue was 
separated by silica gel column chromatography (hexane-EtOAc gradient, 0-5% 
EtOAc) to afford alkyne 41 as a yellow oil (0.967 g 52.1% yield).  1H NMR (500 
MHz, CDCl3) δ 4.88 (t, J = 4.8 Hz, 1H), 3.99 (m, 2H), 3.87 (m, 2H), 2.25 (m, 4H), 
2.16 (m, 2H), 1.98 (t, J = 2.7 Hz, 1H), 1.70-1.58 (m, 6H) 1.49-1.34 (m, 10H); 13C 
NMR (125 MHz, CDCl3) δ 104.67, 84.30, 80.63, 79.53, 68.35, 64.83 (2C), 33.89, 
29.44, 29.07, 29.05, 28.73, 28.05, 27.53, 24.04, 18.74, 18.30, 18.01; IR (neat 
film) νmax 3291, 2932, 2858, 2117, 1461, 1434, 1410, 1140, 1037, 943 cm-1;  
HRMS (CI) m/z [M+H+] calcd C18H29O2 277.2162, found 277.2149. 
 
2-(Heptadeca-8,14-diyn-1-yl)-1,3-dioxolane-d5 (43).  Alkyne 41 (0.175 g, 0.633 
mmol), HMPA (0.165 mL, 0.950 mmol) and dry THF (10 mL) were combined in a 
round-bottom flask and cooled to -78 °C.  n-Butyllithium (0.322 mL, 2.354 M in 
hexanes, 0.760 mmol) was added dropwise over 10 min and the solution was 
then stirred for 30 min at -78 °C.  The cold bath was removed and ethyl bromide-
d5 (0.056 mL, 0.760 mmol), and NaI (0.010 g, 0.063 mmol) were added.  The 
light yellow mixture was then refluxed for 18 h, resulting in a dark yellow solution.  
The reaction was quenched with sat. NH4Cl (~25 mL) and allowed to stir for 5 
min.  The mixture was extracted 3x with Et2O, dried with MgSO4 and the solvent 
removed with the aid of a rotary evaporator.  The yellow crude product was 
purified by silica gel column chromatography (hexane-EtOAc gradient, 0-5% 
EtOAc) to afford 43 as a yellow oil (0.170 g, 87% yield).  1H NMR (500 MHz, 
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CDCl3) δ 4.87 (t, J = 4.8 Hz, 1H), 3.99 (m, 2H), 3.87 (m, 2H), 2.19 (m, 6H), 1.67 
(m, 2H), 1.60 (m, 4H), 1.42 (m, 10H); 13C NMR (125 MHz, CDCl3) δ 104.69, 
80.46 (2C), 79.80, 79.13, 64.84 (2C), 33.90, 29.44, 29.11 (2C), 29.06, 28.75, 
28.26 (2C), 24.06, 18.74 (2C), 18.35, 18.31; IR (neat film) νmax 2932, 2858, 2231, 
1457, 1140, 1037 cm-1; HRMS (ESI+) m/z [M+H+] calcd C20H28D5O2 310.2789, 
found 310.2790. 
 
2-((8Z,14Z)-Heptadeca-8,14-dien-1-yl)-1,3-dioxolane-d5 (56). A round bottom 
flask was charged with Pd on CaCO3 (0.083 g, 0.777 mmol, 3.5% Pb, 5.0% Pd), 
quinoline (0.020 mL, 0.161 mmol), 43 (0.200 g, 0.646 mmol) and absolute 
ethanol (3.0 mL).  The mixture was exposed to H2 atmosphere provided by a 
balloon for 1 h, at which time GC analysis confirmed reduction of the acetylenes 
(56).  The reaction mixture was passed through a sintered glass funnel packed 
with Celite to remove Pd, washed copiously with Et2O, and concentrated under 
reduced pressure by a rotary evaporator.  The residue was subjected to silica gel 
column chromatography (hexane-EtOAc gradient, 0-5% EtOAc) to remove 
quinoline, obtaining 0.200 g (99%) as a clear oil.  1H NMR (500 MHz, CDCl3) δ 
5.37 (m, 4H), 4.88 (t, J = 4.8 Hz, 1H), 3.99 (m, 2H), 3.87 (m, 2H), 2.05 (m, 6H), 
1.67 (m, 2H), 1.44-1.21 (m, 14H); 13C NMR (125 MHz, CDCl3) δ 131.54, 130.04, 
129.73, 129.25, 104.77, 64.89 (2C), 33.90, 29.76, 29.55, 29.46 (2C), 29.40, 
29.35, 29.23 (2C), 27.20, 27.10, 26.99, 24.10; IR (neat film) νmax 2926, 2855, 
1734, 1457, 1141 cm-1; HRMS (CI) m/z [M+H+] calcd C20H32D5O2 314.3102, 
found 314.3117. 
 
 
147 
 
 
 
(Z,Z)-Octadeca-9,15-dienal-d5 (57).  The dioxolane 56 (0.200 g, 0.646 mmol) 
was combined with pTsOH (0.019 g, 0.100 mmol), acetone (6.5 mL) and H2O 
(1.0 mL) in a round-bottom flask equipped with a condenser, and heated to reflux 
(57).  After reacting for 3 h, acetone was evaporated, pTsOH was quenched with 
sat. NaHCO3, and the aldehyde product was extracted 3x with DCM and dried 
with MgSO4.  The crude mixture of 57 (0.162 g, 94% yield) was used in the next 
step without further preparation. 
 
(Z,Z)-Octadeca-9,15-dienoic acid-d5 (58).  The aldehyde 57 (0.160 g, 0.592 
mmol) and DMSO (3.5 mL) were combined in a round-bottom flask to which 
NaH2PO4 (0.163 g, 1.184 mmol) was slowly added in H2O (2.5 mL, exothermic).  
Once the solution had cooled to room temperature, NaClO2 (0.267 g, 2.960 
mmol) was added dropwise over 5 min in H2O (1.0 mL).  The resulting yellow 
solution was stirred under an inert atmosphere for 4 h (58).  To isolate the 
product, the reaction mixture was poured into ice-cold HCl (10%), extracted 4x 
with hexane, and dried with MgSO4.  After rotary evaporation of the organic 
phase, the yellow residue was purified by silica gel column chromatography 
(hexane-EtOAc gradient with 0.1% acetic acid, 0-5% EtOAc) to elute the clear oil 
58 (0.145 g, 86% yield).  1H NMR (500 MHz, CDCl3) δ 5.37 (m, 4H), 2.38 (t, J = 
7.5 Hz, 2H), 2.04 (m, 6H), 1.67 (quint, J = 7.5 Hz, 2H), 1.34 (m, 12H).  13C NMR 
(125 MHz, CDCl3) δ 179.30, 131.53, 129.86, 129.83, 129.20, 33.90, 29.67, 
29.39, 29.35, 29.25, 29.14, 29.07 (2C), 29.03, 27.17, 27.10, 26.98, 24.67.  IR 
(neat film) νmax 3004, 2926, 2854, 2222, 1710 cm-1; HRMS (ESI-) m/z [M-H+] 
calcd C18H26D5O2 284.2643, found 284.2641.  
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(E)-2-(15-(1,3-Dioxolan-2-yl)pentadec-1-en-7-yn-1-yl)-4,4,5,5-tetramethyl-1,3-
dioxa-2-borolane (59).  The diacetylene 41 (0.150 g, 0.540 mmol) and DCM (0.5 
mL) were combined in a conical vial and cooled to 0 °C.  Pinacolborane (0.084 
mL, 0.600 mmol) was added dropwise and stirred for 1 min, then the mixture was 
transferred to a second vacuum purged conical vial at 0 °C containing Schwartz 
reagent (HZrCp2Cl) (0.280 g, 0.108 mmol).  The heterogeneous mixture was 
allowed to assume room temperature, at which time the catalyst dissolved to 
form a clear yellow solution, then was allowed to stir for 16 h.  The mixture was 
transferred to H2O (5 mL) and extracted 3x with DCM, dried with MgSO4 and 
solvents were removed by rotary evaporation (93).  The yellow residue was 
purified by silica gel column chromatography (hexane-EtOAc gradient, 0-4% 
EtOAc) affording a clear oil 59 (0.133 g, 60% yield).  1H NMR (500 MHz, CDCl3) 
δ 6.44 (dt, J = 6.4, 5.0 Hz, 1H), 5.47 (dt, J = 16.4, 1.5 Hz, 1H), 4.87 (t, J = 4.8 Hz, 
1H), 3.99 (m, 2H), 3.869 (m, 2H), 2.17 (m, 6H), 1.68 (m, 2H), 1.52-1.35 (m, 17H), 
1.29 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 154.28, 118.10*, 104.70, 83.00 (2C), 
80.39, 79.89, 64.83 (2C), 35.27, 33.90, 29.44, 29.13, 29.06, 28.76, 28.61, 27.38, 
24.78 (4C), 24.06, 18.74, 18.61; IR (neat film) νmax 3448, 2974, 2931, 2858, 
1739, 1639, 1482, 1398, 1362, 1320, 1146, 971, 850 cm-1; HRMS (ESI+) m/z 
[M+NH4+] calcd C24H45BNO4  421.3472, found 421.3474. 
 
*118.10 not discernible in 13C spectrum, located by HSQC. 
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(E)-(15-(1,3-Dioxolan-2-yl)pentadec-1-en-7-yn-1-yl)boronic acid (60). The 
pinacolborane derivative 59 (0.250 g, 0.620 mmol), NaIO4 (0.796 g, 3.720 mmol), 
NH4OAc (0.287 g, 3.720 mmol), acetone (37 mL), and H2O (18.5 mL) were 
combined in a round-bottom flask and warmed to 50 °C for 18 h (95).  
Subsequently, the acetone was removed by evaporation and the mixture was 
extracted 3x with Et2O.  Cold 1N HCl washes (3x) removed a set of alkene 
signals in 1H NMR likely due to the acetate derivative of boronic acid prior to 
drying with MgSO4 and removal of the solvent with a rotary evaporator.  The 
crude product 60 was obtained as a yellow oil (0.195 g, 98% yield) and taken 
forward without further purification.   
 
 
(E)-2-(Heptadec-14-en-8-yn-1-yl)-1,3-dioxolane-d5 (61).  The crude mixture 60 
(0.095 g, 0.295 mmol) was combined with Pd(OAc)2 (0.010 g, 0.045 mmol), 
[HP(t-Bu)2-Me)-BF4] (0.011 g, 0.045 mmol), and KOt-Bu (0.100 g, 0.885 mmol) in 
a conical vial and purged with three vacuum-argon cycles.  tert-Amyl alcohol (0.5 
mL) and ethyl bromide-d5 (0.027 mL, 0.369 mmol) were added, and the 
heterogeneous mixture stirred at ambient temperature for 24 h.  The brown 
reaction mixture was then passed through a sintered glass funnel containing a 
pad of silica gel, washed copiously with Et2O, and the solvents were evaporated 
under reduced pressure (94).  The product was isolated by silica gel column 
chromatography (hexane-EtOAc gradient, 0-5% EtOAc) as a clear oil 61 (0.084 
g, 92% yield).  1H NMR (500 MHz, CDCl3) δ 5.44 (m, 4H), 4.87 (t, J = 4.8 Hz, 
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1H), 3.99 (m, 2H), 3.87 (m, 2H), 2.16 (dt, J =2.2 Hz, 4H), 2.00 (q, J = 6.7 Hz, 2H), 
1.68 (m, 2H), 1.51-1.35 (m, 12H); 13C NMR (125 MHz, CDCl3) δ 132.08, 128.99, 
104.69, 80.24, 80.14, 64.83 (2C), 33.90, 32.06, 29.45, 29.13 (2C), 29.07 (2C), 
28.81, 28.75, 28.64, 24.06, 18.74, 18.65; IR (neat film) νmax 2999, 2925, 2854, 
2222.5, 1736, 1462, 1258, 1127, 1020, 801 cm-1; HRMS (ESI+) m/z [M+H+] calcd 
C20H30D5O2  312.2945, found 312.2944. 
 
2-((8Z,14E)-Heptadeca-8,14-dien-1-yl)-1,3-dioxolane-d5 (62).  A round-bottom 
flask was charged with Pd on CaCO3 (0.068 g, 0.637 mmol, 3.5% Pb, 5.0% Pd), 
quinoline (0.016 mL, 0.133 mmol), 61 (0.165 g, 0.530 mmol) and absolute 
ethanol (3.5 mL).  The mixture was stirred under 1 atm of H2 provided by a 
balloon for 1 h, at which time GC analysis confirmed reduction of the acetylene 
(56).  The reaction mixture was passed through a sintered-glass funnel packed 
with Celite to remove Pd, washed copiously with Et2O, and concentrated under 
reduced pressure by a rotary evaporator.  The residue was subjected to silica gel 
column chromatography (hexane-EtOAc gradient, 0-5% EtOAc) to remove the 
quinoline, affording 62 as a clear oil (0.150 g, 90% yield).  1H NMR (500 MHz, 
CDCl3) δ 5.42 (m, 4H), 4.87 (t, J = 4.8 Hz, 1H), 3.99 (m, 2H), 3.87 (m, 2H), 2.04 
(m, 6H), 1.67 (m, 2H), 1.46-1.31 (m, 14H); 13C NMR (125 MHz, CDCl3) δ 131.90, 
129.94, 129.81, 129.27, 104.72, 64.84 (2C), 33.92, 32.46, 29.74, 29.54, 29.46 
(2C), 29.26 (2C), 29.20 (2C), 27.20, 27.08, 24.10; IR (neat film) νmax 3003, 2929, 
2852, 1732, 1704, 1458, 1271, 1258, 1189, 1152, 1066 cm-1; HRMS (CI+) m/z 
[M+H+] calcd C20H32D5O2 314.3102, found 314.3095. 
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(9Z,15E)-Octadeca-9,15-dienal-17,17,18,18,18-d5 (63).  Dioxolane 62 (0.145 g, 
0.463 mmol) was combined with p-TsOH (0.013 g, 0.069 mmol), acetone (5.0 
mL), and H2O (0.8 mL) in a round-bottom flask equipped with a condenser and 
the mixture was brought to reflux (57).  After reacting for 3 h, the solvent was 
evaporated, p-TsOH was neutralized with sat. NaHCO3, and the aldehyde 
product was extracted 3x with DCM.  After drying with MgSO4 and evaporation of 
the solvent under reduced pressure, the crude mixture containing 63 (0.120 g, 
96% yield) was taken to the next step without further preparation.   
(9Z,15E)-Octadeca-9,15-dienoic acid-17,17,18,18,18-d5 (64).  Aldehyde 63 
(0.120 g, 0.445 mmol) and DMSO (3.0 mL) were combined in a round-bottom 
flask, to which NaH2PO4 (0.123 g, 0.890 mmol) was slowly added in H2O (1.0 
mL, exothermic).  Once the mixture had returned to room temperature, a solution 
of NaClO2 (0.201 g, 2.23 mmol) in H2O (1.0 mL) was added dropwise over 5 min.  
The resulting yellow solution was stirred under an inert atmosphere for 4 h (58).  
To isolate the product, the reaction mixture was transferred into HCl (10%, cold) 
and extracted 4x with hexane, and dried with MgSO4.  After rotary evaporation of 
the organic phase, the yellow residue was purified by silica gel column 
chromatography (hexane-EtOAc gradient with 0.1% acetic acid, 0-5% EtOAc) to 
elute a clear oil 64 (0.105 g, 83% yield).  1H NMR (500 MHz, CDCl3) δ 10.35 (br, 
1H), 5.39 (m, 4H), 2.38 (t, J = 7.5 Hz, 2H), 2.02 (m, 6H), 1.66 (quint, J = 7.5 Hz, 
2H), 1.34 (m, 12H).  13C NMR (125 MHz, CDCl3) δ 179.82, 131.91, 129.89, 
129.83, 129.24, 34.06, 32.46, 29.68, 29.27, 29.25, 29.15, 29.08, 29.05, 29.00, 
27.23, 27.17, 27.08, 24.70; IR (neat film) νmax 3006, 2926, 2855, 1712, 1462, 
1413, 1285, 966, 910, 735 cm-1; HRMS (ESI-) m/z [M-H+] calcd C18H26D5O2 
284.2643, found 284.2647. 
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APPENDIX 
HL5 media: 1.0 L volume.   
Prepared the following solutions, autoclaved at 15 psi for 20 min and combined: 
o Solution 1: dextrose (14.0 g) in 333 mL of nanopure H2O 
o Solution 2: BD Bacto yeast extract (7.0 g) and Oxoid bacteriological 
peptone (14.0 g) in 333 mL of nanopure H2O 
o Solution 3: buffer-NaH2PO4 (0.520 g) and KH2PO4 (0.520 g) in 333 mL 
of nanopure H2O, adjusted to pH 6.5 with 1.0 N HCl 
Penicillin/streptomycin (pen/strep) antibiotics 
Dissolved penicillin-G potassium (0.300 g) and streptomycin sulfate (0.500 
g) in 50 mL of nanopure H2O and sterile filtered (25 mm/0.2 μm) into a sterile 50-
mL BD Falcon tube.   
 
YPD media: 500 mL volume.   
Dissolved the following components in 500 mL nanopure H2O and 
autoclaved at 15 psi for 20 min: 
o Dextrose: 10.0 g  
o BD Bacto yeast extract: 5.0 g 
o Oxoid bacteriological peptone: 10.0 g 
 
